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GENERAL ABSTRACT 
Demographic attributes of the urban society have prompted a milestone shift towards 
structural aging of global population and increase of life expectancy, crucial to the 
prominence of cancer as one of the non-communicable diseases leading mortality. Currently, 
cancer diseases were accountable for about 9.6 million deaths in 2018, with concerning 
increasing projections of cancer incidence and mortality, by 2030, at a greater proportion in 
developing countries. As a result, there is an increasing trend of production and consumption 
of pharmaceuticals applied in cancer treatments. Once administered and metabolized, such 
drugs are excreted into waterways following to waste water treatment plants (WWTPs), 
ending up in freshwater and coastal ecosystems, where they can be found at a sub ng to ng 
L-1 range. Anticancer drugs are designed to damage DNA and disrupt mechanisms of its 
transcription, replication and synthesis, as well as suppress the cell´s defense, ultimately 
causing cell death. In cancer therapy, drugs are typically administered in a combinatory 
cocktail, that covers different molecular targets, reducing the risk of clonal selection based 
upon cell resistance to a single drug. However, these chemicals may bring potential toxicity 
if discharged into the aquatic environment, both in temperate and tropical zones, particularly 
in the benthic compartment, where they are expected to accumulate. 
In this sense, the present thesis aimed to assess the effects of anticancer agents of 
different classes, namely the cytotoxic platinum-based cisplatin (CisPt), the alkylating agent 
cyclophosphamide (CP) and the endocrine disruptor tamoxifen (TAM), on non-target 
benthic marine species under realistic environmental concentrations, at individual and 
combined exposures. For this purpose, a multi-biomarker approach was applied including 
the assessment of behavioural responses, oxidative stress, biotransformation, neurotoxicity, 
lipid peroxidation and genotoxicity in the temperate polychaete Nereis diversicolor, in 
addition to the evaluation of acute and chronic effects of drugs in tropical and representative 
benthic organisms: the sea urchin Echinometra lucunter, the polychaete Scolelepis squamata 
and the amphipod Tiburonella viscana from the Brazilian coast.  
The main results revealed that single drug exposures caused alteration of AChE 
activity, oxidative stress and oxidative damage and, ultimately, DNA damage in N. 
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diversicolor. Besides, alterations in its burrowing behaviour also occurred, as an ecological 
outcome. These effects were more pronounced in organisms under CisPt at 100 ng Pt L-1, 
CP at 1000 ng L-1 and TAM at 0.5 ng L-1. Findings from bioassays with N. diversicolor 
conducted with drugs in tertiary mixtures indicated that each biomarker effect respond 
differently, according to the trends proposed by models of drugs´s interaction. Toxicity did 
not increase in a dose-response manner but showed different patterns of effects, in a way 
that the highest DNA damage was observed at the set of lowest concentrations (Mixture A), 
an absence of oxidative stress at the intermediary drug levels (Mix B and C), with a potential 
dominance of TAM´s MoA in organisms exposed to Mixture C and D, suggesting an 
antagonist interaction between the cytotoxic drugs. Therefore, the effects ruled by single-
drug MoAs cannot provide estimations and protective measures for a prospective ERA 
regarding scenarios of their combination in the environment. Although evidence on estrogen 
receptors expression is still not disclosed for the herein selected biological models, 
determination of biochemical and genotoxic outcomes from TAM exposure are highlighted, 
since it is assumed to comprise a targeted therapy on nuclear estrogen receptors.  
Anticancer drugs´ concentrations that triggered the above-mentioned responses are 
potentially present in coastal environments, even more prone to be encountered in 
developing regions, where technologies of WWTPs are not efficient or are lacking. 
Accordingly, effects regarding the bioassays conducted with the tropical counterparts 
showed a non-monotonic reduction of viable pluteus larvae of E. lucunter, at CisPt and CP 
treatment respectively at the range from 0.1 to 10 ng Pt L-1, and from 50 to 500 ng CP L-1, 
in contrast to the increasing reduction of embryo larval development under TAM exposure, 
significant over the whole range of concentrations. In polychaetes S. squamata, a significant 
acute toxicity was exerted at the higher pharmaceutical doses (Mix C and D). In the 
amphipod T. viscana demonstrated a higher sensitivity to pharmaceuticals, presenting a 
significant non-linear reduction of survival in Mix B and D, as a potential outstanding effect 
of TAM when present as mixtures. By virtue of the non-monotonicity addressed in the dose-
responses relationships reported in all bioassays, another concern stands out on the urgency 
to the development of a risk analysis and safety assessment designated to anticancer drugs. 
Keywords: Anticancer drugs, cisplatin, cyclophosphamide, tamoxifen, sediment, 
mixture, toxicity, biochemical biomarkers, genotoxicity.   
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RESUMO GERAL 
Atualmente, a dinamica demográfica global demonstra uma excepcionl tendência de 
transição regida pelo envelhecimento populacional e pelo aumento da esperança média de 
vida. Estes fatores, combinados a atributos sociais relacionados aos hábitos modernos e 
exposição a fatores de risco (e.g. dieta inapropriada, tabaco, sedentarismo, consumo de 
álcool, agentes infecciosos), aliados à hereditariedade, contribuem para um significativo 
aumento da incidência dos casos de cancro, classificado como a doença mais preocupante 
do século, após os distúrbios cardiovasculares. Atualmente, o cancro representa 21,7% dos 
casos de morte a nível mundial, com projeções preocupantes para 2030, e maiores 
proporções de incidência em países em desenvolvimento. Dessa forma, estima-se uma 
consequente expansão na necessidade de produção e consumo de medicamentos 
anticancerígenos em todo o mundo, com aumento anual entre 6 – 8% estimado para o ano 
de 2018, comparado com os 6,5% nos últimos 5 anos. 
Após o consumo, via administração oral ou intravenosa, os fármacos 
anticancerígenos são excretados na sua forma parental e metabolizada através de efluentes 
hospitalares e industriais, bem como por descargas de esgotos provenientes de estações de 
tratamento de águas residuais (ETARs), as quais não possuem tecnologia adequada para a 
remoção de moléculas orgânicas complexas. Dessa forma, as águas superficiais e marinhas 
são os destinos finais desses medicamentos. Esta classe terapêutica atua sobre biomoléculas 
e componentes celulares críticos à proliferação celular, tais como DNA, RNA, proteínas, 
membrana fosfolipídica, microfilamentos do citoesqueleto e sinalização celular, a fim de 
causar danos irreversíveis e morte celular. Contudo, estes alvos não são específicos de 
células tumourais, pois, as drogas interferem em células proliferativas normais, como as dos 
organismos aquáticos. 
Apesar da crescente quantidade de informação envolvendo fármacos no âmbito da 
ecotoxicologia aquática, verifica-se uma escassez de dados sobre o impacto de drogas 
anticancerígenas no meio marinho. Em países em desenvolvimento, onde são escassas as 
políticas de saneamento ambiental e a implementação de infraestruturas avançadas em 
ETARs, o cenário de risco ambiental torna-se ainda mais elevado frente à contaminação por 
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estes fármacos. Além disso, a investigação acerca dos efeitos de fármacos em organismos 
nativos de ambiente (sub)tropical é escassa, e ausente relativamente aos anticancerígenos, 
dentro de um âmbito em que os critérios de qualidade ambiental em países em 
desenvolvimento são baseados em extrapolações de respostas geradas em organismos de 
zonas temperadas da Europa e América do Norte. O sedimento consiste num compartimento 
de destino final das substâncias introduzidas nos ecossistemas aquáticos, capaz de acumulá-
las em níveis muito mais elevados do que aqueles observados na coluna de água adjacente. 
Além de atuarem como repositório de compostos químicos, os sedimentos atuam também 
como fonte de poluição após eventos de remobilização. Portanto, por meio do contato com 
a água intersticial e material particulado, as espécies bentónicas estão constantemente 
expostas a misturas de compostos químicos. 
Dessa forma, a presente tese teve como objetivo avaliar a toxicidade de fármacos 
anticancerígenos, globalmente administrados em coquetéis no tratamento contra o cancro, 
em organismos marinhos bentónicos representativos de zonas temperadas e tropicais. Estes 
organismos foram expostos a drogas individualmente e em misturas, a concentrações 
ambientalmente relevantes. Os fármacos selecionados para tal foram os citotóxicos 
cisplatina (CisPt – 0,1 a 100 ng Pt L-1) e ciclofosfamida (CP – 10 a 1000 ng L-1), aplicadas 
no tratamento de tumoures sólidos (e.g. ovário, pulmão e bexiga), e o disruptor endócrino 
tamoxifeno (TAM - 0,5 a 100 ng L-1), mundialmente aplicado no tratamento do cancro da 
mama. Foram usados como modelos os poliquetas Nereis diversicolor de ambientes 
marinhos temperados e o ouriço-do-mar Echinometra lucunter, o anfípoda Tiburonella 
viscana e o poliqueta Scolelepis squamata característicos de ambientes tropicais. Nas 
experiências de exposição com N. diversicolor, que tiveram a duração de 14 dias, avaliaram-
se as respostas de biomarcadores de estresse oxidativo (superóxido dismutase -SOD; catalase 
– CAT; enzima de fase II glutationa-S-transferase – GST; glutationa peroxidase - GPx), dano 
oxidativo (peroxidação lipídica - LPO), de efeito neurotóxico (atividade da enzima 
acetilcolinesterase - AChE), genotoxicidade por dano ao ADN, e alteração do 
comportamento de escavação. Relativamente aos organismos de ambientes bentônicos 
tropicais foram efetuados ensaios agudos (mortalidade) e crônicos (desenvolvimento 
embrio-larval).  
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Os resultados obtidos indicaram que as drogas anticancerígenas, expostas 
individualmente, causam alterações neutotóxicas significativas, estresse e dano oxidativo e 
genotoxicidade em N. diversicolor. Além disso, registram-se alterações no comportamento 
de escavação que podem comprometer a proteção da espécie aos predadores presentes na 
superfície do sedimento, com consequências a nível ecológico. Estas respostas foram mais 
significativas em organismos expostos a CisPt (100 ng Pt L-1), CP (1000 ng L-1) e TAM (0,5 
ng L-1). Relativamente ao bioensaio conduzido em misturas ternárias, constatou-se que o 
perfil de toxicidade não ocorreu de maneira monotónica. A mistura contendo os 
anticancerígenos em menor concentração (Mistura A) foi responsável pelo maior grau de 
dano em ADN, enquanto que nas concentrações intermedias (Misturas B e C) não se registou 
estresse oxidativo. Comparando-se com os resultados obtidos na exposição aos fármacos 
individualmente, as misturas C e D indicaram uma potencial predominância dos efeitos do 
TAM, com efeito antagônico sobre CisPt e CP. Assim, pode-se inferir que as respostas 
desencadeadas pelo modo de ação dos fármacos presentes individualmente não são 
consistentes para gerar estimativas de medidas de proteção de avaliação de risco ambiental 
relativamente a misturas destes compostos. Os efeitos causados pela concentração do 
anticancerígeno TAM (0,5 ng L-1), individualmente ou em misturas, indicaram um modo de 
ação por meio da intrusão da pró-droga na membrana celular. Logo, apesar da ausência de 
evidências referente à expressão de recetores de estrogénio nos modelos biológicos 
selecionados, a terapia administrada com TAM é também potencialmente tóxica em 
organismos não alvos da droga. 
As concentrações das drogas, responsáveis por desencadear as respostas de 
toxicidade aguda, foram detetadas em ambientes temperados, e são encontradas em zonas 
costeiras tropicais. Significativa redução do desenvolvimento embrio-larval do ouriço E. 
lucunter foi verificada nos bioensaios conduzidos com CisPt e CP, respectivamente em 
concentrações entre 0.1 a 10 ng Pt L-1 e 50 a 500 ng CP L-1, de maneira não-monotónica. 
Em contrapartida, o ensaio com TAM indicou uma resposta monotónica de redução 
significativa da viabilidade larval com o aumento da concentração da droga. O ensaio 
conduzido com misturas e poliquetas S. squamata demonstrou significativa toxicidade aguda 
com o aumento da concentração (Misturas C e D), apesar de uma sensibilidade inferior aos 
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anfípodas T. viscana, os quais demonstraram uma redução significativa e não-linear da 
sobrevivência nas misturas B e D, como potencial efeito da ação do TAM.  
Devido aos perfis de toxicidade e dose-resposta não-monotónicos reportados em 
todos os bioensaios conduzidos com concentrações-traço ambientalmente relevantes, 
destaca-se a vulnerabilidade de espécies costeiras às misturas desses contaminantes 
emergentes, bem como à urgência de medidas preventivas à entrada desses compostos no 
meio marinho e ao desenvolvimento ferramentas de avaliação de risco ambiental 
especialmente dirigida a esses fármacos de expressiva toxicidade.  
Palavras-chave: Anticancerígenos, cisplatina, ciclofosfamida, sedimento, 
toxicidade, misturas, biomarcadores bioquímicos, genotoxicidade. 
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1.1 World trends of pharmaceuticals production and usage 
The global demographic outlook demonstrates the fast pace to which population have 
increased 1.1% per year), reaching a record of 7.7 billion people in 2017, with projections 
to a further mark of 8.6 billion in 2030 (United Nations, 2017). Moreover, the current 
scenario of an increasingly interconnected world indicates that over half of this population 
lives in urban areas. By 2030, 43 cities around the world will have 10 million or more 
inhabitants (i.e. megacities), which correspond to an increase of around 30% compared to 
2016 (United Nations, 2016) (Figure 1.1). Another feature of the exceptional urbanization 
transition addressed in the 21st century is that two thirds of these megacities are established 
in zones near the coast, where 41% of humankind is settled (Burke et al., 2001; Martínez et 
al., 2007; Von Glasow et al., 2013).  
 
Figure 1.1: Cities with one million or more inhabitants, in 2016 and projections for 2030. 
Adapted from United Nations (2016). 
  
Low-elevation coastal zones (LECZ) (those with 10 m above sea level) represent 
about 2% of total land area where 13% of global population inhabit (Barbier, 2015). LECZ 
are expanding faster than any other area through immigration and demographic changes 
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(Figure 1.2). The milestone shift of global demographic profiles associated to population 
aging, projected to continue and even accelerate, mainly driven by declining fertility rates 
and remarkable increases in life expectancy (WHO, 2014; Ferlay et al., 2015).  
  
 
Figure 1.2: Representation of urban settlement in low-elevation coastal zones (LECZ), 
where 13% of the world population lives. 
 
In 2010, it was estimated that 524 million people worldwide were aged 65 or older, 
depicting 8% of global population. By 2050, this number is expected to nearly triple to about 
1.5 billion, thus represents 16% of the total. Although there are variations in patterns of 
population growth and levels of urbanization across regions, gains in longevity have been 
especially dramatic in cities of developing countries (WHO, 2016) (Figure 1.3). These trends 
have profound implications in society, once a transition to older populations on the 
demographic structure will occur, followed by health problems associated to chronic non-
infectious and non-communicable diseases (NCD). NCDs mainly comprise cardiovascular 
and respiratory chronic illnesses, as well as cancer diseases, accounting for 67.9% of total 
deaths that occurred worldwide, in 2012, and currently represent the greatest burden on 
health of low, middle- and higher- income countries. However, the present rise of NCDs has 
shown to derive not only from older health status but also from the improvement of living 
standards and broaden socioeconomic, cultural and environmental underlying determinants, 
fitted by risk factors individually managed (e.g. unappropriated diet, tobacco, physical 
inactivity, harmful use of alcohol, infectious agents) (Jemal et al., 2011; American Cancer 
Society, 2014). A rising rate of diseases burden will drive up production and consumption 
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of pharmaceuticals required for different therapeutic applications in a way that global 
medicines spending will reach 1.4 trillion dollars by 2020, an increase of 29-32% compared 
to 2015, in which 63% of the spending will be led by developed nations (Aitken and 
Kleinrock, 2015) (Figure 1.4). 
 
Figure 1.3: Life expectancy (years) by region: estimates 1975-2015 and projections 2015-
2050. Adapted from World Population Prospects: The 2017 Revision (WHO, 2017). 
 
 
Figure 1.4: Projections of global spending (US$) in pharmaceuticals in 2020, by therapeutic 
application and countries. Adapted from Aitken and Kleinrock (2015). 
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1.2 The global scenario of cancer diseases 
Neoplastic or cancer diseases depict a leading concern in global health condition 
responsible for an estimated 9.6 million deaths in 2018, with worrying projections of cancer 
incidence and mortality, by 2030 (Figure 1.5) (WHO, 2014; Ferlay et al., 2015; WHO, 
2017). In 2015, 8.8 million people died from cancer, which represents one in six deaths 
globally reaching countries of all income levels. However, actions aiming to bring cancer 
rates under control are better managed in developed nations through decreasing the 
prevalence of risk factors, early detection measures and prevention action, whereas 
economically less developed countries continue to bear disproportionate burden of infection-
related cancers cases and a rise in exposure to hazard external determinants associated to 
lifestyle (Torre et al., 2015). Therefore, approximately two thirds of global cancer deaths are 
in less developed countries, especially due to late-stage detection and less accessible 
treatment (WHO, 2017).  
 
 
Figure 1.5: Projection of cancer cases between 2012 and 2030 (millions of people). All types 
of cancer are considered with exception of non-melanoma skin cancer (Ferlay et al., 2015). 
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As a result, the United Nations has recognized cancer as a priority not only for health 
but also as a threat to economies and societies, thus placing this disease high on the set of 
commitments of a global agenda of health coverage (i.e. Global Action Plan for the 
Prevention and Control of NCDs) (WHO, 2014). In this scope, nations aim to monitor the 
trends of NCDs and evaluate their progress in an attempt to design preventive and control 
measures. Therefore, substantial increase in availability of affordable basic technologies and 
essential pharmaceutical compounds are required to treat cancer in both public and private 
facilities (WHO, 2014). Since cancer consists of a group of heterogeneous diseases that can 
affect almost any part of the body and has several anatomic and molecular subtypes, specific 
management of prevention, early diagnosis, treatment, palliative and survivorship care are 
enforced, regardless the zone of incidence (Torre et al., 2015). Cancer therapy usually 
involves the alternative of surgery resection, and body´s exposure to agents that kill cancer 
cells, via radiotherapy and the administration of anticancer medicines through systemic 
therapies, in a way that these may be applied individually or in combination, depending of 
the type and stage of the tumour (Helleday et al., 2008; Barczak et al., 2018). Anticancer 
drugs may correspond to different pharmaceutical modalities, regarding cytotoxic 
chemotherapy, in addition to hormonal, targeted and immunotherapies (Palumbo et al., 
2013). 
 It is possible to link the increase of cancer incidences in recent years with the rise of 
drugs production and application, also reflected in global spending on oncology medicine as 
a leading key therapy area driving pharmaceutical expenditure over the next five years, 
including treatment and supportive care (Figure 1.6) (Aitken and Kleinrock, 2015). The 
pipeline of oncology drugs expanded by 45% over the past 10 years (Pineau ad Rink, 2017). 
By 2021, spending on oncology medicine is expected to grow in a range of 9-12% annually, 
compared to the 11% seen over 2016, as the demand of new and targeted therapy options 
raised (Aitken and Kleinrock, 2015) (Figure 1.7). Since 2011, 68 new drugs have been 
approved for 22 indications, including immune-oncology agents that have considerably 
changed the paradigm of cancer treatment. Advances in drug discovery have supported the 
movement towards a more personalized care that relies on the use of validated predictive 
biomarkers. These novel tools are able to identify genetic attributes of a population 
presenting a specific cancer case, thus far more likely to respond to therapy and benefits 
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from a particular drug (Pineau and Rink, 2013). However, conventional treatments, which 
are less effective for specific drivers of cancer, are still widely applied worldwide. They are 
represented by cytotoxic drugs which have been prescribed, since the 1960´s, for various 
solid and hematological malignancies in chemotherapies administered to adults and children 
(Helleday et al., 2008). 
 
Figure 1.6: Sales in 2020 for leading therapy areas of specialty medicines and compound 
annual growth rate (CAGR). 
 
Figure 1.7: Global forecast of spending of oncology pharmaceuticals: EU5 (Germany, Italy, 
France, Spain, UK); United States; Japan; Pharmerging countries (Brazil, Mexico, 
Venezuela, Argentina, China, India, Indonesia, Vietnam, etc.); ROW (Rest of the World). 
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Despite addressed as efficient agents against tumour cells by means of producing 
high levels of DNA damage, those pharmaceuticals are not selective enough to interact only 
with highly proliferative cells by providing cell-cycle arrest and cell death in normal and 
healthy tissues. Such mechanisms often cause undesirable side effects to patients during the 
chemotherapy and may be potent harmful compounds to all eukaryote organisms (Novak et 
al., 2017). 
1.3 Anticancer medicines and the rationale for chemotherapy 
Chemotherapy may be administered to cancer patients through usual routes of 
intravenous, intramuscular or subcutaneous injection. Classification of anticancer drugs is 
established by the Anatomical Therapeutic Classification (ATC), where they are ranked as 
Antineoplastic Agents; Endocrine Therapy; Immunostimulants; and Immunosuppressants, as 
can be seen in Table 1.1 (Booker et al., 2014; Xie et al., 2015). Antineoplastic agents are 
designed to interact directly or indirectly with DNA, by damaging its structure, inhibiting, 
altering and disrupting mechanisms of its transcription, replication and synthesis. Derivatives 
of nitrogen mustards were developed, including the DNA alkylating agents cyclophosphamide, 
chlorambucil and melphalan, widely used in clinical therapeutics (Cheung-Ong et al., 2013. 
Xie et al., 2015). Other examples of DNA-alkylating agents used in cancer treatment include 
nitrosoureas (e.g., carmustine, lomustine, and semustine) and triazenes (e.g., dacarbazine and 
temozolomide) (Cheung-Ong et al., 2013).  
Since most of these pharmaceuticals do not strictly act over tumour drivers, but also in 
mechanisms regarding all growing cells (Kosjek and Heath, 2011; Caley and Jones, 2012; 
Toolaram et al., 2014; Heath et al., 2016), usually leading to detrimental effects in patients 
owing from adverse toxicity to non-targeted tissues. In contrast, there are compounds 
accountable for the disruption of biological processes through mechanisms of blocking cells 
replication factors, or indirectly by recruiting macrophages and monocytes cells (Besse et al., 
2012; Caley and Jones 2012), thus, not directly involved with DNA. Endocrine therapy 
manipulates hormone-dependent receptors with tissue-selective interactions that lead to agonist 
or antagonist activities, represented by the group of selective estrogen receptor modulators 
(SERMs), like tamoxifen (Paterni et al., 2014; An, 2016). Attachment of these endocrine 
disrupting compounds (EDC) to respective binding sites acts competitively and subsequently 
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inhibiting the transcription of estrogen responsive genes responsible for cell replication of 
estrogen receptor positive cells, such as seen in breast and prostate cancer (Pinto et al., 2014). 
 Currently, the aforementioned groups of drugs are some of the main used in cancer 
treatments. Most of chemotherapy regimens in clinical practice consist of a combination of 
several agents from different pharmaceutical groups, in an attempt to provide additive or 
synergistic effects to achieve maximal tumour cell death and avoid resistance (Caley and 
Jones, 2012). In spite to their overall application in chemotherapy, there are strong 
differences in the chemical structure of the several anticancer groups that also have distinct 
modes of action (MoA) (Booker et al., 2014). 
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Table 1.1: Classification of anticancer drugs 
Classification Subcategory Compounds MoA 
Antineoplastic agents 
Alkylating agents 
Nitrogen mustards 
Cyclophosphamide, chlorambucil, 
ifosfamide 
Alkylating agents react with nitrogen (N) and extracyclic oxygen 
(O) atoms of DNA bases to generate a variety of covalent adducts. 
Induce a range of cytotoxic and mutagenic adducts onto DNA 
Nitrosoureas Carmustine, lomustine 
Alkyl sulfonates Busulfan 
Other alkylating agents Temozolomide 
Antimetabolites 
Folic acid analogues Methotrexate 
Structurally similar to endogenous nucleic acids, can be 
incorporated into the metabolic pathways instead of the 
endogenous purine and pyrimidines, thereby affecting the enzyme 
dependent synthesis of DNA and cell reproduction 
Purine analogues Mercaptopurine, tioguanine, cladribine 
Pyrimidine analogues 5-fluorouracil, gemcitabine, capecitabine 
Plant Alkaloids 
Vinca alkaloids and 
analogues 
Vinblastine, vincristine 
Interacts with microtubules or tubulins leading to inhibition of 
synthesis of proteins and nucleic acids, disruption of mitotic 
spindle and eventually cell death 
Podophyllotoxin derivatives Etoposide 
Taxanes Paclitaxel 
Cytotoxic Antibiotics 
and related substances 
Actinomycines Dactinomycin 
Involve direct toxic action on cellular DNA, interfering with DNA 
replication and protein synthesis 
Anthracyclines and related 
substances 
Daunorubicin, doxorubicin, epirubicin 
  
Other antineoplastic 
agents 
Platinum compounds Cisplatin, carboplatin 
E.g.  Cisplatin products highly electrophilic. Act towards 
nucleophilic sites in genomic and mitochondrial DNA, producing 
DNA inter- and intra-strand adducts that result in DNA distortion, 
inhibition of DNA replication and interruption of cell division Methylhydrazines Procarbazine 
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Endocrine Therapy 
Hormones and related 
agents 
 Estrogens Ethinylestradiol, diethylstilbestrol  
Antitumor activity involves suppression of luteinizing hormone 
by inhibition of pituitary function 
Progestogens Megestrol, medroxyprogesterone  
Gonadotropin releasing 
hormone analogues 
Leuprorelin, buserelin  
Hormone antagonists 
and related agents 
 Anti-estrogens Tamoxifen, toremifene Diverse group of compounds bind to oestrogen α (ERα) and β 
(ERβ) receptors and produce oestrogen agonist effects in some 
tissues, but oestrogen antagonist activity in others. Activity 
determined in part by formation of oestrogen receptor–molecule 
complexes that vary in their ability to activate genes when bound 
to ERα or ERβ 
Anti-androgens Flutamide, nilutamide 
Aromatase inhibitors Letrozole, anastrozole 
 Immunostimulants Immunostimulants 
 Colony stimulating factors Filgrastim, lenograstim  
Immune modulation is based on the stimulation of T-cell function 
with antibodies that block or activate regulatory receptors is 
enough to cause the regression of some tumours.  
Interferons Interferon-α natural, interferon-β natural  
 Interleukins Aldesleukin 
Other immunostimulants Lentinan, roquinimex  
 Immunosuppressants Immunosuppressants 
Selective 
immunosuppressants 
Mycophenolic acid, sirolimus 
 Interleukin inhibitors Daclizumab, basiliximab 
Calcineurin inhibitors Ciclosporin, tacrolimus 
Other immunosuppressants Methotrexate, azathioprine 
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1.4 Drug metabolism and excretion 
The major function of drug metabolism in the body is to provide the breakdown of 
the compound into chemically simpler metabolites for elimination, thereby preventing 
unwanted accumulation, as well as potentially toxic levels of endogenous molecules 
(Jančová and Šiller, 2012). In general, the fate of chemical biotransformation includes the 
generation of metabolites, which may be desired for the therapeutic purpose or not, due to 
toxicity. Briefly, drug pharmacokinetics occurs in two phases of biotransformation, 
comprised by the functionalization (Phase I) and conjugation (Phase II) of the compound 
load, in order to increase its polarity and facilitate its elimination through excretion (King, 
2009). Phase I relies on an enzymatic system of defense against most of the xenobiotic 
compounds, composed by members of the cytochrome 450 gene family (CYP 450), flavin-
containing monooxygenases (FMO), monoamine oxidases (MAOs), and xanthine 
oxidase/aldehyde oxidase (Penner et al., 2012). Those enzymes are differently expressed in 
tissues, but broadly distributed in liver, kidney and intestine, acting by means of introducing, 
modifying or unmasking reactive functional groups at the parent drug.  
Phase II reactions occur with the introduction of acetyl, sulfate, glucoronid acid, 
glutathione and amino acids functional groups, either in the parent molecule or in a phase I 
metabolite structurally changed enabling binding sites for conjugation (Liska, 1998; Jančová 
and Šiller, 2012). These reactions are mostly catalyzed by the enzyme uridine 5´- diphospho 
(UDP)-glucoronosyltransferase (UGTs), sulfotransferases (SULTs), glutathione S-
transferase (GSTs) and N-acetyltransferases (NATs). Biotransformation mechanisms 
present low specificity to pharmaceuticals and, in general, enhance polarity of compounds, 
thus favoring the excretion (King, 2009). Nevertheless, this change is often incomplete, with 
parent compounds excreted together with the metabolites in a variable proportion 
(Kümmerer, 2010). 
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1.5 Anticancer compounds as a threat to the aquatic environment  
1.5.1 Pharmaceuticals as Emerging Contaminants (ECs) 
Pharmaceuticals are substances intended for the use in diagnosis, cure, mitigation, 
treatment or prevention of diseases, in humans and animals, also designed to provide 
therapeutic effects in biological systems by their key molecular structures, the active 
pharmaceutical ingredients (APIs) (Daughton and Ternes, 1999; Khetan and Collins, 2007). 
The pharmaceutical compounds also include excipients, additives, inorganic salts and other 
organic chemicals, such as sugars, scents, pigments and dyes (Kummerer, 2010).  A wide 
range of drugs is displayed by the pharmaceutical industry and are often classified according 
to their APIs and purpose (e.g. antibiotics, analgesic, lipid regulators, antidepressants, 
antineoplastics) (Williams, 2005). Classification by similarity in chemical structure and 
behaviour are also usually applied (e.g. antibiotics: penicillins, cephalosporin, quinolones), 
which may or not coincide with biological activity. In addition, sorting can be based on the 
drugs MoA, referring to physiological system to be targeted (i.e. digestive system), or to 
specific binding receptor to which active ingredient interacts (Kummerer, 2008).  
Pharmaceuticals are designed to affect targeted biomolecules and biological critical 
mechanisms via their specific MoA, triggered even at low doses (Fent et al., 2006b; 
Gunnarsson et al., 2008). However, since the end of the last century, new findings regarding 
pharmaceuticals´ molecular particularities and consumption have emerged questions 
whether these chemicals are relevant only to human benefits and healthcare (Williams, 2005; 
Roberts and Bersuder, 2006). According to the societal and health status outlooks, jointly 
with economic forecasts, it is possible to portray not only the hallmark of the increment 
usage of anticancer drugs in coastal urban areas, but also outline their continuous loads into 
aquatic ecosystems worldwide. Considering that, pharmaceuticals have been addressed as 
ubiquitous compounds detected at trace levels (ng – µg L-1) in aquatic compartments, and 
their persistent input has brought biota to a long-term exposure (Smital, 2008). These 
compounds, which profile of distribution, behaviour and biological interactions in the 
aquatic environment are poorly known (Murnyak et al., 2011; Pal et al., 2010; Robles-
Molina et al., 2014) are considered emerging contaminants (ECs), and regulation by legal 
framework are currently under construction or still absent (Rivera-Utrilla et al., 2013). The 
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term “emerging” does not necessarily concern a new phenomenon, but a recognition of 
compounds that have been recently identified in the aquatic environment by the 
improvement of analytical methods, which allowed lowering the detection limit in 
environmental matrices (Glassmeyer et al., 2008; Nikolaou, 2013).   
1.5.2 Environmental Background of anticancer drugs  
The first publication regarding the issue of anticancer drugs in the environment dates 
from the 1980´s and aimed to depict the distribution profile of several classes of 
pharmaceuticals in different aquatic compartments (e.g. sewage influent and effluent, 
surface water and drinking (Aherne et al., 1985; Richardson and Bowron, 1985). These 
authors outlined that anticancer drugs are likely to yield environmental risks, particularly to 
surface waters that receive discharges from sewage treatment plant, since the confirmation 
of hazards verified to nurses after occupational exposure to pharmaceuticals during 
chemotherapy manipulation. Following the improvement of analytical technologies, a set of 
cytotoxic pharmaceuticals were identified in environmental screenings, at a range of ng L-1 
or below (Kummerer et al., 1997; Buerge et al., 2006; Zuccato et al., 2006; Kovalova et al., 
2009;Toolaram et al., 2014). Relevant reviews outlined physico-chemical parameters that 
determine the fate and behaviour of cytotoxics and predict their pathways in aquatic 
compartments according to their chemical structure namely, pKa, bioconcentration factor 
(BCF), octanol/water partition coefficient (Kow), organic carbon partition coefficient (Koc), 
solubility, Henry´s coefficient (KH) and vapor pressure (Kosjek and Heath, 2011; Xie, 2012; 
Toolaram et al., 2014).  
Transformation products (TPs) are by-products of parent compounds and metabolites 
formed through physico-chemical (e.g. photodegradation, hydrolysis, redox reactions) and 
biological factors (e.g. biodegradation) undergone in WWTPs or over the water bodies 
(Mompelat et al., 2009). Those chemicals can also be as toxic or even more toxic than their 
parent compounds (Loffler et al., 2005; Li et al., 2014). Despite their potential importance, 
the formation and fate of TPs from pharmaceuticals has only been scarcely investigated 
(Mompelat et al., 2009). Although a significant number of drugs are excreted and released 
as inactive conjugates, such as glucoronates and sulfates, deconjugation provided by 
bacterial metabolism in WWTPs and in aquatic environment turn metabolites back to the 
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biologically active parent compounds (Noppe et al., 2007; Behera et al., 2011). Therefore, 
mixtures of parental forms, metabolites and TPs started to be also evaluated (Fatta-Kassinos 
et al., 2011; Toolaram et al., 2014; Haddad et al., 2015; Zhang et al., 2017). The studies of 
Kovalova et al. (2009), Negreira et al. (2013, 2014a, 2014b, 2015) and Zhang et al. (2013) 
brought advances in analytical chemistry and processes that underline technologies in 
WWTPs able to remove anticancer drugs, conform to molecules physico-chemical 
properties, stability and metabolism.  
1.5.3 Sources and routes of anticancer drugs to the marine environment 
Cancer treatment is shifting from hospital treatment and medical facilities to home 
treatment (i.e. outpatients) (Johnson et al., 2008; Kosjek and Heath, 2011; Besse et al., 
2012). The generalization of this modality and the availability of molecules in pharmacies 
are growing in order to improve the patient treatment comfort. Consequently, a more diffuse 
discard of parental and metabolized anticancer agents is prone to succeed during home 
treatment, compared to discharges from hospital wastewater effluents, which is directly 
introduced into WWTPs (Kümmerer, 2010; Mater et al., 2014; Zhang et al., 2013) (Figure 
1.8). In general, private households are indicated as the most important sources for 
pharmaceuticals emission into aquatic environment, rather than hospitals (Schuster et al., 
2008; Toolaram et al., 2014). In the case of chemotherapy drugs, although the substantial 
contribution, there is still no clear evidence if household origination is stepping up to or even 
overtake hospital emissions as their distribution patterns depend on various parameters, such 
as the size of hospitals, size of catchment area, population density, purchase of 
pharmaceuticals in town pharmacies, among others (Zhang et al., 2013). WWTPs are 
primarily designed to serve the purpose of removing pathogens, suspended solids, gross 
organic and inorganic matter, rather than removing the vast array of modern chemicals like 
pharmaceuticals, present at trace concentrations of ng to g L-1 in influents (Lenz et al., 
2005; Rowney et al., 2009; Besse et al., 2012). 
 In general, European countries count with conventional sewage treatment processes 
equipped with screening, degritting, sedimentation, biodegradation and adsorption to 
biomass as the main elimination mechanisms for various organic contaminants during the 
passage of conventional activated sludge and confined units (Carballa et al., 2004; Conn et 
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al., 2006; Zhang et al., 2013), although those have shown to be ineffective to remove 
pharmaceuticals (Yang et al., 2017). Combination of advanced and non-conventional 
technologies in WWTPs and water reclamation are considered alternatives to improve the 
elimination performance of elimination of chemotherapy drugs, including electrolysis, UV 
radiation with H2O2, ozonation and membrane bioreactors (MBR) (Česen et al., 2015).  The 
cytostatic drug 5-FU was eliminated from hospital wastewaters to levels below the limits of 
detection by means of biodegradation processes occurring in the MBR system, whereas the 
major pathway by which anthracyclines (doxorubicin, epirubicin and daunorubicin) were 
mainly removed was through adsorption to sewage sludge, able to yield an elimination of  
>90% from the liquid phase (Mahnik et al. 2007). The percentage of removal achieved at 
the end of a batch bioreactor WWTP for tamoxifen, ciprofloxacin and etoposide reached 91, 
84 and 100%, respectively (Ferrando-Climent et al., 2015).  
In contrast, ifosfamide, cyclophosphamide, vincristine, docetaxel and paclitaxel 
showed to be recalcitrant due to the inefficiency of conventional biological treatments of 
WWTPs. Likewise, the alkylating agent cyclophosphamide was also considered resistant to 
mechanical and conventional biological treatment with suspended biomass, after its feasible 
detection in WWTP effluents at 17 ng L-1 (Česen et al., 2015). Alternatively, the use of 
ozonation technology combined to UV and H2O2 (5 g L
-1) treatments showed to remove 99% 
of cyclophosphamide and 94% of ifosfamide from a non-treated wastewater (Česen et al., 
2015). Other studies demonstrated that cyclophosphamide can withstand degradation 
processes over the aquatic pathway, until concentrations detected in surface waters reach a 
range of 0.15 to 17 ng L-1 (Buerge et al. 2006; Moldovan 2006; Busetti et al., 2009).  
In fact, literature review demonstrated inconsistencies in the removal performed 
through biological treatments for the alkylating agents ifosfamide and cyclophosphamide, 
with reports indicating a range from 0 to 72% (Buerge et al., 2006; Kovalova et al., 2012). 
This suggests that the extent to which WWTPs are successful in their removal depends not 
only on how developed are the selected treatment technologies, but also on the experimental 
design and on the physico-chemical properties of the effluent (Česen et al., 2015). Moreover, 
Martín et al. (2012) identified a removal rate of cytotoxic drugs in WWTPs, ranging from 
0% (e.g. doxorubicin, gemcitabine, paclitaxel, cisplatin and vinorelbine) to 100% (e.g. 
etoposide, fluorouracil, methotrexate).  
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Even though they present wide variations in removal rates for different anticancer 
drugs, both within and between the same treatment works, combination of advanced 
technologies promises an alternative solution for preventing cytotoxic drug from 
continuously entering the environment (Zhang et al., 2013). In any case, the occurrence of 
these chemical agents at trace concentrations escalates concern about ecotoxicity risks and 
human health threats. Accordingly, this situation may be even worse in areas without access 
to sanitation system, specifically in densely-populated urban regions (Zhang et al., 2013). 
Despite major improvements in sanitation detected in lower income countries over two 
decades, key differences from developed nations are still depicted by the absence or low 
sewer connectivity in urban areas, as illustrated by zones that rely on poorly managed septic 
tanks with direct discharges into surface waters, because some regions are barely equipped 
with facilities to collect, treat and dispose sewage in an environmentally sustainable manner 
(Roth et al., 2016). Urban centers in Bangladesh, India, Pakistan and Thailand present less 
than 30% of sewer connectivity, whereas Indonesia and Vietnam indicate 2% and 4%, 
respectively. In South America, disparities in sewage collection vary from more than 80% 
in Chile and Peru, 40% in Brazil and to less than 20% in Paraguay and Guyana. These facts 
have major implications on the distribution and loadings of complex organic mixtures 
involving pharmaceuticals into estuarine and marine ecosystems (Abessa et al., 2005; 
Pessatti et al., 2016) (Figure 1.8).  In a worst scenario, those chemicals may also leach into 
groundwater aquifers and harm drinking water supplies (Zhang et al., 2013). Installation and 
development of advanced wastewater treatment technologies require significant investment 
and skilled labor for operation, which was not considered a governmental priority in low-
income regions (Rahman et al., 2009; Gaw et al., 2014). 
In this sense, parent molecules and metabolic products of anticancer compounds 
enter waterways after consumption and metabolism, via untreated, partially treated or even 
treated urban and hospital effluents. Besides that, loads of pharmaceuticals into the marine 
environment, in general, may also occur via wastewater from manufacturing processes, 
disposal of unused or expired drug products, and accidental spills during manufacturing or 
distribution (Díaz-Cruz and Barceló, 2003). Most of the information available about the 
presence of cytotoxic molecules in aquatic systems are focused on the detection of these 
compounds at their main sources, such as hospital influents/effluents and sewage wastewater 
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effluents, where they were detected at levels ranging from 6 to 7973 ng L-1, for methotrexate 
and ciprofloxacin, respectively (Steger-Hartmann et al., 1996, 1997; Ternes, 1998; 
Castiglioni et al., 2005; Lenz et al., 2005; Buerge et al., 2006; Mahnik et al., 2006; 
Moldovan, 2006; Mahnik et al., 2007; Kovalova, 2009; Yin et al., 2010; Martín et al., 2011; 
Isidori et al., 2016). 
 
 
Figure 1.8: Sources and pathways for anticancer drugs into coastal waters. Dashed arrows 
illustrate the additional course of wastewater in developing regions, where raw domestic and 
hospital effluents follow straightforward route into aquatic ecosystems. 
1.5.4 Potential behaviour and fate of anticancer drugs in marine waters 
In the marine environment, physico-chemical and biological conditions are 
significantly different from limnic waters (e.g. salinity, pH, temperature, turbidity, organic 
compounds, microbial population) and may provide different chemical stability and 
persistence for pharmaceuticals compounds (Weigel et al., 2002; Lara-Martín et al., 2014). 
According to Zhang et al. (2013), it is important to point out that part of the available 
information of physico-chemical parameters is estimated by theoretical calculations based 
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on their chemical structures. Sorption behaviour of pharmaceuticals is often poorly predicted 
by the estimation of the Kow (Franco et al., 2009; Lara-Martín et al., 2014). Overall, 
pharmaceuticals consist in polar and highly ionisable molecules, with one or more 
dissociable functional groups, ranging from acid to alkaline. Electrolytes exist either as 
neutral or ionic molecules, depending on their dissociation constant (pKa) and pH of the 
water in which they are dissolved (Rendal et al., 2011). In this sense, the application of 
lipophilicity corrected to pH (log D) is a more reliable strategy that enhances the prediction 
of environmental behaviour of ionisable species due to the fact that sorption mechanisms 
can be pH-dependent and change from hydrophobic to ionic interactions (Schaffer et al., 
2012). Neutral and non-ionised species indicate lower polarity and higher permeability into 
membranes and fatty acids compared to ionic forms (Fu et al., 2009; Rendal et al., 2011). 
The cytotoxic cisplatin is relatively inert, but once in aqueous solutions of low electrolyte 
concentration (as intracellular medium), chlorine ligands are gradually replaced by water in 
a stepwise process to form more reactive aqueous species (i.e. mono and diaquacisplatin) 
(Curtis et al., 2010; Turner and Mascorda, 2014). Likewise, electrostatic interactions in low 
salinity environments provide predominance of reactive complexes, whereas in seawater the 
ionic strength and the presence of chlorine reduces their activity and  induce adsorption onto 
estuarine particles (Curtis et al., 2010). This is suggested to decrease levels of 
pharmaceutical compounds in water and toxicity (Turner and Mascorda, 2015), although 
bioavailability by deposit feeders may build up the intake.  
Therefore, it is crucial to assess whether the levels of these compounds in marine 
waters become more or less reactive, and what are the processes that drive their 
bioavailability and toxicity. Bioassays conducted with ionisable pharmaceutical compounds 
(2,4-dichlorophenol; 2,4,6-triclorophenol; pentachlorophenol; ibuprofen; fluoxetine) at 
different experimental environmental pH (from 6 to 9) indicate that toxicity depends on the 
more toxic uncharged fraction (Nakamura et al., 2008; Xing et al., 2012), but when the ionic 
fraction is greater, detrimental contributions may be shifted towards the ionic form (Bostrom 
and Berglund, 2015). Ibuprofen is anionic at a pH 7 (above its pKa), thus hydrophilic, and 
almost not sorbed onto sediments due to its negative charge, leading to an electrostatic 
repulsion with each other (Oh et al., 2016). In contrast, its sorption was strongly induced by 
hydrophobicity and neutral forms generated at a pH below pKa (Bui and Choi, 2009). Drugs 
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distribution is consistent with tidal events and proximity of sewage outfalls, in a way that 
levels in coastal waters may be orders of magnitude lower compared to the source (e.g. 
wastewater; river water) (Kim et al., 2017), reflecting the dilution that these compounds 
undergo in the marine environment after discharge (Vidal-Dorsch et al., 2012). As such, 
concentrations of pharmaceuticals followed the trend higher during ebb and low tide, and 
minimum during flood and high tides (Lara-Martín et al., 2014). A clear negative correlation 
between drugs concentration and salinity was demonstrated by the decrease in levels of the 
beta-blocker metoprolol (16 ng L-1 upstream to 8 ng L-1 downstream) and the antiepileptic 
carbamazepine (10 ng L-1 upstream to 6 ng L-1 downstream) over the course of an estuary, 
which corroborated with longitudinal and vertical mixing of sewage containing freshwater 
coming from WWTPs (Lara-Martín et al., 2014).  
Although detected at low levels (ng L-1), these concentrations may be significant to 
induce different consequences by virtue of combined effects, that can occur independently 
of a similar or dissimilar MoA (Cleuvers, 2003). Those can be a simple addition of a toxic 
effect (i.e. additive); less than the sum of the separate constituents (i.e. antagonism); and 
effects exerted by the mixture of the components may be significantly higher than the sum 
of their individual toxic effects (i.e. synergism) (Daughton, 2016; Láng and Kőhidai, 2012) 
(Figure 1.9). Unlike many organic contaminants historically studied (e.g. persistent organic 
pollutants), partitioning dynamics of the majority of pharmaceuticals are not only due to 
hydrophobic interactions, but are also influenced by hydrogen bonding, cation exchange, 
cation bridging and surface complexation, which hinder environmental modelling 
approaches of exposure, uptake (i.e. ingestion, dermal exposure, respiration exchange, larval 
stage hazard), trophic transfer and bioaccumulation (Du et al., 2014; Ribeiro et al., 2015; 
Yamamoto et al., 2009). Oh et al. (2013) addressed that there is a high possibility that 
hydrophobic drugs may be trapped in sediments in estuaries and marine waters due to high 
salinity. Binding to organic matter is recognized as one of the dominant transference 
processes affecting their environmental fate. 
 The settling of pharmaceuticals, despite removal from the water column and 
decrease in drugs levels, represent another route of exposure to biota, particularly to benthos. 
Fine-grained sediments tend to accumulate high amounts of contaminants due to the high 
sorptive capacity, and as a reservoir provide sediment dwelling species to be constantly 
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exposed to complex chemical mixtures, either by bulk sediment dermal contact and 
ingestion, such as through interstitial water. Physical disturbances of sediments may occur 
during weather events, incoming tides, sediment transport, rainfall and bioturbation by 
benthic organisms, in addition to dredging, fishing and shipping (Atkinson et al., 2007; 
Eggleton and Thomas, 2004). Those events are widely known to remobilize pharmaceuticals 
once settled in benthic compartments and transfer them back to the water column (Ferguson 
et al., 2013). More oxidizing conditions to which contaminants are exposed in overlying 
water could result in desorption and transformation into more bioavailable or toxic species 
(Eggleton and Thomas, 2004).  
Figure 1.9: Behaviour and fate of anticancer drugs, in conjugation to abiotic and biotic 
processes, in the marine environment. 
 
1.5.5 Occurrence of anticancer compounds in coastal environments 
As an incipient concern, anticancer drugs have been poorly investigated in 
environmental screenings concerned to pharmaceuticals´ occurrence in coastal and marine 
zones, with special attention so far destined to the endocrine disruptor applied in breast 
cancer treatment, tamoxifen. In UK estuaries, tamoxifen was detected at a range between 13 
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and 212 ng L-1 and, due to its high hydrophobicity, it was suggested that its physico-chemical 
properties may provide its persistence in marine ecosystems (Thomas and Hilton, 2004; 
Roberts and Thomas, 2006). This compound was also predominant in sediments sampled in 
the Jamaica Bay (NY, USA) (11.2 ng L-1), where six WWTPs discharge extensive loads of 
biologically treated sewage (Lara-Martín et al., 2015). In the water column, tamoxifen was 
detected at levels from 141 to 224 ng L-1 in sewage-affected sites of the Yangtze River 
Estuary, and at 120 ng L-1 along the shore, whereas in sediment concentrations found were 
from 30 to 431 ng g-1 (Yang et al., 2011). Realistic levels of pharmaceuticals were monitored 
at sampling sites in the Pacific Ocean (from Muir Beach to Monterey Bay – USA), San 
Francisco Bay (USA), Mediterranean Sea (Israel), Balearic Sea (Ebro estuary and 
Barcelona), Northern Adriatic Sea (Italy), Northern Aegean Sea (Greece), and tamoxifen 
was found only at the former location, at a maximum concentration of 93 ng L-1 (Nödler et 
al., 2014). Regarding other drugs than tamoxifen, the study of Biel-Maeso et al. (2018) 
showed that the antimetabolite methotrexate end up in the semi-enclosed waters of Cádiz 
Bay (Spain), at 3.5 ng L-1. 
1.5.6 Ecotoxicological effects of anticancer drugs on marine organisms  
The occurrence of anticancer drugs in the marine environment triggers concerns 
about their potential risks to non-target organisms according to the evidence of their 
unselective MoA towards all eukaryotic cells (Johnson et al., 2013; Heath et al., 2016). Due 
to the MoA that affect not only highly proliferative cells, but also non-tumour ones, any non-
human cells could be vulnerable to biochemical impairments and DNA damage  (Zounková 
et al., 2007; Parrella et al., 2015), with potential effects even at trace concentrations (Bound 
and Voulvoulis, 2004; Colman et al., 2009; Kosjek and Heath, 2011). With regard to 
hormone therapy, eventual homologies between hormone receptors of humans and non-
target organisms may provide binds of drugs to these respective biomolecules and induce 
antagonist and/or agonist mechanisms that are reflected in alteration of metabolism, 
homeostatic control or reproduction. Even though non-target aquatic organisms lack specific 
conserved targets for drug biological effects, interactions via unspecific MoA may operate 
adversely (Fent et al., 2006b; Gunnarsson et al., 2008). The application of selected 
biomarkers to access cytotoxic effects has the potential to offer additional and valuable 
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information regarding impairments of anticancer drugs on marine non-target organisms. 
Although biomarkers of exposure and effect may be relatively nonspecific and reflect the 
influence of multiple environmental stress factors, the evaluation of biochemical and 
genotoxic alterations are rather consistent findings in biomonitoring of anticancer purposes 
(Suspiro and Prista, 2011).  
Compared with the normal counterparts, most cancer cells have inherently increased 
amounts of reactive oxygen species (ROS), especially hydrogen peroxide (H2O2), which are 
crucial to mediate particular signaling pathways in tumour cell growth, proliferation, 
differentiation, protein synthesis, metabolism and cell survival such as superoxide (Hileman 
et al., 2004; Peng and Gandhi, 2012). The high levels of ROS in cancer cells contributes to 
cancer-cell proliferation, DNA alterations, apoptosis, metastasis and angiogenesis 
(Trachootham et al., 2009; Lord and Ashworth, 2012; Gorrini et al., 2013). In contrast, such 
intensive oxidative stress is counteracted by elevated antioxidant defense mechanisms from 
tumour cells (Gorrini et al., 2013). Therefore, it is important to highlight that 
chemotherapeutic drugs are designed to exceed cellular ROS levels and overwhelm 
antioxidant defenses, aiming to induce irreparable damages and subsequently triggering 
tumour cell apoptosis (Liou and Storz, 2010) (Figure 1.10). Cellular antioxidant mechanisms 
may be unable to prevent the interference of ROS provided by drugs on critical cellular 
mechanisms (Conklin, 2004), combined with the inhibition of non-enzymatic molecules (i.e. 
glutathione, flavonoids and vitamins A, C and E) and antioxidant enzymes, as well as the 
enhancement of lipid peroxidation products (LPO) (Gorrini et al., 2013). Cytotoxic therapies 
are able to block glutathione (GSH) synthesis in order to modulate cancer cell sensitivity to 
drugs (Cairns et al., 2011; Conklin, 2004), since GSH metabolism is actively involved in 
resistance mechanisms against anticancer compounds (i.e. anthracyclines, alkylating agents 
and platinum-containing drugs). Alterations in the set of the scavenging system (GSH, 
superoxide dismutase - SOD, and catalase – CAT) and oxidative stress are the first line of 
action of those drugs, thus, mandatory for assessing further processes that involve cell 
damage and death. Although anticancer therapies widely aim to prevent cell replication 
through different cell cycle phases, the MoA based on DNA damage following S phase 
seems ideal to provide cell cycle arrest and death, since attempts to replicate damaged DNA 
can cause increased toxicity more directed to replicating cells than to non- replicating ones 
  
23 
 
(Helleday et al., 2008).Platinum-based compounds and alkylating agents are also known to 
increase ROS to extremely high levels in a way that mitochondrial metabolism is impaired 
and may lead to caspase activation and cell death, being DNA a critical target for cytotoxicity 
(Liou and Storz, 2010; Dasari et al., 2014). Lesions caused by covalently bindings to DNA 
bases, such as base alterations, crosslinks and single strand-breaks, may originate 
chromosomes aberrations and further subsequent malignancies (Lawley and Phillips, 1996, 
Helleday et al., 2008; Suspiro and Prista, 2011). Cell ability to resist and repair those injuries 
are widely divergent over the exposed eukaryotic groups (Kondo et al., 2010). 
Numerous studies were performed with marine species using several classes of 
pharmaceuticals, by exposing them individually, or as mixtures, prodrugs, metabolites or 
TPs, via water or spiked sediments (Aguirre-Martínez et al., 2013; Gonzalez-Rey and 
Bebianno, 2014; Aguirre-Martínez et al., 2016a; Pires et al., 2016a, 2016b). Regarding 
ecotoxicological effects of anticancer agents and its metabolites in marine organisms, studies 
are still scarce and illustrate a critical discrepancy of more extensive present information in 
freshwater bioassays (Figure 1.11). Fortunately, even though the quantitative disparity, the 
quality of acquired data for marine (Table 1.2) and freshwater (Table 1.3) organisms contrast 
in the analysed endpoints. To date, marine experiments have mainly aimed to observe 
biochemical analysis, in order to understand the conditions of oxidative stress that occur as 
responses under chemotherapy administration and corroborate with the prone subtle effects 
mentioned at relevant levels detected in the environment. The biological responses addressed 
across different levels of biological organization reinforce the problematic of anticancer 
agents as emerging contaminants of concern and the need of assessing the risks of priority 
molecules according to their hazardous impacts (Rowney et al., 2009; Ortiz de García et al., 
2014; Lolic et al., 2015). 
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Table 1.2: Ecotoxicity effects of anticancer drugs in marine species. 
Drug Species 
Conc. range 
(ng L-1)a,b 
Time (d)d End-point Effecte Reference 
CisPt 
Mytilus galloprovincialis 100 4 Oxidative stress, 
oxidative damage, 
neurotoxicity, 
genotoxicity, oxidative 
damage 
(DG, G) AChE, LPO 
*↑; 
(G) SOD, T-GPx *↓; 
(DG) SOD, CAT, T-
GPx, GST *↑; LPO *↓ 
Trombini et al. (2016a) 
   
CP Anguilla anguilla 6.5 – 100a 2d Sister chromatid exchange 12.5; 25; 50; 100: *↑ Santos and Pacheco (1995) 
MET 
Ampelisca brevicornis 1 - 103 0 
Oxidative stress, 
oxidative damage, 
genotoxicity 
102 and 103:  EROD, GST, 
GR, LPO and DNA 
Damage *↑ 
Moreira et al. (2016) 
Paracentrotus lividus 10 - 109 d Fertilization EC50 = 106 Aguirre-Martínez et al. (2016b) 
 10 - 109 2 Larval Development EC50 = 1.5 × 106  
Isochrysis galbana 50 - 5×108 4 Growth inhibition EC50 = 8.4 × 107 Aguirre-Martínez et al. (2016b) 
  
25 
 
Ruditapes phillipinarum 100 - 5×104 14 
Oxidative stress, 
oxidative damage, 
neurotoxicity, 
genotoxicity, oxidative 
damage 
102: DBF, DNA Damage 
*↓; 103: DBF, DNA 
Damage *↓, GPx *↑; 104: 
DBF *↓, GPx *↑;            
5×104: DBF, AChE *↓, 
GPx *↑ 
Aguirre-Martínez et al. (2016b) 
TAM 
Paracentrotus lividus 10 - 109 1b Fertilization EC50 = 15 × 106 Aguirre-Martínez et al. (2016b) 
 10 - 109 2 Larval Development EC50 = 109  
 10-8 - 10-6 M 0.5d Fertilization 10-7 M: *↓ Pagano et al. (2001) 
 10-8 - 10-6 M 0.5d Offspring Quality 10-6 M: *↓  
Spherechinus granularis 10-8 - 10-6 M 3 Larval Development 10-6 M: Embryotoxicity *↑ Pagano et al. (2001) 
Strongylocentrotus purpuratus Not informed 4 Larval Development EC50 = 50 Roepke et al. (2005) 
Isochrysis galbana 1 - 5×108 4 Growth inhibition EC50 = 3.5 × 107 Aguirre-Martínez et al. (2016b) 
Ruditapes phillipinarum 100 - 5×104 14 
Oxidative stress, 
oxidative damage, 
genotoxicity, 
oxidative damage 
102: EROD, LPO *↑; 103 
EROD, GR, LPO *↑, GST 
*↓; 104: EROD, LPO *; 
5×104: EROD, GST, GR, 
LPO *↑ 
Aguirre-Martínez et al. (2016b) 
Tautogolabrus adspersus 5×105  -  5×106 b 17 Egg production 5×105: *↓ Mills et al. (2015) 
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 Sparus aurata L. 
105 c 25 Gene expression Vitellogenin *↑ García-Hernández et al. (2016) 
105 c 25 Gene expression 
Immune response (ilb1, 
tnfa, tgfb1,mhc1a, tlr9) *↑ 
 
105 c 25 Sperm concentration *↑  
105 c 25 Sperm motility *↑  
- a Drug exposure through intraperitoneal injection (mg kg-1 body weight); 
- b Drug exposure through oral gavage (mg kg-1 body weight); 
- c Drug exposure through food intake (mg g-1 food); 
- d Time in hours; 
-  e Unit of concentration effect according to respective concentration range; DG (digestive gland); G (gills)  
- CisPt: cisplatin; CP: Cyclophosphamide; MET: methotrexate; TAM: tamoxifen 
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Table 1.3: Ecotoxicity effects of anticancer drugs in freshwater species. 
Drug Taxon Species 
Concentration 
Range 
(mg L-1)a 
Time 
(d)b 
Parameter Endpoint 
Concentration 
of effect 
(mg L-1) 
Reference 
CisPt Algae 
Synechococcus 
leopoliensis 
0.03 - 32 3 Growth Inhibition EC50 0.7 Brezovsec et al. (2014) 
Tetrahymena 
pyriformis 
5 - 70 9b Growth Inhibition IC50 37.3 Bonnet et al. (2003) 
Tetrahymena 
pyriformis 
5 - 70 1b 
Non-specific esterase 
activity 
IC50 26.5 Bonnet et al. (2003) 
Pseudokirchneriella 
subcapitata 
0.1 - 10 4 Growth Inhibition NOEC 0.1 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
0.1 - 10 4 Growth Inhibition LOEC 1 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
0.1 - 10 4 Growth Inhibition EC50 2.3 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
0.05 - 50 3 Growth Inhibition NOEC 0.5 Brezovsec et al. (2014) 
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Pseudokirchneriella 
subcapitata 
0.05 - 50 3 Growth Inhibition LOEC 1 Brezovsec et al. (2014) 
Pseudokirchneriella 
subcapitata 
0.05 - 50 3 Growth Inhibition EC50 1.5 Brezovsec et al. (2014) 
Pseudomonas putida 0.016 - 10 16b Growth Inhibition NOEC 0.03 Zounková et al. (2007) 
Pseudomonas putida 0.016 - 10 16b Growth Inhibition LOEC 0.1 Zounková et al. (2007) 
Pseudomonas putida 0.016 - 10 16b Growth Inhibition EC50 1.2 Zounková et al. (2007) 
Crustacean 
Daphnia magna 0.01 - 3.2 2 Immobilization EC50 ≥ 1000 Zounková et al. (2007) 
Daphnia magna 0.0001 - 0.03 21 
Reproduction 
Inhibition 
NOEC 0.001 Parrella et al. (2014a) 
Daphnia magna 0.0001 - 0.03 21 
Reproduction 
Inhibition 
LOEC 0.003 
 
Parrella et al. (2014a) 
 
Daphnia magna 0.0006 - 0.1 7 
Reproduction 
Inhibition 
NOEC 0.0045 Parrella et al. (2014a) 
Daphnia magna 0.0001 - 0.03 21 
Reproduction 
Inhibition 
EC50 0.001 Parrella et al. (2014a) 
Daphnia magna 0.000001 - 0.1 1 Genotoxicity LOAEC 0.00001 Parrella et al. (2015) 
Daphnia magna 0.000001 - 0.1 1 Genotoxicity NOAEC 0.000001 Parrella et al. (2015) 
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Ceriodaphnia dubia 0.0006 - 0.1 7 
Reproduction 
Inhibition 
LOEC 0.014 Parrella et al. (2014a) 
Ceriodaphnia dubia 0.0006 - 0.1 7 
Reproduction 
Inhibition 
EC50 0.016 Parrella et al. (2014a) 
Ceriodaphnia dubia 0.00003 - 0.3 1 Genotoxicity NOAEC 0.00003 Parrella et al. (2015) 
Ceriodaphnia dubia 0.00003 - 0.3 1 Genotoxicity LOAEC 0.0003 Parrella et al. (2015) 
Thamnocephalus 
platyurus 
(not informed) 1 Mortality LC50 8.44 Parrella et al. (2014a) 
Brachionus 
calyciflorus 
0.05 - 1 2 Population Growth EC50 0.4 Parrella et al. (2014a) 
5-FU Algae 
Pseudokirchneriella 
subcapitata 
0.001 - 100 4 Growth Inhibition NOEC 0.001 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
0.001 - 100 4 Growth Inhibition LOEC 0.01 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
0.001 - 100 4 Growth Inhibition EC50 0.1 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
0.004 - 0.13 3 Growth Inhibition NOEC 0.01 Brezovsec et al. (2014) 
Pseudokirchneriella 
subcapitata 
0.004 - 0.13 3 Growth Inhibition LOEC 0.02 Brezovsec et al. (2014) 
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Pseudokirchneriella 
subcapitata 
0.004 - 0.13 3 Growth Inhibition EC50  0.13 Brezovsec et al. (2014) 
  Pseudomonas putida 0.001 - 10 16b Growth Inhibition NOEC 0.003 Zounková et al. (2007) 
  Pseudomonas putida 0.001 - 10 16b Growth Inhibition LOEC 0.01 Zounková et al. (2007) 
  Pseudomonas putida 0.001 - 10 16b Growth Inhibition EC50  0.027 Zounková et al. (2007) 
  
Synechococcus 
leopoliensis 
0.04 - 13 3 Growth Inhibition EC50  1.2 Brezovsec et al. (2014) 
 
Crustacean 
Daphnia magna 0.01 - 100 2 Immobilization NOEC 1 Zounková et al. (2007) 
 Daphnia magna 0.01 - 100 2 Immobilization LOEC 10 Zounková et al. (2007) 
 Daphnia magna 0.01 - 100 2 Immobilization EC50  36 Zounková et al. (2007) 
 Daphnia magna 0.01 - 2 21 
Reproduction 
Inhibition 
NOEC 0.006 Parrella et al. (2014a) 
 Daphnia magna 0.01 - 2 21 
Reproduction 
Inhibition 
LOEC 0.002 Parrella et al. (2014a) 
 Daphnia magna 0.01 - 2 21 
Reproduction 
Inhibition 
EC50  0.02 Parrella et al. (2014a) 
 Daphnia magna 0.00005 - 5 2 Genotoxicity NOAEC 0.00005 Parrella et al. (2015) 
 Daphnia magna 0.00005 - 5 2 Genotoxicity LOAEC 0.0005 Parrella et al. (2015) 
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Ceriodaphnia dubia 0.0005 - 0.8 7 Reproduction 
Inhibition 
NOEC 0.002 Parrella et al. (2014a) 
  Ceriodaphnia dubia 0.0005 - 0.8 7 
Reproduction 
Inhibition 
LOEC 0.0067 Parrella et al. (2014a) 
  Ceriodaphnia dubia 0.0005 - 0.8 7 
Reproduction 
Inhibition 
EC50  0.003 Parrella et al. (2014a) 
  Ceriodaphnia dubia 0.000006 - 0.06 1 Genotoxicity NOAEC 0.000006 Parrella et al. (2015) 
  Ceriodaphnia dubia 0.000006 - 0.06 1 Genotoxicity LOAEC 0.00006 Parrella et al. (2015) 
 
Fish 
Danio rerio 0.00001 - 0.1 180 Hystopathology   F1 generation: 0.1 Kovács et al. (2015) 
 Danio rerio 0.00001 - 0.1 180 Genotoxicity   
F1 
generation: 0.001 
Kovács et al. (2015) 
 Danio rerio 0.00001 - 0.1 180 Gene expression   
F1 generation: 
0.00001; 0.001 
Kovács et al. (2015) 
 Cyprinus carpio 2.5a 7 
Micronucleus 
frequency 
  *↑ 
Grisolia and Cordeiro 
(2000) 
CP Algae 
Pseudokirchneriella 
subcapitata 
10 -1000 4 Growth Inhibition NOEC 250 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
10 -1000 4 Growth Inhibition LOEC 500 Zounková et al. (2007) 
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Pseudokirchneriella 
subcapitata 
10 -1000 4 Growth Inhibition EC50 930 Zounková et al. (2007) 
  Pseudomonas putida 63 - 10000 4 Growth Inhibition NOEC 1000 Zounková et al. (2007) 
  Pseudomonas putida 63 - 10000 4 Growth Inhibition LOEC >1000 Zounková et al. (2007) 
 Crustacean Daphnia magna 6.3 - 1000 2 Immobilization EC50 >1000 Zounková et al. (2007) 
 Fish 
Astyanax 
bimaculatus 
4 - 32a 24b 
Micronucleus 
frequency 
 8; 16*↑ 
Matsumoto and Cólus 
(2000) 
DOX 
Algae 
Pseudokirchneriella 
subcapitata 
0.1 - 63 4 Growth Inhibition NOEC 1 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
0.1 - 63 4 Growth Inhibition LOEC 10 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
0.1 - 63 4 Growth Inhibition EC50 13 Zounková et al. (2007) 
Pseudomonas putida 1 - 1000 16b Growth Inhibition NOEC 1 Zounková et al. (2007) 
Pseudomonas putida 1 - 1000 16b Growth Inhibition LOEC 10 Zounková et al. (2007) 
Pseudomonas putida 1 - 1000 16b Growth Inhibition EC50 >1000 Zounková et al. (2007) 
Crustacean 
Daphnia magna 0.01 - 10 2 Immobilization EC50 0.01 - 10 Zounková et al. (2007) 
Daphnia magna 0.000002 - 0.02 1 Genotoxicity NOAEC 0.000002 Parrella et al. (2015) 
Daphnia magna 0.000002 - 0.02 1 Genotoxicity LOAEC 0.00002 Parrella et al. (2015) 
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  Ceriodaphnia dubia 0.000005 - 0.05 1 Genotoxicity NOAEC 0.000005 Parrella et al. (2015) 
  Ceriodaphnia dubia 0.000005 - 0.05 1 Genotoxicity LOAEC 0.00005 Parrella et al. (2015) 
ETO 
Algae 
Pseudokirchneriella 
subcapitata 
10 - 1000 4 Growth Inhibition NOEC <10 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
10 - 1000 4 Growth Inhibition LOEC 10 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
10 - 1000 4 Growth Inhibition EC50 250 Zounková et al. (2007) 
Pseudokirchneriella 
subcapitata 
3.5 - 350 3 Growth Inhibition NOEC 10.7 Brezovsec et al. (2014) 
Pseudokirchneriella 
subcapitata 
3.5 - 350 3 Growth Inhibition LOEC 34.3 Brezovsec et al. (2014) 
Pseudokirchneriella 
subcapitata 
3.5 - 350 3 Growth Inhibition EC50 30.4 Brezovsec et al. (2014) 
Pseudomonas putida 100 - 1000 16b Growth Inhibition NOEC 200 Zounková et al. (2007) 
Pseudomonas putida 100 - 1000 16b Growth Inhibition LOEC 250 Zounková et al. (2007) 
Pseudomonas putida 100 - 1000 16b Growth Inhibition EC50 630 Zounková et al. (2007) 
Crustacean 
Daphnia magna 1 - 100 2 Immobilization EC50 1 - 100 Zounková et al. (2007) 
Daphnia magna 1 - 100 1 Mortality LC50 1.5 Zounková et al. (2007) 
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  Daphnia magna 0.1 - 3 21 
Reproduction 
Inhibition 
NOEC 0.1 Parrella et al. (2014a) 
  Daphnia magna 0.1 - 3 21 
Reproduction 
Inhibition 
LOEC 0.3 Parrella et al. (2014a) 
  Daphnia magna 0.1 - 3 21 
Reproduction 
Inhibition 
EC50 0.2 Parrella et al. (2014a) 
  Daphnia magna 0.00003 - 3 1 Genotoxicity NOAEC 0.00003 Parrela et al. (2015) 
  Daphnia magna 0.00003 - 3 1 Genotoxicity LOAEC 0.0003 Parrela et al. (2015) 
  Ceriodaphnia dubia 0.03 - 3 7 
Reproduction 
Inhibition 
NOEC 0.3 Parrela et al. (2014a) 
  Ceriodaphnia dubia 0.03 - 3 7 
Reproduction 
Inhibition 
LOEC 0.0003 Parrela et al. (2014a) 
  Ceriodaphnia dubia 0.03 - 3 7 
Reproduction 
Inhibition 
EC50 0.1 Parrela et al. (2014a) 
  Ceriodaphnia dubia 0.00001 - 0.1 1 Genotoxicity NOAEC 0.00001 Parrela et al. (2015) 
  Ceriodaphnia dubia 0.00001 - 0.1 1 Genotoxicity LOAEC 0.0001 Parrela et al. (2015) 
IMA Algae 
Pseudokirchneriella 
subcapitata 
0.120 - 12 3 Growth Inhibition NOEC 0.38 Brezovsec et al. (2014) 
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Pseudokirchneriella 
subcapitata 
0.120 - 12 3 Growth Inhibition LOEC 1.19 Brezovsec et al. (2014) 
  
Pseudokirchneriella 
subcapitata 
0.120 - 12 3 Growth Inhibition EC50 2.29 Brezovsec et al. (2014) 
  
Synechococcus 
leopoliensis 
1 - 16 3 Growth Inhibition EC50 5.3 Brezovsec et al. (2014) 
 
Crustacean 
Daphnia magna 0.018 - 3 21 
Reproduction 
Inhibition 
NOEC 0.003 Parrela et al. (2014a) 
 Daphnia magna 0.018 - 3 21 
Reproduction 
Inhibition 
LOEC 0.009 Parrela et al. (2014a) 
 Daphnia magna 0.018 - 3 21 
Reproduction 
Inhibition 
EC50 0.3 Parrela et al. (2014a) 
 Daphnia magna 0.0002 - 0.2 1 Genotoxicity NOAEC 0.0002 Parrela et al. (2015) 
 Daphnia magna 0.0002 - 0.2 1 Genotoxicity LOAEC 0.002 Parrela et al. (2015) 
 Ceriodaphnia dubia 0.0005 - 10 7 
Reproduction 
Inhibition 
NOEC 0.00037 Parrella et al. (2014a) 
 Ceriodaphnia dubia 0.0005 - 10 7 
Reproduction 
Inhibition 
LOEC 0.0009 Parrella et al. (2014a) 
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Ceriodaphnia dubia 0.0005 - 10 7 
Reproduction 
Inhibition 
EC50 0.1 Parrella et al. (2014a) 
Ceriodaphnia dubia 0.00003 - 0.03 1 Genotoxicity NOAEC 0.00002 Parrela et al. (2015) 
Ceriodaphnia dubia 0.00003 - 0.03 1 Genotoxicity LOAEC 0.0002 Parrela et al. (2015) 
Fish 
Danio rerio 0.00029 - 0.15 3 Cell Viability IC50 0.004 Novak et al. (2016) 
Danio rerio 
0.000001 - 
0.001 
1 Genotoxicity LOEC 1 Novak et al. (2016) 
CAP Crustacean 
Daphnia magna 1 - 400 21 
Reproduction 
Inhibition 
NOEC 6.1 Parrella et al. (2014a) 
Daphnia magna 1 - 400 21 
Reproduction 
Inhibition 
LOEC 1.9 Parrella et al. (2014a) 
Daphnia magna 1 - 400 21 
Reproduction 
Inhibition 
EC50 0.02 Parrella et al. (2014a) 
Daphnia magna 0.0025 - 2.25 1 Genotoxicity NOAEC 0.002 Parrella et al. (2015) 
Daphnia magna 0.0025 - 2.25 1 Genotoxicity LOAEC 0.02 Parrella et al. (2015) 
Ceriodaphnia dubia 2.5 - 200 7 
Reproduction 
Inhibition 
NOEC 0.6 Parrella et al. (2014) 
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  Ceriodaphnia dubia 2.5 - 200 7 
Reproduction 
Inhibition 
LOEC 1.9 Parrella et al. (2014a) 
  
Ceriodaphnia dubia 2.5 - 200 7 
Reproduction 
Inhibition 
EC50 2.4 Parrella et al. (2014a) 
Ceriodaphnia dubia 0.012 - 120 1 Genotoxicity NOAEC 0.012 Parrella et al. (2015) 
Ceriodaphnia dubia 0.012 - 120 1 Genotoxicity LOAEC 0.12 Parrella et al. (2015) 
TAM 
Crustacean 
Daphnia pulex 0.00012 - 5.2 14 
Reproduction 
Inhibition 
NOEC 0.00067 Borgatta et al. (2016) 
Daphnia pulex 0.00012 - 5.2 14 
Morphological 
abnormalities 
NOEC 0.00012 Borgatta et al. (2016) 
Daphnia magna 1 - 10 1 Immobilization EC50 1.5 DellaGreca et al. (2007) 
Ceriodaphnia dubia 1 - 10 7 
Population Growth 
Inhibition 
EC50 0.0008 DellaGreca et al. (2007) 
Thamnocephalus 
platyurus 
1 - 10 1 Mortality LC50 0.4 DellaGreca et al. (2007) 
Rotifera 
Brachionus 
calyciflorus 
1 - 10 2 
Population Growth 
Inhibition 
EC50 0.25 DellaGreca et al. (2007) 
Brachionus 
calyciflorus 
1 - 10 1 Mortality LC50 1 DellaGreca et al. (2007) 
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Fish 
Oryzias latipes 0.001 – 0.625 21 Hatchability  0.125; 0.625: *↓ Sun et al. (2007) 
Oryzias latipes 0.001 – 0.625 21 d Fecundity  0.625:  *↓ Sun et al. (2007) 
 
Oryzias latipes 0.001 – 0.625 21 d Fertility  0.625:  *↓ Sun et al. (2007) 
Oryzias latipes 0.001 – 0.625 21 d Vitellogenin  0.025: *↓ ♀ Sun et al. (2007) 
Oryzias latipes 0.001 – 0.625 21 d Vitellogenin  0.001 *↑ ♂ Sun et al. (2007) 
Pimephales 
promelas 
0.01 - 8a 7 Vitellogenin LOEC (♀) 0.1 ↑; 8 ↓ Chikae et al. (2004) 
Pimephales 
promelas 
0.01 - 8a 7 Vitellogenin LOEC (♂) 0.1 ↑ Chikae et al. (2004) 
Pimephales 
promelas 
0.00018 - 0.018 42 Vitellogenin NOEC 0.00018 Williams et al. (2007) 
VIN Fish 
Astyanax 
bimaculatus 
4 - 32 24b 
Micronucleus 
frequency 
 8; 16; 32*↑ 
Matsumoto and Cólus 
(2000) 
Cyprinus carpio 20 
2, 7, 
14, 30 
Micronucleus 
frequency 
 *↑ 
Grisolia and Cordeiro 
(2000) 
BLEO Fish Cyprinus carpio 12.5a 48b 
Micronucleus 
frequency 
 *↑ 
Grisolia and Cordeiro 
(2000) 
- 5-FU: 5-fluorouracil; DOX: doxorubicin; ETO: etoposide; IMA: imatinib; CAP: capecitabine; VIN: vinblastine; BLEO: bleomycin. 
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Figure 1.10: Induction and scavenging of ROS levels in cancer cells: Balance between basal 
(yellow) and excessively high ROS levels (pink), into moderate and ROS-mediated 
mutagenic events (blue). 
 
 
Figure 1.11: Number of papers published per year (Until December 2017) regarding 
ecotoxicological data of anticancer drugs, considering bioassays with freshwater (FW) and 
seawater (SW) organisms. 
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1.6 Environmental Risk Assessment of anticancer drugs 
1.6.1 Efforts in the marine environment 
An Environmental/Ecological Risk Assessment (ERA) framework is currently 
considered as the best scientifically approach to evaluate the potential effects of a wide array 
of chemicals (e.g. industrial and pesticides) and stressors on communities and ecosystems 
(Tarazona et al., 2010). It consists of a set of tools to identify the likelihood for effects and 
characterize the nature and magnitude of risks to human and ecological health, thus able to 
help risk managers and decision makers to define protection measures (USEPA, 2001; 
Tarazona et al., 2010). To date, pharmaceuticals have been evaluated in much the same 
manner of traditional chemical compounds assessed under a risk spectrum. However, several 
special aspects must be considered when applying the ERA framework to pharmaceuticals. 
These include, a range of physical and chemical attributes that influence the behaviour and 
fate of the compounds in the environment, besides the potential biological activities driven 
by their respective MoAs.  
For this reason, the Committee for Medicinal Products for Human Use (CHMP) of 
the European Medicines Agency created a guideline for the ERAs of medicinal products for 
human use, based on a step-wise tiered ERA approach able to reduce the uncertainty of risk 
to a level deemed acceptable to make a regulatory decision (EMA, 2006; Williams, 2007; 
Grung et al., 2008). Several draft versions of an ERA guidance have been produced by the 
European Directive, since 2001, with further scientific revisions and public consultation 
until the release of a final guidelines. Nevertheless, ERA procedures proposed for 
pharmaceuticals still have some limitations regarding the targeted concerns. Its methodology 
is exclusively required for pharmaceutical molecules under marketing authorization and 
excludes compounds released in the market before its publication (Carlsson et al., 2006; 
Besse et al., 2012). In addition, while ERA of conventional pharmaceutical compounds 
covers sewage works and freshwater compartments, the environmental risk in marine 
ecosystems is still not addressed, with even less attention directed pharmaceuticals bound to 
sediments (Aguirre-Martínez et al., 2016b). The Marine Strategy Framework Directive of 
the European Union (Directive 2008/56/2008) (European Comission, 2008) aims to protect, 
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by 2020, the coastal resources based upon marine-related economic and social activities 
according to the particular features of each European region, that should identify and assess 
pharmaceuticals as a predominant pressure. The monitoring of prioritized pharmaceuticals 
and relevant metabolites in coastal aquatic resources is also part of the sustainable 
development goals (SDGs), established by the Agenda 2030 of the United Nations (Osborne 
et al., 2015). Pharmaceuticals concentrations surveys used to assess risk may be achieved 
either by mathematical models, compiling hydrological properties of catchments, chemical 
emissions profiles and underlying assumptions used in fate and distribution calculations, or 
by monitoring data, reflecting the real environmental complexity, hydrodynamic and 
chemical processes (Williams et al., 2007).  
In the first phase of the two-tiered ERA approach (Figure 1.12), the Predicted 
Environmental Concentration (PEC) of pharmaceuticals molecules in the aquatic 
environment is calculated based on its persistence, bioaccumulation and toxicity of the 
compounds (Koschorreck and Hickmann, 2008). But PEC only provides a rough insight of 
the overall situation at a national or regional level because it accounts for the following 
parameters: annual drug consumption (mg.year-1), rates of metabolism and excretion from 
patients, dilution factors from effluents, predicted drug partitioning and susceptibility to 
biotransformation/degradation (Zhang et al., 2013). Therefore, the array of molecules prone 
to be present in the final effluent and likely to be released into receiving waters are 
considered for prioritization of potential risks, prior to implement a monitoring program 
(Johnson et al., 2008; Besse et al., 2012; Booker et al., 2014; Isidori et al., 2016; Santos et 
al., 2017). Although PECs play an important role for decision-making, with acceptable 
consistency, they may induce a slight overestimation and provide unreal and “worst-case 
scenarios” (Steger-Hartmann et al., 1996; Coetsier et al., 2009; Zhang et al., 2013). Instead, 
measured environmental concentrations (MECs) in water bodies (Buerge et al., 2006; 
Coetsier et al., 2009) represent a more realistic approach for performing a reliable ERA 
(Blasco and Delvalls, 2008). For both predicted and measured screening approaches, a wide 
knowledge regarding pharmaceuticals inputs in the environment is required. It encompasses 
the form in which they are released, their removal and transformation, as well as their 
pathways and transport that ultimately determine their concentration in different 
environmental compartments. If PEC or MEC is below 10 ng L-1, according to EMA 
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(Europe), or to 1 µg L-1 according to FDA (USA), the assessment stops because it is assumed 
that no environmental risk is expected (USFDA, 1998; Koschorreck and Hickmann, 2008). 
However, due to the ecotoxicological responses triggered by the environmental levels of 
anticancer drugs, the threshold criteria set up might be unrealistic to protect the marine 
environment. Lists of priority anticancer drugs were established based on PEC and MEC 
and indicate that the following drugs may pose risk to surface waters: the alkylating agents 
ifosfamide and cyclophosphamide; the antimetabolites capecitabine and methotrexate; the 
tyrosine kinase inhibitor imatinib; the antiandrogen bicalutamide; methotrexate; and the 
antiestrogen tamoxifen (Besse et al., 2012; Aguirre-Martínez et al., 2016b).  
 If levels are equal or higher than the recommended threshold, Phase II of the tiered-
approach is required, and should include environment fate and effects of cytotoxic 
compounds (Toolaram et al., 2014). Screening data of active and metabolites of anticancer 
drugs occurrence are compiled to ecotoxicity data, based on the lowest concentration of the 
compound accountable for adverse effects on wildlife (i.e. Predicted No Effect 
Concentration, PNEC) (Schowanek et al., 2001; Länge and Dietrich, 2002). Calculation of 
PNEC is often difficult for most of those pharmaceutical compounds once ecotoxicological 
data is still too scarce on acute and chronic toxicity tests. Extrapolation of acute responses 
to predict chronic ones are performed, depicting an unrealistic paradigm, because low 
concentrations and long-term exposures are likely to occur in the environment, thus limiting 
efficient risk assessment and robust outcomes (Claessens et al., 2013). The European 
Medical Agency proposes that PNEC should be estimated from chronic assays with 
organisms of each trophic level (algae, aquatic invertebrates and fish), and the lowest value 
should be used for risk characterization. Despite subtle effects have been registered, together 
with acute endpoints, most of the studies have been performed with general toxicity 
responses, rather than a specific endpoint corresponding to the drug´s MoA (Bound and 
Voulvoulis, 2004; Ferrando-Climent et al., 2014).  
Further, ERA demands an estimation of the hazard quotient (PEC or MEC/PNEC) 
for the respective environmental compartment. If the ratio is <1, interpretation relies on an 
environmental concentration lower than levels resulting in adverse effects for wildlife. 
Alternatively, if the ratio PEC or MEC/PNEC is >1, levels present in the environment exceed 
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those prone to harm biota, subsequent approaches must be taken to analyze risk-management 
options (Grung et al., 2008).  
 
Figure 1.12: Flow chart for the ERA (Environmental Risk Assessment) based on the 
European Medicines Agency Guideline (EMA, 2006). 
1European Chemicals Bureau (ECB, 2003) Technical Guidance Document in support of Commission 
Directive 93/67/EEC on Risk Assessment for new notified substances. 
1.6.2 The ERA approach involving cytotoxic drugs  
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Anticancer drugs act by a distinctive MoA, by generating a highly stressful cellular 
condition via directly or indirectly interaction with DNA, interference on mechanisms and 
biomolecules of cellular protection and disruption of cell cycle, at last, aiming to interrupt 
cell proliferation and provide cell death. Moreover, since acting in cell factors and DNA 
structure and function, anticancer drugs possess mutagenic, cytotoxic, genotoxic, teratogenic 
and carcinogenic properties that generally ensure the absence of safe doses in laws and 
environmental regulations, as well as the unfeasibility to estimate threshold levels for lowest 
effect concentrations (Kosjek and Heath, 2011). In other words, even admitted as a 
therapeutic class of pharmaceuticals, anticancer agents are, foremost, chemicals and 
metabolites with carcinogenic or mutagenic potential, which load into the wastewater system 
are formally banned by the European Community (ECHA, 2008). 
Although in most cases genotoxicity of chemicals is a criterion of exclusion for legal 
market approval (and thus use), pharmaceuticals may be genotoxic and carcinogenic, and 
are not always completely unavoidable in consumer products. Environmental safety data for 
anticancer drugs is limited and uncertainties and gaps in the ERA of some anticancer drugs 
are attributed to the few ecotoxicological data available (Lenz et al., 2007a; Besse et al., 
2012; Toolaram et al., 2014). Genotoxicity and cytotoxicity may be triggered by long-term 
exposure to very low levels of chemicals and have a hereditary and delayed-onset nature that 
may lead to major consequences at the population level (Llorente et al., 2012). Approaches 
to evaluate the risks associated with this class of compounds to marine species must be 
developed and incorporated in official protocols for monitoring and determining the 
maximum permitted levels of anticancer drugs in the environment. A set of genotoxicity 
bioassays is of particular importance for this kind of assessment but, currently, only 
mutagenicity tests performed with micronucleus in human lymphocytes, bacterial reverse 
mutation test conducted with Salmonella typhimurium (Ames test) and Escherichia coli 
(SOS chromotest) are standardized (Giuliani et al., 1996; Yasunaga et al., 2006). It is 
important to bear in mind that eukaryotic cells cover a broader range of genetic effects than 
prokaryotic cells, and interpretations are likely to be limited when ERA is based only in tests 
conducted with bacteria.  
1.7 Tropical and temperate marine species 
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Frameworks and guidelines regarding ERA and monitoring of pharmaceuticals are 
concentrated in United States and in northern or central European countries, although limited 
information is available in Mediterranean countries (Aguirre-Martínez et al., 2015). In spite 
of this, there is a marked absence of legislation about this issue in developing regions, as 
notably Africa, South America and small island nations in Oceania, particularly concerning 
the marine environment (Bayen et al., 2013; Gaw et al., 2014). Urbanization pace is 
accelerating in low-income regions, which are now in the stage of relocation of global 
pharmaceutical industries (e.g. Asian countries). Moreover, pharmaceutical and chemical 
industries are normally not enforced to comply to environmental regulations, resulting in 
growing trends of environmental pollution, which include a vast array of pharmaceuticals 
released in the marine environment through untreated domestic sewage (Rehman et al., 
2015; Hussain et al., 2016; Ashfaq et al., 2017). Consequently, concentrations of 
pharmaceutical compounds are several hundred times higher in aquatic compartments of 
developing countries than in other regions (Larsson et al., 2007; Rehman et al., 2015; Ashfaq 
et al., 2017), which may lead to a more severe environmental toxicity (Rehman et al., 2015). 
Such issue is relevant considering that most of those vulnerable nations reside in sub-tropical 
and tropical climates (Dyer et al., 1997; Kwok et al., 2007). Despite these regions have 
shown increasing efforts to detect or estimate environmental concentrations of 
pharmaceuticals, there is still a paucity of studies describing toxicological endpoints 
associated with their occurrence (Bayen et al., 2013).  
In general, ecotoxicological tests conducted with tropical and subtropical species are 
much less developed than those from temperate regions (Adams and Stauber, 2008). That 
paucity of tropical dataset has contributed to an environmental quality criteria of developing 
countries relied on extrapolations from evidences generated in developed countries, based 
on temperate and coldwater species endemic from Europe and North America (Kwok et al., 
2007). Therefore, it becomes questionable whether such extrapolation from temperate to 
tropical counterparts is reliable for regulation standards and decision-making (Peck et al., 
2002; Wang and Leung, 2015), along with the estimate of toxicity information of freshwater 
species to protect saltwater species (Leung et al., 2014; Wang et al., 2014). Differences on 
relative sensitivity between coastal tropical and temperate species may be attributed to a 
variety of parameters, major characterized by temperature and salinity-related influences in 
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chemical bioavailability, uptake and detoxification metabolism (Daam and Van Den Brink, 
2010). Those mechanisms may operate as species- and chemical-specific and are not easy to 
decouple once tropical organisms will always experience higher temperatures and salinities, 
optimum for their health status (Dyer et al., 1997; Wang et al., 2014). Previous findings with 
saltwater species indicated that chemical sensitivity is not solely explained by those intrinsic 
physico-chemical parameters, but also by species composition of the testing taxa (Wang et 
al., 2014). Temperate saltwater species are more susceptible to un-ionised ammonia, 
chromium, lead, nickel and tributyltin, whereas tropical species are more sensitive to copper, 
zinc, mercury, pentachlorophenol and phenol (Kwok et al., 2007; Wang et al., 2014). Hence, 
temperate data cannot be used to assure suitable environmental protection for tropical or 
even to polar regions (Chapman et al., 2006). The need of proper risk assessments for 
contaminants under tropical conditions has long been recognized (Daam and Van Den Brink, 
2010). Thus, the development of studies regarding the effects induced by pharmaceuticals 
on tropical marine species is required. This type of study could produce information on the 
early warning responses caused by pharmaceuticals in the marine environment (Bayen et al., 
2016). Marine ecotoxicity testing with anticancer drugs is in its infancy and elucidations 
about sensitivity and biological responses are still lacking in datasets. Knowledge gaps need 
to be filled for indigenous species from tropical and temperate coastal zones to accomplish 
future regulatory purposes demanding PNECs. 
1.8 Selected biological models 
1.8.1 Polychaete Nereis diversicolor 
Polychaetes constitute the major class of the phylum Annelida, and the family 
Nereididae is among the most diverse group, comprised by over 43 genera and 540 species 
(Bakken and Wilson, 2005). These organisms are most common in intertidal soft-sediments 
of coasts of the North Atlantic of America, North Africa and Northern of Europe (Fidalgo 
and Costa et al., 2006). They are found in shallow marine habitats distributed from the 
estuaries to the deep sea, and in some freshwater systems. These sediment-dweller organisms 
exert impact on physical, chemical and biological properties of the marine benthos, through 
habits of burrowing that contribute to sediment reworking (Gillet et al., 2008) and transport 
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of chemicals from deeper layers of sediments to the water column interface. Hence, they 
change the organic matter status and metabolism of surrounding microbiota, besides 
providing absorption of resuspended contaminants via uptake by other epibenthic species 
(Moreira et al., 2006; Gillet et al., 2008). 
The ragworm Nereis (Hediste) diversicolor (O. F. Muller) is recognized as an 
ecological key-species in soft bottom communities, behaving as a deposit and filter feeder, 
organic matter and detritus scavenger (Solé et al., 2009). Besides of its ecological relevance, 
N. diversicolor comprises an important component of monitoring programs. Due to its low 
mobility and tolerance to inhabit contaminant-rich sediments, N. diversicolor is subjected to 
chronic exposure of environmental disturbances (Dean, 2008; Lewis and Watson, 2012), and 
contributes as a pathway of accumulation of contaminants into higher levels of the food 
chain (Scaps, 2002; Coelho et al., 2008). Therefore, increasing research has been conducted 
with this species aiming to evaluate behavioural, biochemical and genotoxic alterations as 
part of an environmental quality assessment and field monitoring (Saiz-Salinas and Francés-
Zubillaga, 1997; Mouneyrac et al., 2003; Moreira et al., 2006; Poirier et al., 2006; Durou et 
al., 2007b; Solé et al., 2009; Gomes et al., 2013). Moreover, laboratory-controlled exposures 
are increasing, and so far they have been used to test the toxicity of trace metals (Bonnard et 
al., 2009; Neave et al., 2012), polycyclic aromatic hydrocarbons (PAHs) (Catalano et al., 
2012), nanoparticles (Cong et al., 2011; García-Alonso et al., 2011; García-Negrete et al., 
2013; Buffet et al., 2014a, 2014b; Cong et al., 2014; Moschino et al., 2014; Thit et al., 2015 
and to a less extent, pharmaceuticals (Maranho et al., 2014, 2015; Pires et al., 2016a, 2016b). 
1.8.2 Polychaete Scolelepis squamata 
The polychaetes S. squamata (Muller, 1806) belong to the family Spionidae, which 
depict significant biomass of macrobenthic fauna in intertidal zones of sandy beaches, as 
well as in deep sea environment (Amaral et al., 2006). They possess a vast worldwide 
occurrence from a latitudinal range of 58 °N to 35 °S (Maria et al., 2011). Individuals can 
reach lengths of about 80 mm (Pardo and Amaral, 2004). This species is considered a deposit 
feeder, feeding at the sand-water interface using the palps or directly with the mouth, 
although it can act as a suspension feeder (Dauer, 1983). Like N. diversicolor, burrowing 
presents an ecological relevance in modifying the physico-chemical properties of the marine 
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benthos (Speybroeck et al., 2007). Previous studies established that S. squamata 
opportunistically changes its feeding behaviour according to environmental conditions, and 
in the intertidal zone feeds predominantly on suspended matter (Pardo and Amaral, 2004; 
Dean, 2008). The individuals of S. squamata built temporary vertical tubes and occasionally 
burrow to a depth of 40 cm below the sediment surface (Maria et al., 2011). Moreover, those 
features are likely important to select this species as a bioindicator, particularly along the 
Southeastern to Southern Brazilian coast, where there is a high abundance, particularly in 
sandy beaches in São Paulo and Rio de Janeiro areas (Pardo and Amaral, 2004; Amaral et 
al., 2006).  
1.8.3 Sea urchin Echinometra lucunter 
Echinometra is the most ubiquitous and abundant shallow-water sea urchin in the 
tropics, from North Carolina to Southern Brazil, inhabiting beds of seagrass, on hard bottoms 
covered with algae, rock, shell hash or sand (McClanahan and Muthiga, 1998). The species 
E. lucunter has two basic feeding modes, based on algal drift and benthic grazing, although 
may occasionally consume benthic animals, such as sponges and corals. Besides consuming 
a large fraction of the benthic primary production, E. lucunter can erode reef substratum, 
reducing its complexity and suitability to other coral reef species. Yet, about half of the food 
consumed will not be absorbed and becomes detritus. Several marine fishes and 
invertebrates, as well as shorebirds, feed on Echinometra in the intertidal zone (McClanahan 
and Muthiga, 2007).  
Altogether, this species exerts important roles as driver of disturbance and marine 
community structure. Specimens are commonly reported from shallow waters between the 
average low tide and depths of 10 m. Temperature and dissecation are the main drivers 
influencing their distribution and abundance in the upper depth limit, whereas the lower one 
is represented by predation (Arakaki and Uehara, 1991; Beddingfield and McClintock, 
2000). Since embryonic and larval development stages of sea urchin are sensitive to 
chemical compounds present in seawater, they become suitable organisms for testing 
developmental, reproductive and cytogenetic effects of marine pollution (Bottger and 
Mcclintock, 2001; Pusceddu et al., 2007; Maranho et al., 2010; Sousa et al., 2014; Pusceddu 
et al., 2018). 
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1.8.4 Amphipod Tiburonella viscana  
Components of the Amphipoda Order comprise the largest group of peracarid 
crustaceans, containing more than 9000 species worldwide (Hughes and Ahyong, 2016). 
Amphipod crustaceans are extremely widespread, occurring from the abyssal depths, 
throughout the ocean and extending into freshwater and groundwater. Overall, amphipods 
are relevant in structuring benthic communities, excluding members of other groups by 
preying upon or disrupting settling larvae, modifying sediment stability and space 
availability for burrowers (Grant, 1981). Unlike many crustaceans, amphipods do not have 
a free larval phase, and by brooding their offspring, amphipods can exclude larger and 
competitive superior species through preying upon settling larvae and newly settled 
juveniles (Highsmith and Coyle, 1991). Amphipods are trophically diverse and include 
scavengers, detritivores, filter feeders, predators, and herbivores; whilst they can constitute 
a large component of the diet of polychaetes, nemerteans, crustaceans, fish, birds, and 
benthic feeding mammals (Hughes and Ahyong, 2016). Besides their ecological role in 
community structure, several species of amphipods are standardized for sediment toxicity 
tests, although sensitivity to pollution may be species dependent (Afli et al., 2008). The 
species T. viscana (Barnard, 1964) present important features as bioindicators, such as ease 
collection, a short life cycle, low dispersion and mobility, direct contact with sediments due 
to burrowing habit, and a wide sensitivity to pollutants (Abessa et al., 1998; Melo and 
Nipper, 2007; Maranho et al., 2010; Buruaem et al., 2013; Sousa et al., 2014). T. viscana 
occurs in the Brazilian coast between 23.5° and 25.03° S, inhabiting intertidal zones of sandy 
beaches, associated with seagrass banks, until 21m depth (Wakabara et al., 1991; Melo and 
Nipper, 2007).  
 
 
1.9 Selected Drugs  
The pharmaceuticals elected for the toxicity assessment in the present thesis were: 
cisplatin, cyclophosphamide and tamoxifen. They were chosen according to a combination 
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of criteria regarding their consumption and environmental occurrence. Despite the increase 
in the number and quality of innovative new drugs currently released in the pharmaceutical 
market (Aitken and Kleinrock, 2015), these three drugs have been traditionally applied 
during decades in single and combinatory chemotherapies worldwide, thus with more 
clinical information available and knowledge about its MoA. Table 1.4 indicates some 
relevant physico-chemical properties that provide insights regarding the solubility and 
lipophilicity of compounds (Emadi et al., 2009; Dasari and Tchounwou, 2014; Shagufta, 
2018). Since occupational exposure to these drugs provide hazards to human health, they 
were outlined to yield unselective cytotoxic risks once ending up in the aquatic environment 
(Xie et al., 2012; Toolaram et al., 2014). In this sense, environmental screenings including 
anticancer pharmaceuticals, cisplatin, cyclophosphamide and tamoxifen were targeted as 
causing environmental risk due to their presence in aquatic compartments (Lenz et al., 2005; 
Zuccato et al., 2005; Tauxe-Wuersch et al., 2006; Johnson et al., 2008; Orias et al., 2015). 
However, research gaps in toxicity to coastal and marine organisms, from tropical and 
temperate zones, are still a caveat in the current knowledge. 
1.9.1 Cisplatin 
Platinum-based compounds are widely applied in cancer therapy to treat solid 
tumours, mainly ovarian, colorectal, head and neck and non-small cell lung. The remarkable 
anticancer property of platinum agents relies on the induction of ICLs (Deans and West, 
2011). They are formed by a covalent linkage between nucleotide residues situated in bases 
of opposite strands, avoiding the separation of DNA double strands during replication 
(Deans and West, 2011). Although ICLs represent only 5% of bindings generated by 
platinum agents, their severe genotoxic lesion, usually irreparable, efficiently lead to cell 
death (Zamble and Lippard, 1995).  
Cisplatin (CisPt) (also denominated cis-diamminedichloroplatinum (II)) is the major 
platinum crosslinking drug, firstly approved by FDA in 1978 (Dasari et al., 2014). CisPt is 
composed of two strong amine ligands interacting with the platinum ion, and two chloride 
ligands, which are the functional groups that allow platinum ion to bind to DNA bases 
(Florea and Büsselberg, 2011). Following intravenous administration, 90% of the cisplatin 
binds with biomolecules and is distributed to tissues, particularly liver, prostate and kidney 
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(Visacri et al., 2017). CisPt is primarily excreted by kidneys, although removal of the drug 
through urine is incomplete, with approximately 25 to 50 % eliminated after 5 days of 
intravenous administration (Visacri et al., 2017). Overall, administration of cisplatin per 
course varies from 20 to 200 mg m-2 (Vermorken et al., 1986). The average values of parent 
cisplatin excreted in urine in the first 12 h, 12–24 h and 24–48 h were 42 %, 9.4 %, and 9% 
of dose administered (Gullo et al., 1980; Visacri et al., 2017). CisPt undergo aquation at 
greatly lowered concentrations of chloride (4–20 mM), where one or two chloride ligands 
are displaced by water molecules (Kartalou and Essigmann, 2001; Ma et al., 2015). This 
mechanism provides cisplatin activation just after its entrance in the cell through the 
generation of mono and diaquacisplatin reactive metabolites, with high electrophilic 
potential and able to attack nucleophilic biomolecules as DNA. CisPt is known to increase 
ROS to extremely high levels in a way that mitochondrial metabolism is impaired and may 
lead to caspase activation and cell death (Liou and Storz, 2010; Dasari and Tchounwou, 
2014).  
1.9.2 Cyclophosphamide 
The advent of chemotherapy fundamentals emerged at the first four decades of the 
20th century. Breakthrough advances undertaken in World War II after an accidental spill of 
sulfur mustards leading to the markedly depletion of both bone marrow and lymph nodes in 
men exposed to those chemicals, following discoveries of potential anticancer therapeutic 
(Huang and Li, 2013). In this course, cyclophosphamide (CP) was developed as a mustard 
prodrug with cytotoxic and alkylating purposes (Emadi et al., 2009).  
The CP dosage commonly administered in humans varies widely depending on the 
clinical indication, and can be defined as low (1–3 mg kg-1 or 40–120 mg m-2), daily orally 
administered; intermediate (15–40 mg kg-1 or 600–1,500 mg m-2), via intravenous, every 3 
to 4 weeks; and high (> 120 mg kg-1 or > 5,000 mg m-2), every 2 days. After consumption, 
CP undergoes subsequent activation and transformation by the CYP 450 enzymes to yield 
the major cytotoxic species activation, the phosphoramide mustard (PAM) and acrolein. 
These species form labile covalent DNA adducts and inter-strand crosslinks, accountable for 
blocking DNA replication and avoiding cell proliferation (Lawley and Phillips, 1996). 
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According to Bagley et al. (1973), not more than 20% of injected CP is excreted intact in 
urine, at any dose level. 
1.9.3 Tamoxifen 
To date, the chemotherapeutic drug with more ecotoxicological information available 
is the selective estrogen-receptor modulator (SERM) tamoxifen (TAM). TAM is a SERM of 
the triphenylethylene chemical family which possess the ability to antagonize the 
proliferative action of estrogen through competitive binding to its respective receptor 
(Goldstein et al., 2000). TAM has become the most prescribed drug in hormone therapy of 
primary and recurrent breast cancer around the world, irrespective of menopausal state 
(Kiyotani et al., 2012). It has shown extensively success on overall survival in clinical trials 
in women whose tumours are estrogen receptor-positive (HER+) and effective in therapies 
of metastic breast cancer (Mueller and Korach, 2001; Lim et al., 2018). Its MoA is based on 
stable complex binding with receptors of 17 β-estradiol (Yang et al., 2015). The drug has 
estrogen receptor antagonist properties, with no activation of the receptor to which it is 
attached, and finally counteracts the proliferative mechanism of oestrogen. Nevertheless, it 
also has an agonist action in other tissues, with fully activation of the binding receptor (Mater 
et al., 2014; Ma et al., 2015). TAM prodrug is metabolized into two more potent molecules, 
4-hydroxy-N-desmethyltamoxifen (endoxifen) and 4-hydroxytamoxifen (Besse et al., 
2012). 
 
 
 
 
Table 1.4: Physico-chemical characteristics of the drugs investigated. 
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1.10 Aim of the thesis 
The pseudo-persistence of pharmaceutical compounds in the aquatic environment is 
an ongoing worldwide problem, requiring extensive awareness on the environmental quality 
and detrimental responses to non-target biota. Even though anticancer drugs are 
encompassed in such overall environmental issue, the introductory aspects mentioned above 
involving their potential MoA in non-target species portray an emerging concern, even less 
outlined in the environmental context of low/middle income countries. Accordingly, the 
main objective of this thesis was to assess the MoA and toxicity of anticancer drugs, at 
environmentally relevant concentrations, on benthic marine species of temperate (Portugal) 
and subtropical (Brazil) zones. 
To achieve this purpose, the thesis is structured in the following chapters: Chapter 1 
is a general introduction that reviews the hallmark of environmental problem caused by 
anticancer drugs, addressing the trends of increase in cancer burden and following outcomes 
in pharmaceutical consumption that ultimately leads to their introduction in the marine 
environment. Potential sources and routes into the marine environment are discussed, 
including their fate and behaviour. Data regarding their occurrence and ecotoxicological 
Properties Cisplatin Cyclophosphamide Tamoxifen 
Molecular Structure 
 
 
CAS Number 15663-27-1 6055-19-2 54965-24-1 
pKa 5.3 - 7.2 2.3 - 11.1 8.8 (Basic) 
Log Kow -2 0.6 6.3 
Water Solubility 4 ×104 mg L-1 3 ×103 mg L-1 17 mg L-1 
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effects are discussed, calling attention for their MoA in the marine environment and in the 
biota. 
In order to determine whether realistic trace concentrations of traditionally prescribed 
anticancer agents represent a chronic threat to the marine sediment biota, Chapters 2 to 4 
describe the effects of the cytotoxic cisplatin (Chapter 2), the alkylating agent 
cyclophosphamide (Chapter 3) and the endocrine disruptor tamoxifen (Chapter 4) on the 
sediment dweller Nereis diversicolor, by evaluating the behavioural responses, oxidative 
stress, biotransformation, neurotoxicity, lipid peroxidation and genotoxic outcomes. 
Furthermore, in Chapter 5, such multi-biomarker approach was applied to respond whether 
anticancer drugs in mixtures induce distinct responses from the single-drug exposure 
scenario.  
In Chapter 6, chronic and acute endpoints of anticancer agents individually and in 
mixtures were determined, for the first time, in native benthic organisms (sea urchin, 
polychaetes and amphipods) from a coastal tropical environment, in Brazil. Lastly, a general 
discussion of the results from the previous chapters is summarized jointly with the 
conclusions and future perspectives pertained to environmental risks of this therapeutic class 
and the study of the benthic compartment (Chapter 7). 
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 Chapter 2 
Ecotoxicological assessment of the 
anticancer drug cisplatin in the 
polychaete Nereis diversicolor 
 
Published in: 
 Fonseca, T.G., Morais, M.B., Rocha, T., Abessa, D.M.S., Aureliano, M., Bebianno, 
M.J., 2017. Ecotoxicological assessment of the anticancer drug cisplatin in the polychaete 
Nereis diversicolor. Sci. Total Environ. 575, 162–172. doi:10.1016/j.scitotenv.2016.09.185 
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Abstract  
Anticancer drugs are designed to inhibit tumour cell proliferation by interacting with 
DNA and altering cellular growth factors. When released into the water bodies of municipal 
and hospital effluents these pharmaceutical compounds may pose a risk to non-target aquatic 
organisms, due to their mode of action (cytotoxic, genotoxic, mutagenic and teratogenic). 
The present study aimed to assess the ecotoxicological potential of the alkylating agent 
cisplatin (CisPt) to the polychaete Nereis diversicolor, at a range of relevant environmental 
concentrations (i.e. 0.1, 10 and 100 ng Pt L-1). Behavioural impairment (burrowing kinetic 
impairment), ion pump effects (SR Ca2+-ATPase), neurotoxicity (AChE activity), oxidative 
stress (SOD, CAT and GPXs activities), metal exposure (metallothionein-like proteins - 
MTLP), biotransformation (GST), oxidative damage (LPO) and genotoxicity (DNA 
damage), were selected as endpoints to evaluate the sublethal responses of the ragworms 
after 14-days of exposure in a water-sediment system. Significant burrowing impairment 
occurred in worms exposed to the highest CisPt concentration (100 ng Pt L-1) along with 
neurotoxic effects. The activity of antioxidant enzymes (SOD, CAT) and second phase 
biotransformation enzyme (GST) was inhibited but such effects were compensated by MTLP 
induction. Furthermore, LPO levels also increased. Results showed that the mode of action 
of cisplatin may pose a risk to this aquatic species even at the range of ng L-1.  
Keywords: Cisplatin, anticancer drugs, polychaetes, oxidative stress, genotoxicity.  
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2.1 Introduction 
The increase of global cancer incidence in the human population led to an increase 
of development, prescription and combination of drugs, with cytotoxic and cytostatic modes 
of action (Suspiro and Prista, 2011). They were designed to inhibit cell replication and 
transcription through direct or indirect interaction with DNA and induce mutagenic, 
cytotoxic, genotoxic and carcinogenic effects (Johnson et al., 2008; Besse et al., 2012; 
Parrella et al., 2014a). Excretion of chemotherapeutic drugs, unchanged or metabolized by 
patients, is considered the primary source by which these pharmaceuticals enter the water 
bodies, via municipal and/or hospital effluents (Johnson et al., 2008; Liu et al., 2010; Booker 
et al., 2014). Therefore, concern is now emerging about their fate in aquatic systems and 
long-term exposure to organisms at environmentally relevant concentrations. 
Among the cytotoxic drugs used in chemotherapy, platinum-based drugs (i.e. 
cisplatin; carboplatin; oxaliplatin) comprise the class L01XA of the anatomical therapeutic 
chemicals (ATC) which are used individually or in combination to treat various tumours, 
such as ovarian, testicular, bladder and lung cancers (Deans and West, 2011; Parrella et al., 
2014a). Cisplatin (CisPt), or cis-diammine-dichloroplatinum II, was approved for clinical 
uses in 1978 and is considered one of the most promising and widely used platinum-based 
therapeutic anti-cancer drugs (Arnesano and Natile, 2009; Gómez-Ruiz et al., 2012). Within 
24 h of intravenous infusion (i.e. 50-100 mg/m2 body surface), patients excrete 28 ± 4% of 
platinum complexes via urine (Dwyer et al., 2000; Vermorken et al., 1986), 40% in the form 
of monoaquacisplatin (Hann et al., 2003). In aqueous solutions of low chloride levels (i.e. 
intracellular fluids), CisPt chloro ligands are gradually hydrolysed according to the ionic 
strength of receiving waters in a stepwise process to generate cis-[PtCl(H2O)(NH3)2]
+ 
(monoaquacisplatin) and cis-[PtCl(H2O)(NH3)2]
+ (diaquacisplatin), the former  being 
associated with antitumour activity and toxicity (Hann et al., 2003; Lenz et al., 2005; Curtis 
et al., 2010).  More than 75% of CisPt enters sewage treatment plants and surface waters as 
the reactive monoaquacisplatin (Hann et al., 2003), with a propensity to interact with biotic 
and abiotic matrix (Curtis et al., 2010; Vyas et al., 2014).  
The contribution of platinum (Pt) from Pt-based drugs to the environment is smaller 
compared to other Pt sources such as car catalytic converters (Lenz et al.2007a; Curtis et al., 
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2010). Pt from chemoterapeutic drugs was detected in sewage treatment plants influents (1 
ng.L-1 to 250 µg L-1) and effluents (i.e. 2 µg L-1 to 150 µg L-1), from hospitals (< 10 to 145 
µg L-1) and surface waters (0.01 to 0.54 ng L-1) (Kümmerer et al., 1999; Lenz et al., 2005, 
2007a, 2007b; Vyas et al., 2014) but in the form of CisPt was only detected in hospital 
effluents (1.7 ng Pt L-1) (Hann et al.2005) and surface waters (0.0028 to 0.0125 ng Pt L-1) 
(Vyas et al., 2014) (Table 2.1). However, the behaviour and fate of CisPt in the marine 
environment remains unclear (Turner and Mascorda, 2015). Although pharmaceuticals are 
mainly hydrophilic and tend to be present in the dissolved form of the water column, the 
highly soluble CisPt molecule (log Kow = -2.19) has a high potential to be adsorbed to 
suspended solids and sewage sludge (Lenz et al.2005; 2007a; 2007b). The interaction with 
the solid fraction induces the formation of complexes with organic matter and partitions with 
the sediments (Moreno-González et al., 2015), where CisPt settles.  Sediments can then act 
as a reservoir of these compounds and provide their continual remobilization to the water 
column via resuspension or trophic transfer (Buruaem et al., 2012; Araujo et al., 2013; 
Rodrigues et al., 2013). 
Environmentally relevant concentrations of CisPt in aquatic sediments is unknown. 
Only Pt levels were detected in coastal and estuarine waters, ranging from 0.02 to 25 ng g-1 
(Tuit and Ravizza, 2000; Pratt and Lottermoser, 2007; Prichard et al., 2008; Cobelo-García 
et al., 2011). However, CisPt adsorption to sediments decrease from river to estuarine waters 
which is consistent with the reduction of reactivity of the CisPt degradation (Curtis et al., 
2010; Turner and Mascorda, 2015) and indicates that dispersal of CisPt is favored towards 
the marine environments, where physico-chemical conditions inhibit the hydroxo species 
formation (Turner and Mascorda, 2015). 
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Table 2.1: Concentrations of total Pt from Pt-based anticancer drugs (e.g. cisplatin; carboplatin; oxaliplatin) and Pt detected from cisplatin drug 
(ng L-1), in aquatic compartments. 
Hospital Effluent Wastewater Treatment Plants (WWTPs) Surface Water 
Detection Method Reference 
Total Pt Pt CisPt 
WWTPs influent 
(Total Pt) 
WWTPs influent 
(Total Pt) 
Total Pt Pt CisPt 
- - 3,000 - 250,000 (a) 2,000 - 150,000 (a) - - ICP-MS; HPLC-ICP-MS 
Lenz et al. (2007a, 
2007b) 
4,700 - 145,000 - - - - - ICP-MS Lenz et al. (2005) 
30 - 84,590 - - - 0.01 - 0.540 0.0028 - 0.0125 (b) ICP-MS Vyas et al. (2014) 
<10 – 601 - - - - - 
Adsorptive 
Voltammetry 
Kummerer et al. (1999) 
38.2 - 110.6 - 38.2 - 110.6 - - - 
Adsorptive 
Voltammetry 
Steger-Hartmann et al. 
(1997) 
- 1.7 (a) - - - - HPLC-ICP/MS Hann et al. (2005) 
(a) 24-hour composite samples; (b) Estimated concentration according to effluent rate discharge. 
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Although the MoA and uptake of CisPt to aquatic organisms remains poorly 
understood, the uptake in cancer cells occurs by passive diffusion or via copper transporter 
proteins, such as copper transporter 1 (CTR 1) (Holzer et al., 2006). CisPt reactive products 
are highly electrophilic and act towards nucleophilic sites in genomic and mitochondrial 
DNA, producing DNA inter- and intra-strand adducts that result in DNA distortion, 
inhibition of DNA replication and interruption of cell division (Gonzalez et al., 2001; Fuertes 
et al., 2003; Dasari and Tchounwou, 2014). Furthermore, CisPt has DNA-unrelated effects 
and can bind to nitrogen and sulphur nucleophilic sites of proteins, phospholipid membranes 
and cytoskeleton, while enzyme activities, receptor and protein functions are highly affected, 
with consequent metabolic impairment that can lead to cellular apoptosis or necrosis 
(Gonzalez et al., 2001; Fuertes et al., 2003; Dasari and Tchounwou, 2014; Gatti et al., 2015). 
The resistance to counteract CisPt activity is mainly due to the reduction of CisPt 
accumulation in cells; the increase of DNA repair; Pt inactivation through conjugation with 
glutathione; and binding to methalothioneins (Arnesano and Natile, 2009; Tadini-
Buoninsegni et al., 2014).  
The ecotoxicological impact of CisPt in aquatic organisms is scarce and was mainly 
reported for freshwater species, such as protozoans (Tetrahymena pyriformis), rotifers 
(Brachionus calyciflorus), microalgae (Pseudokirchneriella subcapitata), crustaceans 
(Daphnia magna; Ceriodaphnia dubia) and fish (Danio rerio), which showed effects on 
growth and reproduction inhibition (Bonnet et al., 2003; Zounková et al., 2007; Brezovsek 
et al., 2014), acute immobilization (Zounková et al., 2007), embryotoxicity (Kovács et al., 
2015), cytotoxicity (Gajski et al., 2016) and mortality (Parrella et al., 2014a; Kovács et al., 
2015). CisPt causes genotoxic effects in aquatic organisms, such as the induction of DNA 
strand breaks as observed in the microcrustaceans Daphnia magna and Ceriodaphnia dubia 
after 24 hours of exposure (10 and 300 ng Pt L-1, respectively) (Parrella et al., 2015), and in 
the marine mussel Mytillus galloprovinciallis after exposure to 100 ng Pt L-1 (Trombini et 
al., 2016a).  
Benthic and epibenthic species accumulate contaminants by dermal contact and 
dietary strategies, such as filtration of suspended solids and/or intake of sediment particles 
and fractions associated to organic matter (Simpson et al., 2005), but little is known about 
the fate of pharmaceuticals in these species. The polychaete Nereis (Hediste) diversicolor is 
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a deposit feeder that also scavenges for organic matter and detritus on the sediments surface 
where it plays a relevant ecological role due to bioturbation, particle mixing and irrigation 
of benthic galleries (Solé et al., 2009). Therefore, N. diversicolor was considered a suitable 
model for biomonitoring purposes and application in ecotoxicology assays with emergent 
contaminants (Cong et al., 2011; Buffet et al., 2014a), including pharmaceutical compounds 
(Maranho et al., 2015). 
Adverse sublethal effects regarding physiological and biochemical responses after 
exposure of benthic species to different classes of pharmaceuticals (e.g. anti-inflammatory; 
oral contraceptive; anticonvulsant; antidepressant) were reported (Maranho et al., 2014; 
2015). Biomarkers of behaviour impairment, neurotoxicity (acetylcholinesterase – AChE), 
antioxidant activity (superoxide dismutase – SOD; catalase – CAT; glutathione-peroxidases 
– GPx), biotransformation (glutathione-S-transferases – GST), oxidative damage (lipid 
peroxidation - LPO) and genotoxicity (DNA strand breaks) were considered reliable 
endpoints to assess pharmaceuticals toxicity (Aguirre-Martínez et al., 2013; Gonzalez-Rey 
and Bebianno, 2013; Maranho et al., 2014; 2015). In this sense, the present study aims to 
assess the adverse effects of the CisPt anticancer drug to the ragworm N. diversicolor, at a 
range of relevant environmental scenarios (i.e. 0.1, 10 and 100 ng Pt L-1). The approach 
involves the assessment of behavioural impairment (burrowing kinetic impairment), ion 
pump effects (SR Ca2+-ATPase), neurotoxicity (AChE activity), oxidative stress (SOD, 
CAT, GPXs activities), biotransformation (GST activities), metal exposure  
(metallothionein-like protein- MTLP), oxidative damage (LPO) and genotoxicity (DNA 
damage), after 14 days of exposure to a contaminated water-sediment system. To the best of 
our knowledge, this is one of the first multibiomarker approaches encompassing anticancer 
drugs and marine organisms, with relevance to understand their risk in coastal and benthic 
habitats.  
2.2  Materials and Methods 
2.2.1 Chemicals 
Analytical standard of cis-platinum (II) diamine dichloride (CisPt) (CAS 15663-27-
1) was obtained from Sigma-Aldrich (Portugal). CisPt stock solution (123.07 mg L-1) was 
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prepared in ultrapure Milli-Q water. For safety handling of cytotoxic drug, experimental 
work was performed using class II biological safety cabinet, with appropriate clothing (open-
back, impervious chemotherapy protection gown, double powder-free latex gloves and 
safety goggles). Test solution concentrations were selected according to a range of Pt-based 
anticancer drugs levels screened in water bodies and effluents (Table 2.1) and were 0.1, 10 
and 100 ng Pt L-1 (all nominal concentrations). 
2.2.2 Sediment characterization 
Sediments were sampled in the Ria Formosa lagoon (Tavira, Portugal), and sieved 
through a 2-mm mesh to remove large debris. Sediments were dried at 80°C (adapted from 
Thain and Bifield, 2001; ASTM, 2009) to remove volatile compounds and water. Grain size 
distribution was assessed on dry aliquots of sediments according to the method proposed by 
Royse (1970). Organic matter content was determined by loss on ignition (550°C, for 5 h), 
by the method described by Gross (1971). Results obtained were 22.3% of sand, 77.7% of 
fines and 0.55% or organic matter content. 
2.2.3 Experimental design 
Specimens of N. diversicolor (5-7 cm length; 0.21 g ± 0.06) were supplied from an 
aquaculture of the Portuguese Institute of the Sea and Atmosphere (IPMA) (Tavira, Portugal) 
and transported alive to the laboratory in tanks with natural seawater and sediments and 
maintained at constant aeration for one week. Twenty animals were randomly transferred to 
plastic aquaria of 10 L (each animal/30 cm2), in a triplicate design, with a proportion of 1:4 
sediments/water. Systems were kept under constant aeration and a light period of 12:12 
hours. Natural seawater was renewed every 48 hours followed by redosing of CisPt to 
maintain nominal concentrations in the water phase during the experiment. Physico-
chemical parameters: salinity, temperature and pH were determined in seawater (35.45 ± 
1.2; 18.3 ± 0.8 °C; 7.99 ± 0.07, respectively). For each biochemical analysis (i.e. antioxidant 
enzymes; AChE; LPO/MT), measurements were carried out individually (n = 6 per 
treatment). Animals were collected at the beginning of the experiment (Control CT 0) and 
after 14 days of exposure (Control CT 14; 0.1, 10 and 100 ng Pt L-1). Organisms used for 
behavioural (n = 15 per treatment) and comet assays (n = 15 per treatment) were immediately 
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handled, whereas those for biochemical endpoints were rinsed with clean seawater, frozen 
in liquid nitrogen and stored at -80 °C until further use. 
2.2.4 Sarcoplasmic reticulum Ca2+ - ATPase 
Preparation of sarcoplasmic reticulum vesicles 
Isolated sarcoplasmic reticulum vesicles (SRV), prepared from freshly obtained 
skeletal rabbit muscles described elsewhere (Fraqueza et al., 2012) were suspended in 0.1 
M KCl, 10 mM HEPES (pH 7.0), diluted 1:1 with 2.0 M sucrose and frozen in liquid nitrogen 
prior to storage at -80 °C. Protein concentrations were determined spectrophotometrically at 
595 nm, by the Bradford method, using bovine serum albumin as a standard. The percentage 
of each protein present in the SRV preparations was determined through densitometry 
analysis of SDS-polyacrylamide gel electrophoresis (7.5% acrylamide). The SR Ca2+-
ATPase analysed by SDS polyacrylamide gel electrophoresis comprised at least 70% of the 
total protein in the SR-vesicles. The SERCA-1, (sarcoplasmic, or endoplasmic reticulum 
Ca2+-ATPase-1) was the predominant isoform in the SR preparations (Fraqueza et al., 2012). 
ATP Hydrolysis by Calcium Pump 
Steady-state assays of the sarcoplasmic reticulum Ca2+-ATPase were measured 
spectrophotometrically at 25˚C using the coupled enzyme pyruvate kinase/lactate 
dehydrogenase assay (Aureliano et al., 2008), under the following conditions: 25 mM 
HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 50 μM CaCl2, 2.5 mM ATP, 0.42 mM 
phosphoenolpyruvate, 0.25 mM NADH, 18 IU lactate dehydrogenase and 7.5 IU pyruvate 
kinase, with or without CisPt. The experiments were initiated by the addition of 10 μg/ml 
calcium ATPase, in the presence or absence of 4% (w/w) of calcium ionophore A23187. 
CisPt concentrations (up to 4 and 8 mM) were added to the medium immediately prior to 
protein addition. Furthermore, within the concentration range studied, CisPt solutions did 
not affect the coupled enzyme method used in the assays, as observed upon addition of 40 
μM ADP. Briefly, after the addition of the enzymes to the medium, NADH was added 
followed by the vesicles from skeletal muscle sarcoplasmic reticulum. Then, after the 
addition of ATP the absorbance was recorded during about 1 minute (basal activity) and 
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after the ionophore was added the decreased of the absorbance was measured during about 
2 minutes (uncoupled ATPase activity). The ATPase activity and the inhibition of CisPt was 
measured taken into consideration the decrease of OD per minute in the absence (100%) and 
in the presence of CisPt (Fraqueza et al., 2012). 
2.2.5 Behaviour assay 
Unexposed and exposed worms were submitted to a burrowing test according to 
Bonnard et al. (2009). Ten animals were carefully placed individually in 150 mL-plastic 
containers, filled with natural seawater and 5 cm of sediments. Over a period of 30-minutes, 
the position of each worm was recorded every two minutes to establish the time that each 
worm was fully buried. The results are expressed as the percentage (%) of unburied 
specimens over time (min).  
2.2.6 Biochemical analysis  
Neurotoxicity 
For AChE activity determination, whole tissues were individually homogenized in 
100 mM Tris-HCl buffer (pH 8) containing Triton 0.1 % and centrifuged at 12,000 g (30 
min, 4 °C). The supernatant was split into two 500 µL aliquots for total protein determination 
and AChE activity. The assay was conducted by inserting the reaction mixture in each 
microplate well, containing 50 µL of the sample, 0.75 mM 5,5-dithiobis-2-nitrobenzoic acid 
(DTNB) in 0.1 M Tris HCl, and 3 mM acetylcholine (ATC). The method measures the 
absorbance of 5-mercapto-2-nitrobenzoato (yellow) (coefficient of extinction of  = 13.6 
mM-1 cm-1) formed by the reaction of thiocholine, a product of ATC cleavage by AChE with 
DTNB, at 405 nm (λmax for DTNB is 412 nm) (Ellman et al., 1961; Colovic et al., 2013). 
AChE activity is expressed as ATC.min-1 mg-1 protein.  
Antioxidant enzymes 
Tissues for the measurement of antioxidant enzymes were individually homogenized 
in 20 mM Tris-HCl buffer (0.5 M sucrose, 0,075 M KCl, 1 mM DTT, 1 mM EDTA), adjusted 
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to pH 7.6 and centrifuged at 500 g (15 min, 4 °C) to separate the cytosolic fraction. The 
supernatants were further re-centrifuged at 12,000 g (45 min, 4 °C), to separate the 
mitochondrial fraction. Antioxidant enzymes activities were determined in the cytosolic 
fraction. SOD activity was analysed according to the method of McCord and Fridovich 
(1969), by measuring the decrease of absorbance of substrate cytochrome-c through xanthine 
oxidase/hypoxanthine system, at 550 nm. Results are expressed as U mg-1 protein. CAT 
activity was determined by spectrophotometry using a microplate reader by measuring the 
decrease of absorbance at 240 nm due to the presence of hydrogen peroxide concentration 
(Greenwald, 1985). CAT is expressed in µmol min-1 mg-1 protein. Total GPX activity was 
measured in a microplate reader, at 340 nm, based on the method adapted from Lawrence 
and Burk (1976). The reaction consists in the reduction of oxidized glutathione linked to the 
oxidation of NADPH in the presence of excess glutathione reductase. Cumene 
hydroperoxide and H2O2 were used as substrates for T-GPx and Se-GPx, respectively. 
Results are expressed in nmol min–1 mg–1 protein.  
Glutathione-S-transferases (GST) 
The activity of GST was measured in the spectrophotometric assay according to the 
method described by Habig et al. (1974). The conjugation of the worm samples with 0.2 mM 
reduced GSH with 0.2 mM 1-chloro-2,4-dinitrobenzene (CDNB) in a mixture of 0.2 M 
KH2PO4/K2PO4 buffer (pH 7.9) was measured, with a molar extinction coefficient (ε) of 0.6 
mM-1 cm-1. The change in absorbance was recorded at 340 nm. GST activity is expressed in 
nmol min-1 mg-1 protein.  
Metallothionein-like proteins (MTLPs) 
Whole tissues of N. diversicolor were individually homogenized in Tris-HCl buffer 
(0.02 M, pH 8.6) and butylated hydroxy toluene (BHT) (10 μl BHT per mL Tris–HCl buffer). 
The homogenate was centrifuged at 30,000g for 45 min (4°C). Aliquots of the supernatant 
were separated for further use in LPO and total proteins quantification (Cravo et al., 2012). 
The remaining supernatant was heat-treated at 80 °C for 10 min to precipitate the high 
molecular weight proteins, and re-centrifuged at 30,000 g for 45 min at 4 °C. The obtained 
cytosolic fraction was stored at −80 °C for MTLP quantification by differential pulse 
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polarography according to the method described by Bebianno and Langston (1989). Levels 
of MTLPs are expressed as mg mg-1 protein. 
Oxidative damage 
LPO was assessed by determining the absorbance of malondialdehyde (MDA) and 
4-hydroxyalkenals (4-HNE) concentrations, at 540 nm, following the method described by 
Erdelmeier et al. (1998), adapted for microplate reader. LPO is expressed as nmol MDA + 
4-HNE mg−1 protein. 
Total proteins concentration 
Total proteins concentration was determined following the method described by 
Bradford (1976), adapted for microplate reader using bovine serum albumin (BSA) as a 
standard.  
Genotoxicity assay 
Genotoxicity endpoint was assessed by the Comet assay, based on the slightly 
modified protocol of Singh et al. (1988), and described in Gomes et al. (2013). Extraction 
of the polychaetes coelomocytes was performed at the beginning and end of the exposure 
period, according to Lewis and Galloway (2008). Briefly, coelomic fluid of N. diversicolor 
(n=15) was extracted from the posterior region of the polychaete body into 20 µL of PBS 
buffer with a 0.5 mL-syringe fitted with hypodermic needle. The mixture was centrifuged at 
835 g (3 min, 4 °C), and the pellets were used for the comet assay. Slides were previously 
cleaned in alcohol/ether and coated with 0.65 % normal melting point agarose (NMA) in 
Tris-acetate EDTA. Isolated cells from centrifugation were suspended in 0.65 % low melting 
point agarose (LMA, in Kenny's salt solution; 0.4 M NaCl, 9 mM KCl, 0.7 mM KH2PO4, 
2Mm NaHCO3, 1000 ml Milli-Q water) and casted on the microscope slides. Then slides 
with the embedded cells were immersed for 1 hour, in a lysis buffer (100 mM EDTA, 2.5 M 
NaCl, 10 mM Tris, 1% Triton X-100, 10% Dimethylsulfoxide,1% Sarcosil, pH 10, 4 °C) for 
the diffusion of cellular components and DNA immobilization in agarose. Following the 
lysis step, slides were gently placed in an electrophoresis chamber containing electrophoresis 
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buffer (300 mM NaOH, 1 mM EDTA, adjusted at pH 13, 4 °C) and left for 15 min to permit 
DNA unwinding. The electrophoresis was performed at 25 V and 300 mA, over 5 min.  
Afterwards, microscope slides were soaked with neutralizing solution (0.4 mM Tris, 
pH 7.5), for 15 min, and finally rinsed with distilled water and dried overnight. For further 
comets assessment, slides were stained with 4,6-diamidino-2-phenylindole (DAPI, 1 mg ml-
1) and analysis made through optical fluorescence microscope (Axiovert S100) coupled with 
a camera (Sony). The image analysis system Komet 5.5 (Kinetic Imaging Ltd) was used to 
score 50 randomly chosen cells for each slide, at a total magnification of ×400. The amount 
of DNA in the comet tail (tail DNA %) was used and results are expressed as mean ± standard 
deviation.  
Statistical analysis  
Data was tested for normality and homogeneity of variance by Kolmogorov-Smirnov 
and Brown-Forsyth tests, respectively. Once these assumptions were tested, one-way 
analysis of variance (ANOVA or non-parametric Kruskal-Wallis test was performed. As a 
result of these tests, all data, except GPx, was treated as parametric. The post-hoc Tukey test 
for multiple data comparisons was applied to discriminate significant differences among 
treatments (p < 0.05). Behavioural status of organisms was analysed by linear regression, 
considering the interval of continuous burrowing in the sediments. Principal component 
analysis (PCA) was used to evaluate the influence CisPt concentrations on biochemical 
biomarkers and DNA damage, in control and exposed polychaetes. Statistical analysis was 
conducted with GraphPad Prism® software (v. 6, 2014) and PAST® software (v. 3.10, 
2015). 
2.3 Results 
2.3.1 Effects of CisPt in Ca2+ - ATPase activity 
Sarcoplasmic reticulum (SR) plays a crucial role in calcium homeostasis and in 
regulating muscle contraction. Sensitivity of SR Ca2+-ATPase activity has been documented 
by the increase of basal cytosolic Ca2+ concentration after incubation with toxic and/or 
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contaminant metals solutions (Aureliano and Crans, 2009). In the present study, the 
inhibition of the SR Ca2+-ATPase activity by CisPt was analysed to relative higher 
concentrations (8 mM) of CisPt. As observed in Figure 2.1, even for concentrations up to 8 
mM of CisPt, the activity of the calcium pump was only inhibited about 40%. For this ion 
pump activity, it was estimated an IC50 of about 13.7 mM for CisPt solutions. 
 
Figure 2.1: Inhibition of sarcoplasmic reticulum calcium pump by CisPt. 
 
2.3.2 Behavioural Assay 
Burrowing behaviour of polychaetes over time is presented in Figure 2.2. Linear 
regression showed no significant differences among slopes in the burrowing of worms 
exposed to the different treatments (p > 0.05). Nevertheless, a similar trend of burrowing 
kinetic was observed between unexposed organisms (Y = -12X + 106; r = 0.97; p < 0.05) 
and those exposed to 0.1 ng Pt L-1 (Y = -14X +114; r = 0.9615; p < 0.05), where all 
polychaetes were fully buried after 8 minutes. Meanwhile, specimens exposed to 10 (Y = -
10X + 106; r = 0.96; p < 0.05) and 100 ng Pt L-1 (Y = -7.1X + 97.14; r = 0.93; p < 0.05) 
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showed a slower burrowing rate, with organisms unable to burrow the sediment by the end 
of the assay. 
 
Figure 2.2: Burrowing behaviour of N. diversicolor unexposed (CT14 – control at day 14) 
and exposed to CisPt (0.1, 10 and 100 ng Pt L-1), expressed as percentage of unburied 
organisms over time (minutes). 
 
2.3.3 Biochemical analysis 
Neurotoxicity 
Results of AChE activity are expressed in Figure 2.3. AChE levels were similar 
between controls over time (p > 0.05). An increasing trend was observed for polychaetes 
exposed to 0.1 ng Pt L-1 and 10 ng Pt L-1 although not significantly different from controls 
(p > 0.05). Polychaetes exposed to 100 ng Pt L-1 showed a significant inhibition of AChE 
activity compared to controls (p > 0.05). 
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Figure 2.3: AChE activity (mean ± standard deviation) (ATC.min-1.mg-1 protein) in N. 
diversicolor unexposed (CT0 and CT14) and exposed to CisPt (0.1, 10 and 100 ng Pt L-1) 
for 14 days. Different letters indicate statistically significant differences among treatments 
(One-way ANOVA; p < 0.05). 
 
Antioxidant enzymes 
In the present study, antioxidant enzymes of control polychaetes did not change over 
time (p > 0.05). SOD activity showed a significant inhibition (i.e 2.3-fold) in worms exposed 
to 100 ng Pt L-1 (p < 0.05) (Fig. 2.4A). Similarly, exposure to the highest CisPt concentration 
resulted in a clear inhibition (i.e. 2.3-fold) of CAT activity (p < 0.05) (Fig. 2,4B). In contrast, 
CisPt yielded a significant increase in GPx Se-dependent activity and levels ranged from 
0.05 ± 0.01 nmol min-1 mg-1 protein to 0.22 ± 0.07 nmol min-1 mg-1 protein for worms 
exposed to 100 ng Pt L-1 (p < 0.05) (Fig. 2.4C). Regarding T-GPx, the activity indicated a 
bell-shape behaviour, where the activity of this enzyme was significantly inhibited after 0.1 
ng Pt L-1 exposure and induced after 100 ng Pt L-1 exposure (Fig. 2.4D) (p < 0.05). 
Furthermore, GST activity was only inhibited at the highest CisPt concentration (p < 0.05) 
(Fig. 2.4E). 
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Figure 2.4: Mean ± standard deviation of (A) SOD, (B) CAT, (C) GPx Se-dependent, (D) 
Total GPx, (E) GST and (F) MT in N. diversicolor unexposed and exposed to CisPt (0.1, 10 
and 100 ng Pt L-1) for 14 days. Different letters indicate statistically significant differences 
among treatments (One-way ANOVA (A, B, C, D, F) and Kruskal Wallis (E); p < 0.05). 
 
Metallothionein-like Proteins (MTLPs) 
Results showed a significant increase in MTLPs levels (p < 0.05) only at the highest 
CisPt concentration (100 ng Pt L-1), accounting for a 2-fold increase when compared to 
controls (Fig. 2,4F). 
Oxidative damage 
LPO products over the exposure conditions presented an increasing trend but only 
significant at the highest drug concentration compared to controls (p < 0.05) (Fig. 2,5). 
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Figure 2.5: LPO activity (mean ± standard deviation) (MDA+ 4-HNE nmol.mg-1 protein) in 
N. diversicolor unexposed (CT0 and CT14) and exposed to CisPt (0.1, 10 and 100 ng Pt L-
1) for 14 days. Different letters indicate statistically significant difference among treatments 
(One-way ANOVA; p < 0.05). 
 
2.3.4 Genotoxicity  
Genotoxicity data, expressed as percentage of DNA tail, are presented in Figure 2,6. 
No changes in DNA damage were observed for any treatment (p > 0.05). 
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Figure 2.6: DNA (mean ± standard deviation) in tail, in N. diversicolor unexposed (CT0 
and CT14) and exposed to CisPt (0.1, 10 and 100 ng Pt L-1) for 14 days. Different letters 
indicate statistically significant differences among treatments (One-way ANOVA; p < 0.05). 
 
2.3.5 Principal Component Analysis (PCA) 
Biochemical biomarkers and genotoxicity data were integrated in a multivariate 
analysis in order to detect patterns of variation (Figure 2.7). PCA results indicated that the 
two principal components represent 89.8% of total variance (PC1 = 75.6 %; PC2= 14.2%). 
High correlation loadings in the first component indicated that antioxidant enzymes SOD, 
CAT, GST and AChE activity were inhibited at the highest CisPt level (i.e. 100 ng Pt L-1). 
SOD and CAT neutralize ROS, and their decrease together with GST reduction favor the 
depletion of cell defenses while Se-GPx, MT and LPO were the opposite. The second 
component indicates a relationship between LPO and genotoxicity endpoints. The overall 
PCA clear separates the worms exposed to 100 ng Pt L-1 from controls and from those 
exposed to the lower CisPt concentrations. Moreover, worms exposed to 0.1 ng Pt L-1 were 
closely associated to those for controls, reflecting the effectiveness of antioxidant systems 
and absence of harmful effects at this level of CisPt concentration. 
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Figure 2.7: Principal Component Analysis (PCA) of biochemical biomarkers and DNA 
damage analysed in N. diversicolor at controls (CT0 and CT14) and CisPt-contaminated 
conditions, for 14 days. 
 
2.4 Discussion 
CisPt is widely used for treatment of different types of tumours including head and 
neck, lung, ovarian, leukaemia, breast, brain, kidney and testicular cancers (Dasari and 
Tchounwou, 2014). CisPt acts in mammals over the N7 centres of purine residues, especially 
guanine, mainly generating 1,2-intrastrand d (GpG) adducts and 1,2-intrastrand d (ApG), 
besides the enhancement of oxidative stress and damage in mitochondrial proteins, which 
result in an overall failure of cellular function and apoptosis (Chu, 1994; Dasari and Bernard 
Tchounwou, 2014; Reedijk, 1999). The drug´s MoA and toxicity was extensively studied in 
mammals, where ototoxicity, nephrotoxicity and gastro toxicity are the main side effects 
0.1 
CisPt 
M
T 
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(Karasawa and Steyger, 2015). The diffuse, worldwide and frequent discharge of effluents 
containing cytotoxic drugs in coastal water bodies brings ecological and environmental 
concern regarding the chronic exposure of these chemicals to biota, even at low 
concentrations. Ecotoxicological assays with anticancer drugs in aquatic organisms are now 
emerging, although approaches with marine benthic species are lacking. 
In the present study, the effects of CisPt on the function of the sarcoplasmic reticulum 
Ca2+-ATPase were investigated to evaluate putative effects on calcium homeostasis. It was 
assumed that the onset of contraction in polychaetes muscle is triggered by similar 
mechanisms as in vertebrates, once previous studies have shown that energy transduction 
catalysed by Ca2+-ATPase is highly conserved through evolution, as observed in marine 
invertebrates (Garcia et al., 1975; Cario et al., 1995; Landeira-Fernandez et al., 2001). CisPt 
had no effect on Ca2+-ATPase activity, in particular for the CisPt concentrations normally 
found in the environment (Figure 2.1). Therefore, inhibition of Ca2+-ATPase activity by 
cisplatin seems unlikely as a cause of CisPt toxicity, although CisPt can decrease ATPase 
activity in vitro. Other studies estimated IC50 values in the order of 2 to 5 mM for similar ion 
pumps, but for longer incubation periods such as 2 hours (Uozumi and Litterst, 1985). 
However, the lower ATPase activity inhibition by CisPt can, at least in part, be due to the 
solvent (DMSO) used. It can react with CisPt and therefore and in this situation is not a good 
solvent. Recently it was reported that IC50 values increased up to about 10- and 60-fold, 
respectively, for carboplatin and cisplatin prepared in DMSO whereas no effects were 
observed for others Pt complexes such as oxaliplatin and satraplatin (Hall et al., 2014). 
Therefore, certain precautions should be taken when using solvents in in vitro and in vivo Pt 
drugs studies. The multibiomarker approach linking behavioural, biochemical and 
genotoxicity endpoints provide important information about the impact caused by pollutants 
in aquatic organisms (Durou et al., 2007; Gusso-Choueri et al., 2016). Burrowing 
impairment comprises an ecological valuable biomarker of stress reflecting disturbances in 
organisms´ fitness, such as food seeking and predator avoidance (Bonnard et al., 2009).  
The suitability of burrowing behaviour is a reliable and sensitive biomarker when 
defence mechanisms are not enough to prevent impairments (Amiard-Triquet, 2009; Buffet 
et al., 2012). N. diversicolor plays an important ecological role due to bioturbation, that 
provides irrigation and particle mixing via burrowing and feeding (Thit et al., 2015). 
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Alteration of such behaviour provide harmful ecological outcomes (Bonnard et al., 2009). 
In addition, increase of burrowing time may facilitate worm predation on the sediment 
surface (Amiard-Triquet, 2009). Results on behaviour (Figure 2.2) clearly indicate a 
perturbation on burrowing of organisms exposed to the highest CisPt concentration (100 ng 
Pt L-1) that were not fully buried by the end of the assay (Fig. 2.2). To date, burrowing 
responses of endobenthic organisms after exposure to pharmaceuticals are lacking. 
Meanwhile, Cong et al. (2014) addressed an increase in burrowing time in specimens of N. 
diversicolor exposed to Ag nanoparticles, at concentrations of 50 and 100 µg Ag mg-1 d.w. 
in the sediments, corroborating with high cytotoxic and genotoxic potential of Ag 
nanoparticles on burrowing behaviour. Decrease burrowing of N. diversicolor, compared to 
controls, was also observed after exposure to copper (Buffet et al., 2011; Thit et al., 2015) 
and sediment-spiked copper oxide nanoparticles (Thit et al., 2015).  
Alteration of behaviour and locomotion may be a response to neurotransmitters 
inhibition, which play a key role in the nervous system (Boyd et al., 2002; Bonnard et al., 
2009). AChE activity is vital for normal muscular function and behaviour of most species, 
because it is involved in the nervous transmission by a rapid hydrolysis of the 
neurotransmitter acetylcholine in acetate and choline at the nervous systems (Payne et al., 
1996; Carajaville et al., 2000). Inhibition of AChE is well-recognized as a biomarker of 
exposure to neurotoxic compounds (Aguirre-Martínez et al., 2016a; Damásio et al., 2011). 
Herein, AChE levels increased with increasing Pt concentrations until 10 ng Pt L-1, following 
a strongly inhibition at the highest CisPt concentration (100 ng Pt L-1) (Fig. 2.3). This 
behaviour depicts a hormesis phenomenon, comprised by the stimulation of a response 
(AChE activity) at a dose below the pharmacological/toxicological threshold (Calabrese and 
Blain, 2005; Aguirre-Martínez et al., 2016a) that is in an attempt to mitigate the neurotoxic 
effects against the transitory drug effect (Milan et al., 2013; Aguirre-Martinez et al., 2016a).  
According to Calabrese and Baldwin (2001) it is an adaptive response that results in 
an improved physiological fitness, for a finite and generally short period.  In this sense, 
behavioural interferences at 10 ng Pt L-1 may be associated to such mitigation effort, whereas 
at 100 ng Pt L-1 it may be due to AChE inhibition, thus neurotoxicity (Milan et al., 2013; 
Aguirre-Martinez et al., 2016a). A similar upregulation followed by an inhibition of AChE 
activity was observed in the clam Ruditapes phillipinarum after exposure to caffeine (5 to 
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50 µgL-1) and carbamazepine (0.1 to 50 µg L-1) for 14 days (Aguirre-Martinez et al., 2016a). 
This trend was also addressed at fluoxetine exposure using the clam Venerupis 
philippinarum (1 and 5 µg L-1; Munari et al., 2014) and the mussel Mytillus galloprovincialis 
(75 ng L-1; Gonzalez-Rey and Bebianno, 2013). 
Levels of AChE activity in N. diversicolor also increase significantly after 14 day-
exposure to sediment spiked with ibuprofen, carbamazepine, fluoxetine and EE2, showing a 
situation where hormesis did not occur, due to a combination of the test organisms, dose and 
pharmaceutical compounds selected (Cossu et al., 2000; Gonzalez-Rey and Bebianno, 2013; 
Maranho et al., 2015; Aguirre-Martinez et al., 2016a). CisPt is an organo-metallic compound 
designed to perform neurological side-effects in human erythrocytes, arising neurotoxicity 
as an effect of interaction of the molecule with AChE (Aljafari, 1995). The electrophilic 
reactive products of hydrolysis, containing Pt may be the key factor for the inhibition of 
AChE activity and this may be the case in the worms exposed to the highest CisPt 
concentration.  
CisPt hydrolysed species are strongly electrophilic and can react with nucleophile 
binding sites, including the thiol groups SH- of biomolecules. In this sense, the nucleophile 
reduced glutathione (GSH) is one of the main target of CisPt drug (Gonzalez et al., 2001) 
and acts as a protection ligand against drug toxicity and side effects without interfering in 
the antitumour activity (Reedjik, 1999). It has an important role in regulation of inner 
mitochondrial permeability and enzyme function by keeping SH- in the reduced state, thus 
acting on protection against oxidative stress (Reedjik, 1999). GSH reacts with CisPt and 
other electrophilic compounds to form deactivated conjugates that are readily excreted by a 
GS-conjugated export pump. This reaction may occur spontaneously or with the enzymatic 
help of GST (Fuertes et al., 2003; Penner et al., 2012). GSH depletion in cells may lead to 
the reduction of GST activity, as observed in worms exposed to 100 ng Pt L-1 (Fig. 2.4E). In 
addition, CisPt-GSH conjugation generates thiyl radicals (RS●) able to produce reactive 
oxygen species (ROS) (Slater, 1984; Desoize, 2002; Aquilano et al., 2014).  
In order to prevent ROS interaction with critical cellular macromolecules, SOD plays 
the primary defense role against oxygen toxicity by catalyzing the conversion of O2
-, to H2O2 
through dismutation reaction, whilst CAT degrades H2O2 to H2O (Van den Berg et al., 2005). 
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In the present study, the significant decrease of both enzyme activities in worms exposed to 
the highest CisPt concentration (Fig. 2.4) indicate an impairment of their activity that could 
be attributed to a possible excess of reactive oxygen intermediate species. Hence, the 
increase of Se-GPx in worms exposed to 100 ng Pt L-1 may be a response to counteract the 
impairment of hydrogen peroxide metabolism, usually provided by SOD and further 
generation of pro-oxidant products required for neutralization (Catalano et al., 2012; Gomes 
et al., 2014). Se-GPx acts by reducing organic peroxides and is known as a critical tool to 
mitigate oxidative stress caused by a wide diversity of electrophilic species (Prahbu et al., 
2004).  
Previous biochemical approaches using N. diversicolor indicated a noteworthy 
responsiveness of antioxidant system to contaminated sediments (Durou et al., 2007; 
Kalman et al., 2009; Maranho et al., 2014). The trend of detoxification process encompasses 
the increment of GST and of CAT levels, which might suggest a relationship between those 
enzymes playing their role against oxidative stress, due to an improvement of neuromuscular 
status and the absence of LPO products (Solé et al., 2009; Buffet et al., 2011; Buffet et al., 
2014a). In the present study, the first axis of PCA (75.6%) supports the connected 
mechanisms of biochemical impairments but does not occur in worms exposed to the higher 
concentration where a clear inhibition of SOD, CAT and GST indicate a lack of enough 
protection against ROS, neurotoxicity and membrane damage, as supported by the PCA 
analysis (Fig. 2.7). The deficiency on enzymatic activities in the worms exposed to the 
highest CisPt concentration suggest a precarious state of biochemical conditions, promoting 
a high susceptibility for biological systems (Cossu et al., 2000), as observed in burrowing 
behaviour, and propensity to lipid peroxide generation (Buffet et al., 2012). 
The induction of MTLP was recognized as a potential biomarker of metal exposure 
in aquatic organisms (Amiard et al., 2006; Won et al., 2008). These cysteine-rich metal-
binding proteins act on metal detoxification and homeostasis by forming inactive complexes 
with metal in the cytosol or excreted through their thiol groups (Gagné et al., 2008; Won et 
al., 2008; Huska et al., 2009). The presence of MTLPs in annelids was addressed by several 
authors (Geracitano et al., 2004; Perez et al., 2004; Poirier et al., 2006; Won et al., 2008). 
However, previous studies reported no significant relationship between MTLP induction and 
the overall metal concentrations in N. diversicolor, suggesting that this biomarker does not 
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reflect metal bioavailability on this biological model (Poirier et al., 2006; Gomes et al., 
2013). Comprehension of functional genomic and transcriptomic responses of MTLPs in 
ragworms was first described by McQuillan et al. (2014), which identify two putative MTLP 
genes encoding cysteine-rich proteins (i.e. Cd/Se MT and atypical MTLP), after Cu long-
term exposure. In the present study, MTLP levels significantly increased in worms exposed 
to the highest CisPt concentration (i.e. 100 ng CisPt L-1) (Fig. 2.4). On the route to DNA 
attack, CisPt species interact with biomolecules containing methionine and cysteine residues 
(Reedjik, 1999), followed by an increase of the thiol-containing protein levels (Jamieson and 
Lippard, 1999; Siddik et al., 2003; Supalkova et al., 2008).  
MTLP overexpression seems to be an useful cellular defence against CisPt and is 
determinant in drug resistance during chemotherapy, by decreasing the level of the 
antitumour agent available for interaction with the target DNA (Doz et al., 1993; Hagrman 
et al., 2003; Smith et al., 2006). Besides evidence on modulation of drug responses, MTLPs 
also mediate a decrease in toxicity of CisPt (Jamiesen and Lippard, 1999). Despite the 
remarkable binding strength of GSH to CisPt and outcomes in drug resistance, MTLPs trap 
on the drug molecule is significantly higher and limits the amount of the drug available for 
binding to DNA (Doz et al., 1993; Fuertes et al., 2003; Hagrman et al., 2003). In this sense, 
MTLPs indicate a potential antioxidant performance regarding electrophilic cytotoxic agents 
(Doz et al., 1993; Geret et al., 2003; Gagné et al., 2008) for the highest CisPt concentration, 
induced by the decrease of the other antioxidant enzymes activity. Likewise, levels of LPO 
increased with the increasing CisPt concentration (Fig. 2.5) but were only significant at 100 
ng Pt L-1 confirming a decrease in the antioxidant lines of defense, leading to alterations such 
as protein degradation and membrane damage (Viarengo et al., 1990; Viarengo et al., 2007; 
Gomes et al., 2014). Consequently, unpaired electrons in the lipid molecules give rise to 
hydroperoxide radicals, able to trigger chain reactions based on assemblage of electrons from 
other lipid structures. The LPO pathway may also arise from the depletion of GSH and 
NADH resulting in dehydrogenase inhibition and uncoupling of oxidative phosphorylation 
(Dasari and Tchounwou, 2014). This process leads to hydroxyl radical formation and more 
oxidative stress. The decrease of the activity of GST enzymes implies the need to protect 
cells against peroxides (Hurst et al., 1998). In this sense, the action of Se-GPx is an important 
alternative to counteract harmful electrophiles produced during oxidative damage (Fig. 2.7). 
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Despite the increase in Se-GPx activity, the defence pathway is not enough in particular for 
the worms exposed to the highest concentration, as accounted in PCA by the positive 
relationship between both Se-GPx and LPO products (Fig. 2.7). The detection of genotoxic 
alterations caused by exposure to cytotoxic drugs at environmental conditions could be of 
great relevance to address aquatic ecotoxicological impacts.  
Polychaetes are highly sensitive to genotoxic damage (Lewis and Galloway, 2008; 
Catalano et al., 2012; Buffet et al., 2013; Maranho et al., 2014). Agents such as CisPt binds 
covalently to base residues on DNA strands producing DNA-DNA intra- and inter-strand 
cross-links (ICLs) (Siddik, 2003) that, respectively, comprise the link of two nucleotides in 
the same and opposite strands (Deans and West, 2011). Intra and inter-strand cross-links 
binds strongly to prevent DNA strands separation, thus blocking DNA replication and 
transcription (Jamisien and Lippard, 1999; Noll et al., 2006; Deans and West, 2013). The 
absence of detection of the double and single strand breaks in CisPt contaminated worms, 
assessed by alkaline comet assay, may be attributed to the presence of ICLs and DNA-DNA 
intra-strand crosslinks, leading to the closure of DNA strands and less DNA migration in 
electrophoresis (Merk and Speit, 1999). Contrarily, genotoxicity outcome by strand breaks 
formation occurred in freshwater daphnids Daphnia magna and Ceriodaphnia dubia 
exposed to CisPt (100 ng L-1 and 300 ng L-1, respectively) over 24 h (Parrella et al., 2015). 
DNA damage was also present throughout the 14 days of exposure of M. galloprovincialis 
to 100 ng Pt L-1, suggesting that CisPt exerts its toxic effects probably by direct breaking of 
DNA strands and ROS production (Trombini et al., 2016a). In general, CisPt induces DNA 
repair mechanisms to remove adducts and promote cell survival, by stalling the helix 
distorting occasioned by chemotherapeutic drugs and UV radiation (Siddik, 2003). Through 
the SOS chromotest, CisPt drug was recognized as a potent inducer of SOS reparation system 
in Escherichia coli PQ37, where DNA repair mechanism and recombinant enzymes were 
expressed (Lantzsch and Gebel, 1997; Nowosielska et al., 2004; Parrella et al., 2015).  
Thus, certain mutations of genes responsible for repair pathways inherent to each 
species may be prone to generate differences in sensitivity to cytotoxic drugs (Huang and 
Li, 2013) that need to be confirmed in this case. Still, the absence of genotoxicity, in the 
present study, may also stems from the remarkable induction of antioxidant potential at the 
highest drug concentration, acting to supply the overwhelmed enzymes activity against CisPt 
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toxicity. In addition, the nucleophilic trapping capacity of MTLP and GSH to CisPt are 
widely known to contribute to resistance to the drug, once its availability to nucleus is 
reduced (Doz et al., 1993). According to the European Medicine Agency (EMA) guidelines, 
ecotoxicological assays with representative aquatic species of each trophic level must be 
performed to screen and assess environmental risk posed by drugs (EMA, 2006). 
Nevertheless, these bioassays are only required for pharmaceuticals under processes for 
production authorization and market implementation, which discard anticancer drugs for the 
submission to such a procedure (Besse et al., 2012). Besides, very few studies exist that 
apply the biochemical, metabolic and physiological responses in aquatic organisms exposed 
to chronic environmental realistic concentrations (Fent et al., 2006b; Maranho et al., 2014).  
This study clearly demonstrates the response of multibiomarker approach involved 
in behaviour assessment, oxidative stress and genotoxic responses that are consistent to the 
MoA of this drug in this species. Despite that the responses addressed are mostly depicted 
at the highest CisPt concentration, Pt concentration at ng L-1 range reflects that very low 
concentrations combined with chronic exposure may represent a hazard for aquatic species. 
In addition, the bioassay was conducted with only one pharmaceutical compound, whereas 
a mixture of several other compounds with similar and different MoA towards anticancer 
activity, also at low concentrations, have already been detected in coastal waters (Besse et 
al., 2012). The present approach and exposure stand out of a standardized and classic biotest 
applied for regulatory considerations, and holds significance based on the reality and 
complexity of the benthic aquatic environment, including the environmentally realistic 
concentrations of the chosen drug. 
2.5 Conclusions 
To the best of our knowledge, this is the first (eco)toxicity assessment dealing with 
cytotoxic drugs between water and sediment compartments. The present study indicate that 
CisPt has the potential to induce neurotoxic effects that may alter the burrowing profile of 
polychaetes. Inhibition of antioxidant enzymes activity (SOD, CAT) and biotransformation 
(GST) and potential accumulation of pro-oxidant radicals led to stress able to further increase 
membrane susceptibility to lipid peroxidation. These biological alterations were only 
observed at highest CisPt levels, which if detected in the environment may depict a high 
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biological risk. Nevertheless, the lack of enough biochemical protection to prevent 
impairment was verified at ng L-1 range highlighting concern regarding the drug potential to 
non-target aquatic species. Putting all biomarkers data together, confirm, once again, the 
reliability of this species for ecotoxicology assays, as well as the sediment compartment as 
an important target, especially regarding emergent contaminants such as anticancer 
pharmaceuticals.
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 Chapter 3  
Environmental relevant levels of 
the cytotoxic drug cyclophosphamide 
produce harmful effects in the 
polychaete Nereis diversicolor 
Published in: 
 Fonseca, T.G., Auguste, M., Ribeiro, F., Cardoso, C., Mestre, N.C., Abessa, D.M.S., 
Bebianno, M.J., 2018. Environmental relevant levels of the cytotoxic drug 
cyclophosphamide produce harmful effects in the polychaete Nereis diversicolor. Science 
of the Total Environment 636, 798–809. https://doi.org/10.1016/j.scitotenv.2018.04.318 
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Abstract 
Cytotoxic drugs applied in chemotherapy enter the aquatic environment after 
patients’s metabolism and excretion, in both main compounds and their respective 
metabolites. The increased consumption and discharge of these drugs raise concern on the 
genotoxic burden to non-target aquatic species, due to their unselective action on DNA. 
Settlement and adsorption of cytotoxic drugs to aquatic sediments pose risks to benthic 
species through chronic exposure. The aim of the present study was to assess the effects 
induced by the anticancer drug cyclophosphamide (CP) on the polychaete Nereis 
diversicolor, after 14 days of exposure to environmental relevant concentrations (10, 100, 
500 and 1000 ng L-1). Burrowing impairment, neurotoxicity (Acetylcholinesterase - AChE 
activity), oxidative stress (superoxide dismutase – SOD; catalase – CAT; glutathione 
peroxidases - GPXs activities), biotransformation (glutathione-S-transferases - GST), 
oxidative damage (lipid peroxidation - LPO) and genotoxicity (DNA damage) were 
assessed. Burrowing impairments were higher at the lowest CP concentrations tested. The 
higher CP levels tested (500 and 1000 ng L-1) induced a significant inhibition on the 
enzymatic antioxidant system (SOD, GPx) and on GST activity. DNA damage was also 
significant at these concentrations as an outcome of CP metabolism, and high levels of 
oxidative damage occurred. The results showed that the prodrug CP was metabolically 
activated in the benthic biological model N. diversicolor. In addition to the potential 
cytotoxic impact likely to be caused in aquatic species with similar metabolism, N. 
diversicolor proved to be reliable and vulnerable to the cytotoxic mode of action of CP, even 
at the lower doses.  
Keywords: Anticancer drugs, cyclophosphamide, sediments, polychaetes, oxidative 
stress, genotoxicity. 
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3.1 Introduction 
Anticancer drugs (or antineoplastic drugs) are a group of pharmaceuticals routinely 
and widely administered in chemotherapy all over the world, whether individually or in 
combination with other cytotoxic agents. In 2012, 14.1 million new cancer cases were 
reported around the world, and the World Health Organization estimates an enhancement of 
57% of new cases until 2030 (WHO, 2014). Besides the subsequent increase of cytotoxic 
prescriptions, approximately 80% of oncology patients receive treatment at oncology wards 
and go home after drug administration (i.e. out-patients). Additionally to conventional 
elimination into hospital sewage systems, metabolites and unchanged fractions of the 
administered drug are excreted through urban effluents, following to municipal WWTPs, 
where elimination of these substances is incomplete (Johnson et al., 2008; Kosjek and Heath, 
2011). Furthermore, these chemicals may also be released directly to the water bodies, in 
regions not properly attended by sewage collection and treatment systems (Abessa et al., 
2005; Pessati et al., 2016).  
Consequently, anticancer drugs are detected at low levels (ng to µg.L-1 range) in 
aquatic systems (Crane et al., 2006; Johnson et al., 2008; Kosjek and Heath, 2011; Booker 
et al., 2014; Mater et al., 2014) and long-term exposure to non-target species has led to the 
concern of genotoxic burden of cytotoxic drugs to aquatic species (Steger-Hartmann et al., 
1996, 1997; Buerge et al., 2006; Ferrando-Climent et al., 2014). In general, the conventional 
chemotherapy drugs act directly on the DNA double strand, in order to avoid the synthesis 
and proliferation of tumour cells (Farber, 1973). Such covalent interaction primarily alters 
the DNA helical structure, influences the binding of chromatin protein and induces DNA 
strand breaks, subsequently producing genotoxic effects, followed by the death of the tumour 
cells (Harris, 1976; Ou and Lien, 1985). However, once these “targets” are not specific 
drivers of cancer cells, normal growing cells are also affected through the same MoA by 
which they may be killed or left unrepaired, followed by genomic instability with neoplastic 
transformation and eventual carcinogenic mutations (Johnson et al., 2008; Kosjek and Heath 
2011; Ferrando-Climent et al., 2014). Acting unselectively on DNA, it has been 
hypothesized that anticancer drugs may harm all eukaryotic organisms by cytotoxic, 
genotoxic, mutagenic and carcinogenic effects (Johnson et al., 2008; Vyas et al., 2014). The 
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biological risk posed by these anticancer molecules and their metabolites in aquatic species 
is not well elucidated (Mater et al., 2014), with few data on acute and chronic 
ecotoxicological assessments in algae Tetrahymena pyriformis (Bonnet et al., 2003), 
Pseudomonas putida (Zounková et al., 2007) and Pseudokirchneriella subcapitata 
(Zounková et al., 2007; Brezovsec et al., 2014; Česen et al., 2016); polychaete Nereis 
diversicolor (Fonseca et al., 2017); bivalve mollusc Mytilus galloprovincialis (Trombini et 
al., 2016a); cladocera crustaceans Daphnia pulex (DellaGreca et al., 2007; Borgatta et al., 
2015, 2016), D. magna (Zounková et al., 2007; Parrella et al., 2014a, 2014b, 2015) and 
Ceriodaphnia dubia (DellaGreca et al., 2007; Parrella et al., 2014a, 2014b, 2015); 
crustacean amphipod Ampelisca brevicornis (Moreira et al., 2016); and the fishes Danio 
rerio (Kovács et al., 2015), Pimephales promelas (Winter et al., 2007) and Oryzias latipes 
(Sun et al., 2011). Limited information exists regarding Environmental risk assessment 
(ERA) for anticancer drugs. ERA guidelines are assigned only for newly authorized 
pharmaceuticals (since 2006) and does not include molecules prone to cause genotoxicity 
impairments in aquatic ecosystems (Johnson et al., 2008; Aguirre-Martínez et al., 2016b). 
Cyclophosphamide (CP) is one of the oldest and most frequently prescribed cytotoxic 
and alkylating agents used in cancer treatment, approved since 1960´s (Gilard et al., 1994; 
Buerge et al., 2006; Česen et al., 2015). It consists of a phosphoramide ring linked to a 
bifunctional moiety containing two chloro-ethyl groups. CP is a prodrug and its activation 
consists in the oxidation by cytochrome P450 mixed function oxidase to form 4-hydroxy-
CP (4-OHCP), undergoing subsequent transformations to yield the major cytotoxic species, 
the phosphoramide mustard (PAM) and acrolein (Figure 3.1).  
After administration, around 80% of the dose is excreted as metabolites, which 
accounts for substantial amounts of metabolites disposed into sewage systems (Bagley et al., 
1973; Steger-Hartmann et al., 1996). In the absence of metabolic activating systems, CP fails 
to bind to DNA and its genotoxic activity is prevented. Even without metabolic activation 
by S9-rat extracted fraction, the parental drug CP caused mutagenic effects in the bacteria 
Escherichia coli and Salmonella typhimurium, and in the cyanobacteria Synecococcus 
leopoliensis (320 mg L-1) (Česen et al., 2016), indicating that not only the metabolites are 
involved in cellular impairments (Mohn and Ellenberger, 1976; Benedict et al., 1977; 
Balbinder et al., 1981; Winckler et al., 1984). Research concerning CP and its 
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ecotoxicological effects in aquatic organisms is scarce and do not comprise exposure routes 
by which species would uptake the drug. Data available addresses the drug as a toxic positive 
control in in vivo short-term bioassays assessing mortality, immobilization, growth and 
reproduction inhibition, larval development and genotoxicity as end-points with CP levels 
far from environmental relevant concentrations (Matsumoto and Cólus, 2000). 
 
 
Figure 3.1: CP metabolism pathway. Enzymatic activation by cytochrome P-450 enzyme 
system generates 4-hydroxycyclophosphamide, coexisting with the non-cytotoxic 
aldophosphamide metabolite. It decomposes into acrolein, that is toxic, and the DNA-
binding phosphoramide mustard. 
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Considering that most of cytotoxic drugs are highly polar, with low Kow, the fraction 
of drugs adsorbed into sewage sludge could be neglected and distribution is assumed to be 
mainly in the water column (Kosjek and Heath, 2011; Seira et al., 2016). Negligible 
biodegradability, volatilization and adsorption of CP to biosolids confirms this assumption 
(Steger-Hartmann et al., 1996, 1997; Buerge et al., 2006). However, pharmaceuticals are 
multi-functional ionisable compounds and conventional partitioning models are not suited 
for a straightforward prediction of their environmental fate (Kwon and Armbrust, 2008). 
Once in the aquatic environment, hydrophobic interactions providing adsorbance of polar 
compounds to particulates may not be disregarded, especially for organic cations, which are 
formed during intra-molecular cyclizations for cytotoxic drugs activation (e.g. CP 
aziridinium cation) (Emadi et al., 2009). Therefore, specific transformations in coastal 
environments may allow their adsorption, transference and persistence to the sediments 
(Kosjek and Heath, 2011; Maranho et al., 2014; Moreno-González et al., 2015).  
Sediments are the ultimate sink for contaminants in the marine environment, posing 
benthic species at risk through chronic exposure and bioaccumulation (Araujo et al., 2013; 
Buruaem et al., 2012; Rodrigues et al., 2013; Vethaak et al., 2017). Nevertheless, aquatic 
ecotoxicological assessment of anticancer drugs involving sediments is lacking (Fonseca et 
al., 2017). In addition, to the best of our knowledge, only two studies exist on the occurrence 
of anticancer drugs in river sediments, where levels ranged below the detection limit 
(Zuccato et al., 2000) and 391 ng kg-1 (bicalutamide), 392 ng kg-1 (doxifluridine), and 250 
ng kg-1 (tamoxifen) (Azuma et al., 2017). So far, no screening approach was directed to the 
coastal environment. The levels of CP detected in hospital effluents, WWTPs influents and 
effluents, surface waters and sediments are indicated in Table 3.1. Data suggests that this 
drug and its metabolites are likely to contribute to overall toxicity in receiving waters 
(Kiffmeyer et al., 1998; Yasunaga et al., 2006; Kosjek and Heath, 2011; Česen et al., 2016).  
Polychaetes are widely used in marine environmental health assessments due to their 
ecological key role in benthic dynamics (Solé et al., 2009), and their rapid and easy response 
to disturbances induced by different stressors (Sivadas et al., 2010; Cong et al., 2011; Buffet 
et al., 2014; Maranho et al., 2015). The species Nereis (Hediste) diversicolor is highly 
recommended for ecotoxicological assessment regarding their physiological and 
biochemical responses after exposure to different classes of pharmaceuticals (e.g. anti-
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inflammatory; oral contraceptive; anticonvulsant; antidepressant drugs) (Aguirre-Martínez 
et al., 2013; Maranho et al., 2014, 2015; Pires et al., 2016a; Fonseca et al., 2017). Exposure 
to the cytotoxic drug cisplatin, at trace concentrations (0.1; 10 and 100 ng Pt L-1) in seawater, 
caused behavioural and biochemical impairments in this species, after 14 days of exposure 
(Fonseca et al., 2017). 
The aim of the present study is to assess the effects induced by the anticancer drug 
CP in the polychaete N. diversicolor, exposed to a range of environmental relevant 
concentrations of CP detected in water compartments. For this purpose, the following 
biomarkers were assessed (1) behavioural impairment (burrowing kinetic impairment), (2) 
neurotoxicity (acetylcholinesterase - AChE activity), (3) oxidative stress (superoxide 
dismutase – SOD; catalase – CAT; glutathione peroxidases - GPXs), (4) Phase II conjugation 
reaction (glutathione-S-tranferases - GST activity), (5) oxidative damage (Lipid 
peroxidation LPO) and (6) genotoxicity (DNA damage), after exposure for 14 days to a 
contaminated water-sediment system.  
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Table 3.1: Concentrations of CP in water (ng L-1) and sediments (ng g-1). 
Study area 
Hospital 
Effluent 
STP Influent 
STP 
Effluent 
Surface Water River 
Sediment 
Detection Method Reference 
Upstream Downstream 
Australia - - 125 - < 100 - 
SPE; LC-MS/MS 
(ESI) 
Busetti et al. (2009) 
Canada  < 4 - 22 4 - 21   - 
SPE; LC-MS/MS 
(ESI) 
Rabii et al. (2014) 
China 6 - 2,000 - - - - - 
SPE; UPLC-MS/MS 
(ESI) 
Yin et al. (2010) 
Thailand - - -  1,907 - SPE; HPLC-MS/MS Usawanuwat et al. (2014) 
England - - 19 - 0.37 - - - 
SPE; LC-MS/MS 
(ESI) 
Llewellyn et al. (2011) 
Germany 19 - 4,500 < 6 - 143 < 6 - 17 - - - SPE; GC-MS (EI) Steger-Hartman et al. (1997) 
Germany 146 - - - - - SPE; GC-MS (EI) Steger-Hartman et al. (1996) 
Germany - - nd - nd - LC-MS/MS (ESI) Ternes (1998) 
Italy - - - - nd (8 rivers) - 
SPE; HPLC-MS/MS 
(ESI) 
Calamari et al. (2003) 
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Italy - - nd - 9 - - - 
SPE; HPLC-MS/MS 
(ESI) 
Castiglione et al. (2005) 
Italy - - 0.6 - nd - SPE; HPLC-MS/MS Zuccato et al. (2005) 
Italy - - - - 2.2 - 10.1 < 12 SPE; HPLC-MS/MS Zuccato et al. (2000) 
Japan - - - - nd nd SPE; UPLC-MS/MS Azuma et al. (2017) 
Norway < 2 - 21 < 2 2 - - - 
SPE; LC-TOF/MS 
(ESI) 
Thomas et al. (2007) 
Romania - - - - < 30 - 64.8 - SPE; GC-MS (EI) Moldovan (2006) 
Spain < 1.1 - 43 8 - 26 7 - 25 < 0.9 < 0.9 - 20 - SPE; UPLC QqLiT Ferrando-Climent et al. (2014) 
Spain - - - - < 3 - SPE; HPLC-MS/MS Valcárcel et al. (2011) 
Spain     7.8 - 13.7 - SPE; LC-MS (ESI) Franquet-Griell et al. (2017) 
Spain 5.73 
< 3.1 - 
13,100 
3.1 - - - SPE; LC-MS (ESI) Gomez-Canela et al. (2012) 
Spain - < 2.1 <2.3 - < 1.7 - 
SPE; HPLC-MS/MS 
(ESI) 
Martín et al. (2011) 
Spain - nd nd - - - 
SPE; HPLC-MS/MS 
(ESI) 
Martín et al. (2014) 
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Spain  nd - 43.8 nd - 25 - - - SPE; LC-MS/MS  Negreira et al. (2014a) 
Slovenia 14 - 22,000 19-27 17 - - - SPE; GC-MS (EI) Česen et al. (2015) 
Switzerland - 2 - 11 2 - 10 - 0.15 - 0.17 - 
SPE; LC-MS/MS 
(ESI) 
Buerge et al. (2006) 
Switzerland 0.161 - - - - - 
SPE; HPLC-MS/MS 
(ESI) 
Kovalova et al. (2012) 
- STP (Sewage treatment plant). 
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3.2 Materials and Methods 
3.2.1 Chemicals 
Cyclophosphamide monohydrate (Cytoxan) (CAS 0768) was purchased from Sigma-
Aldrich (Portugal). For safety handling of the cytotoxic drug, experimental work was 
performed using class II biological safety cabinet, with appropriate clothing (open-back, 
impervious chemotherapy protection gown, double powder-free latex gloves and safety 
goggles). CP stock solution (40 mg L-1) was diluted in ultrapure Milli-Q water to prepare 
test solutions. 
3.2.2 Experimental setup  
Sediments and specimens of N. diversicolor were handpicked during summer, at low 
tide at the intertidal estuarine mudflat in Mira River estuary (Vila Nova de Milfontes), 
located in the Southwest coast of Portugal (37.729031 N, -8.751585 W). The site is 
considered undisturbed and was used as a reference site for sediment quality assessment 
(Ferreira et al., 2003; Moreira et al., 2006; Fonseca et al., 2017). Sediments were mainly 
composed of silt and clay (73% of particles <63 µm), with a organic matter content of 7.8%. 
Animals were transported alive to the laboratory with sediments and water from the site of 
origin. The organisms were acclimated for 5 days in aerated aquaria filled with natural 
filtered seawater (salinity 35) from the Ria Formosa lagoon (Faro, Portugal) and sediments 
from the sampling site. The sediments were wet-sieved through a 2-mm mesh for removal 
of large debris and other living organisms, followed by drying at 80°C (Thain and Bifield, 
2001; ASTM, 2009; Maranho et al., 2014), to remove volatile compounds and water. 
Sediments were then re-hydrated with the same amount of water (w.w./d.w.). Dried aliquots 
of the sediments were used to determine grain size distribution by the method proposed by 
Royse (1970). Organic matter content was determined by loss on ignition (550°C, for 5 h), 
as described by Gross (1971).  
The 14-day bioassay was carried in 20-L glass aquaria, with a proportion of 1:4 
sediment/seawater (Faro, Ria Formosa), under constant aeration, controlled temperature (19 
± 2°C), salinity (35 ± 1.8) and light period (12:12 hours). Each treatment was performed in 
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triplicate, including seawater controls (day 0: CT0; day 14: CT14), solvent control (0.001% 
DMSO) and CP at a range of concentrations based on reported levels in the environment 
(Table 3.1). Polychaetes were divided into groups of 75 per treatment (25 per aquarium). 
Over the 14 days of exposure, water was renewed every 48 hours avoiding sediment 
resuspension, with redosing of the drug in the water phase (0, 10; 100; 500 and 1000 ng L-
1) in order to simulate the input of pharmaceuticals in aquatic system. Animals used in the 
burrowing and comet assays were immediately handled for respective analysis, while those 
regarding biochemical end-points were rinsed with clean seawater and stored at -80 °C until 
further use.  
3.2.3 Burrowing Assay 
Worms of control conditions (day 0: CT0; day 14: CT14) and those exposed to the 
different CP concentrations were submitted to a burrowing test according to Bonnard et al. 
(2009). Fifteen animals of each treatment were carefully placed individually in 150 mL-
plastic containers, filled with natural seawater and 5 cm of sediments. Over a period of 30-
minutes, the position of the polychaetes was recorded every two minutes, to assess the time 
for fully burrowing. The results are expressed as the percentage (%) of unburied specimens, 
over time (min).  
3.2.4  Biochemical analysis  
Neurotoxicity 
Animals (2 specimens per aquaria, in triplicate; total of 6 organisms per treatment) 
were individually homogenized in 100 mM Tris-HCl buffer (pH 8.0) and 0.1% Triton. The 
homogenates were centrifuged at 12,000 g, for 30 min, at 4 °C, and further separated in 
aliquots for total protein determination (Bradford, 1976) and AChE activity analysis (Ellman 
et al., 1961). AChE activity was measured through the increase of the absorbance of the 
yellow compound resulting from the production of 5-mercapto-2-nitrobenzoate ( = 13.6 
mM-1 cm-1) formed by the reaction of thiocholine, a product of acetylcholine cleavage by 
AChE with DTNB, at 405 nm (Ellman et al., 1961; Colovic et al., 2013). AChE activity is 
expressed as ATC.min-1 mg-1 protein. 
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Tissue preparation for enzyme activities analysis 
Whole organisms (2 specimens per aquaria, in triplicate; total of 6 organisms per 
treatment) were homogenized in 20 mM Tris-HCl buffer (0.5 M sucrose, 0,075 M KCl, 1 
mM DTT, 1 mM EDTA, pH 7.6), according to the protocol described by Geret et al. (2002). 
The homogenates were centrifuged at 500 g, for 15 min, at 4 °C, and the supernatants 
obtained centrifuged again (12,000 g, 45 min, 4 °C). Aliquots (150 µL) of the cytosolic 
fraction were separated for determination of each antioxidant enzyme activity (SOD, CAT, 
GPX) and biotransformation (GST). In addition, total proteins concentrations (mg protein g-
1 tissue) were determined following the method described by Bradford (1976), adapted for 
microplate reader using bovine serum albumin (BSA) as a standard.  
Antioxidant enzymes activities 
SOD activity was assessed by measuring the decrease of absorbance of the substrate 
cytochrome-c by xanthine oxidase/hypoxanthine system, at 550 nm (McCord and Fridovich, 
1969), and the results are expressed as U mg-1 protein. CAT activity was determined 
spectrophotometrically by measuring the decrease of absorbance at 240 nm (Greenwald, 
1985). GPX activity was measured at 340 nm by using cumene hydroperoxide and H2O2 as 
substrates for T-GPx and Se-GPx, respectively (adapted from Lawrence and Burk, 1976). 
The activity of CAT, Se- and T-GPx are expressed in nmol min-1 mg-1 protein.  
Biotransformation 
GST activity was measured in the cytosolic fraction by the conjugation of 0.2 mM 
reduced glutathione (GSH) with 0.2 mM CDNB (molar coefficient of extinction = 0.6 mM-
1 cm-1) in a reaction mixture of 0.2 M KH2PO4/K2PO4 buffer (pH 7.9), at 340 nm (adapted 
from Habig et al., 1974). The results are expressed in nmol CDNB min-1 mg-1 protein. 
Oxidative damage 
LPO was determined in whole organisms (2 specimens per aquaria, in triplicate; total 
of 6 organisms per treatment), by the absorbance of malondialdehyde (MDA) and 4-
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hydroxyalkenals (4-HNE) concentrations, at 540 nm (adapted from Erdelmeier et al., 1998). 
LPO is expressed in nmol MDA + 4-HNE mg−1 protein. 
Genotoxicity assay 
DNA damage was assessed by the alkaline Comet assay, adapted from Singh et al. 
(1988) and described by Gomes et al. (2013). Slides were previously cleaned in alcohol/ether 
and coated with 0.65 % normal melting point agarose (NMA) in Tris-acetate EDTA. 
Coelomocytes present in the coelomic fluid of N. diversicolor (5 specimens per aquaria, in 
triplicate; total of 15 organisms per treatment) were extracted from the posterior region of 
the polychaete body into 20 µL of PBS buffer in a 0.5 mL-syringe fitted with hypodermic 
needle, based on the procedure described by Fonseca et al. (2017). The mixture was 
centrifuged at 835 g (3 min, 4 °C) and the pellet suspended in 0.65 % low melting point 
agarose (LMA, in Kenny's salt solution; 0.4 M NaCl, 9 mM KCl, 0.7 mM KH2PO4, 2Mm 
NaHCO3, 1000 ml Milli-Q water) and casted on the microscope slides. Subsequently, slides 
were immersed in a lysis buffer (100 mM EDTA, 2.5 M NaCl, 10 mM Tris, 1% Triton X-
100, 10% Dimethylsulfoxide,1% Sarcosil, pH 10, 4 °C), over one hour, for the diffusion of 
cellular components and DNA immobilization in agarose. Slides were then placed in 
electrophoresis chamber, embedded with buffer (300 mM NaOH, 1 mM EDTA, adjusted at 
pH 13, 4 °C) and left for 15 min to permit DNA unwinding. The electrophoresis was 
performed at 25 V and 300 mA, over 5 min. Afterwards, slides were neutralized with 
appropriate buffer (0.4 mM Tris, pH 7.5), rinsed with distilled water and left to dry 
overnight. Slides were analysed with an optical fluorescence microscope Axiovert S100 
(total magnification of ×400), coupled with a camera, with an aid of 4,6-diamidino-2-
phenylindole (DAPI, 1 mg ml-1). Image analysis was made with the software Komet 5.5 
(Kinetic Imaging Ltd) by classifying 50 randomly chosen cells from each slide. The amount 
of DNA in the comet tail (DNA tail %) was used as an end-point and results are expressed 
as mean ± standard deviation.  
3.2.5 Statistical analysis 
Obtained data were tested for normality (Shapiro-Wilk test) and homogeneity of 
variances (Levene´s test) in order to determine whether they satisfy the assumptions 
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associated with parametric tests, and one-way analysis of variance (ANOVA) or the non-
parametric Kruskal-Wallis were applied. Tukey´s or Dunn´s post-hoc tests were performed 
to compare treatment effects. Results were significant when p < 0.05. Burrowing 
behavioural data was analysed by linear regression. Principal Component Analysis (PCA) 
were applied to evaluate the relationship among biomarkers responses and between 
pharmaceuticals levels. Statistical analysis was carried out using the Statistica 8.0 software 
(Statsoft Inc., 2007, USA). 
3.3 Results  
3.3.1 Behavioural Assay 
Results of burrowing assessment are indicated in Figure 3.2. Slopes of trend lines 
depicting by linear regression analysis showed significant statistical differences between all 
treatments (p < 0.05). Both control conditions (CT0 and CT14) indicate similar trend, as 
well as for animals exposed to the concentration of 100 ng L-1, that was entirely overlapped 
by CT0. Perturbation in burrowing, however, were higher with the decrease of 
cyclophosphamide levels. Polychaetes exposed to 1000 ng L-1 were fully buried after the 
first 5 minutes, whereas at 500 ng L-1, animals lasted 20 minutes at surface until complete 
burrowing while among those exposed to 10 ng L-1 not all the animals were buried. 
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Figure 3.2: Burrowing behaviour of N. diversicolor from control conditions (day 0: CT0; 
day 14: CT14) and those exposed to CP-contaminated systems (10, 100, 500 and 1000 ng L-
1), expressed as percentage of unburied organisms over time (lines with symbols). 
Continuous lines represent least-square best-fit regression lines, with respective equations. 
3.3.2 Biochemical analysis 
Neurotoxicity 
AChE activity did not change between controls over time (p > 0.05). A slight 
decreasing in AChE activity was observed in polychaetes exposed to the lowest CP 
concentrations (10 ng L-1), although not significant (p > 0.05). With the increase of CP 
concentrations, AChE activity was similar to the controls (p > 0.05) (Figure 3.3).  
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Figure 3.3: AChE activity (mean ± S.D.) (ATC.min-1.mg-1 protein) in N. diversicolor 
unexposed (CT 0 and CT 14) and exposed to CP (10, 100, 500 and 1000 ng L-1) for 14 days. 
Absence of letters indicates no significant differences among treatments (Kruskal-Wallis, p 
> 0.05). 
 
Antioxidant and biotransformation enzymes  
Antioxidant enzymes activities were similar between controls over time (p > 0.05). 
Despite no significant statistical differences between CP-treatments and controls, it was 
observed an increase in SOD activity in ragworms exposed to 10 and 100 ng L-1 of CP, 
followed by an inhibition in organisms exposed at the higher CP levels (i.e. 500 and 1000 
ng L-1) (Figure 3.4A). A significant 2-fold increase in CAT activity was detected in worms 
exposed to concentrations of 10 and 500 ng L-1 (Figure 3.4B), whereas no significant changes 
were observed for GPx Se-dependent activity with CP increasing levels (p > 0.05). On the 
other hand, a clear decreasing trend in T-GPx activity was detected with increasing CP 
concentrations, significantly different from controls only in polychaetes exposed to 500 and 
1000 ng L-1 (p < 0.05). Likewise, GST activity decreased with the increasing CP 
concentrations, significant at 100, 500 and 1000 ng L-1 (p < 0.05) (Figure 3.5). 
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Figure 3.4: Antioxidant enzymes activities (mean ± S.D.) of (A) SOD, (B) CAT, (C) GPx 
Se-dependent, (D) T-GPx in N. diversicolor of control conditions (CT0 and CT14) and 
exposed to CP (10, 100, 500 and 1000 ng L-1) for 14 days. Different letters indicate 
significant difference among treatments (ANOVA: SOD, CAT; Kruskal-Wallis: GPx Se-
dependent, T-GPx; p < 0.05). Absence of letters indicates no significant differences among 
treatments (p > 0.05). 
 
 
Figure 3.5: Biotransformation enzyme activity (mean ± S.D.) in N. diversicolor of control 
conditions (CT0 and CT14) and exposed to CP (10, 100, 500 and 1000 ng L-1) for 14 days. 
Different letters indicate significant differences among treatments (Kruskal-Wallis, p < 
0.05). 
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Oxidative damage 
An increase of oxidative damage was clear in polychaetes with the increase of CP 
concentrations with significant differences at 500 and 1000 ng L-1 compared to controls (p 
< 0.05) (Figure 3.6). 
 
Figure 3.6: LPO activity (mean ± standard deviation) (MDA+ 4-HNE nmol.mg-1 protein) in 
animals of control conditions (CT0 and CT14) and exposed to CP at 10, 100, 500 and 1000 
ng L-1 for 14 days. Different letters indicate significant differences among treatments 
(ANOVA, p < 0.05).  
 
3.3.3 Genotoxicity  
Data of DNA tail (%) and DNA damage grade after 14 days of exposure are presented 
in Table 3.2. Despite all polychaetes exposed to CP treatments indicated DNA damage 
compared to its respective control (p<0.05), the grade of impairment was always between 
minimal to mid damage. 
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Table 3.2: Genotoxic effects in polychaetes N. diversicolor unexposed and after 14 days of 
exposure to CP. DNA damage (average ± SEM) is expressed as tail DNA %. Frequency of 
coelomocytes distributed by grade of DNA damage (%). Different letters represent statistical 
differences between treatments, during the exposure period. Percentage of coelomocytes 
distributed through damage criteria (i.e. Minimal to Extreme). 
Treatment DNA Tail (%) 
DNA Damage grade (%) 
Minimal Low Mid High Extreme 
Control 7.5a (± 0.4) 69.2 30.8 0 0 0 
10 ng CP L-1 10.26b (± 0.57) 59 30.1 10.9 0 0 
100 ng CP L-1 10.59b (± 0.36) 51.5 46.2 2.3 0 0 
500 ng CP L-1 9.97b (± 0.42) 57.2 40.0 2.8 0 0 
1000 ng CP L-1 11.83b (± 0.55) 50.8 41.2 8.0 0 0 
 
3.3.4 Principal Component Analysis (PCA)  
PCA results indicate a two-dimensional pattern explaining 81.4% of the total 
variance (PC1= 46.3 %; PC2 = 36.2 %) (Figure 3.7). Overall, the plot score indicated a clear 
separation between organisms from control conditions and contaminated treatments, in 
which CT0 and CT14 organisms are close-related in both axis projections. The first axis 
mainly explains the decline in SOD, T-GPx, GST, in addition to the induction of oxidative 
and significant DNA damage as detrimental effects of suppression of the lines of defense, in 
animals exposed to the two highest CP levels. In the second component it is highlighted the 
divergence of biomarkers profile between control groups and the lowest CP concentration 
(i.e. 10 ng L-1). The non-monotonic behaviour of burrowing in such exposed group elicited 
a reduced number of animals excavating. Likewise, at the lower CP level, SOD, CAT and 
Se-GPX are triggered, although no significant differences were detected (p > 0.05).  
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Figure 3.6: Principal Component Analysis (PCA) integrating responses of antioxidant 
enzymes (SOD, CAT, Se-GPx, T-GPx, GST), AChE, DNA Tail, oxidative damage (LPO) 
and burrowing behaviour of N. diversicolor, exposed to control conditions (CT0: day 0; 
CT14: day 14) and to different CP concentrations (10, 100, 500 and 1000 ng L-1). 
 
3.4 Discussion  
CP is a widely used chemotherapy agent applied worldwide, with diffuse release in 
aquatic systems through hospital and domestic wastewater discharges. Despite that its 
partition is preferential through the water phase, geochemical and hydrodynamic data 
indicate that CP may settle in the sediments (Xie 2012; Kosjek and Heath, 2011). Coastal 
polychaetes have been increasingly applied as bioindicators in ecotoxicological assessments 
evaluating biochemical alterations caused by pharmaceuticals (Maranho et al., 2014; Pires 
et al., 2016a, 2016b; Fonseca et al., 2017). The species Nereis diversicolor indicates, as 
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addressed in previous studies, high sensitivity to low levels (ng L-1 and g-1) of 
pharmaceuticals containing different physico-chemical properties and MoA, translated by 
disturbances in behaviour, energy status, oxidative stress, neurotoxicity, oxidative damage, 
and genotoxicity (Maranho et al., 2014, 2015; Pires et al., 2016a; Fonseca et al., 2017).  
In the present study, burrowing activity seemed to be non-monotonic over CP levels. 
In other words, such behaviour was most impaired at lower concentrations, whereas at the 
highest concentrations (i.e. 1000 ng L-1) all polychaetes were fully buried by the end of the 
assay (Figure 3.2). As stated by Doyotte et al. (1997), it is not a general rule that an increase 
in contaminant concentrations induces the expected harmful effect, as proposed by the dose-
response curve. Lagarde et al. (2015) reviewed different profiles of non-monotonic dose 
responses for various physiological and behavioural effects, in several organs or systems. 
Accordingly, the present burrowing profile corroborated with a bell-shaped dose-effect 
relationship in which minimal effects are induced at the two extreme doses (control and 1000 
ng L-1), although the mechanisms involved in the burrowing at the highest CP concentration 
may be different to the observed in controls. Hence, at very high doses, unspecific effects 
will, for instance, occur because the organism would be completely overwhelmed by the 
substance, through non-specific biological mechanisms (Lagarde et al., 2015). Many 
components of signaling pathways and their cross-talk could contribute to understand the 
non-linearity and dynamical monotonicity in response to stimuli (Wijk et al., 2015).  
Contrarily to the present results, animals remained emerged at the highest 
concentration of the cytotoxic drug cisplatin (100 ng Pt L−1), together with neurotoxic effects 
associated to AChE inhibition (Fonseca et al., 2017). CP has been widely reported to inhibit 
brain and retinal AChE activity in different biological models (Al-Jafari et al., 1993, 1995; 
Kamal et al., 2010) with hydrophobic interactions providing CP positioning within the acyl 
pockets and catalytic site of the enzyme (Shakil et al., 2011). However, herein, no effects of 
neurotoxicity were observed (Figure 3.3), as a potential result of docking between the 
enzyme and CP that may not be well accomplished in the present biological model (Valasani 
et al., 2013). Besides, CP levels applied herein are too low to observe neurotoxic effects, 
compared to concentration range (mg – g L-1) used in experiments with vertebrates (Santos 
and Pacheco, 1995). 
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In general, cancer cells are characterized by increased aerobic glycolysis, followed 
by high levels of reactive oxygen species (ROS), which need to be counteracted by 
expression of ROS-scavenging systems for the success of the first stage of tumour formation 
(Gorrini et al., 2013). The administration of anticancer drugs relies on the enhancement of 
ROS levels to trigger cancer cells death through signaling pathways and cellular damage 
(Conklin et al., 2004; Gorrini et al., 2013). CP produces additional oxidative stress through 
the acrolein metabolite (Arumugam et al., 1999; Dumontet et al., 2001; Oboh and Ogunruku, 
2010). In this sense, its cytotoxic MoA combined with the suppression of cellular defenses 
are effective to impair normal growing cells, including marine non-target species (Fonseca 
et al., 2017). In the present study, although significant differences were not statistically 
detected in SOD activity when compared to controls (p > 0.05), data showed a slight 
induction of SOD activity at the two lowest concentrations (Figure 3.4A), triggered as a 
potential consequence of polychaetes adaptation to overcome the stress from the drug (Sun 
and Zhou, 2008). At the two highest levels of CP, SOD activity was inhibited (Figure 3.4A), 
as observed at 14-day of exposure to the anticancer drug CisPt, at 100 ng Pt L-1 (Fonseca et 
al., 2017). In rats, the inhibition of  SOD activity was also observed in animals treated with 
intraperitoneal injection, either with 5 or 100 mg CP kg-1 (Patel and Block, 1985).  
Conversely, in the marine mussel Mytilus galloprovincialis, over the 2-week 
exposure to CisPt (100 ng Pt L-1), a higher induction and detoxification of SOD activity was 
observed in the digestive gland compared to the  gills, denoting the primary role of the former 
in recovery processes in this species (Faria et al., 2009; Trombini et al., 2016). Giving the 
predominant role of SOD as the first line of defense in ROS scavenging, by converting the 
highly reactive superoxide anion (O2
•-) into hydrogen peroxide (H2O2), its depletion yields 
cell redox unbalance by O2
•- accumulation, thus elevating the oxidizing potential (Djordjevic 
et al., 2011; Ben Ameur et al., 2012; Cozzari et al., 2015). Regarding the second line of 
defense against ROS, CAT activity acts as a catalyst of the SOD activity by-product H2O2 
for its detoxification into water (Faria et al., 2009; Gonzalez-Rey and Bebianno, 2012). Even 
though it is expected a coping behaviour among enzymes in the metabolic pathway, CAT 
activity responses depicted a non-monotonic profile over CP levels not in accordance to 
SOD (Figure 3.4B),  which may be attributed to the interference of other ROS detoxifying 
process, as stated by Aguirre-Martínez et al., (2013) and Gonzalez-Rey and Bebianno 
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(2011). In the case of CP metabolism, the CYP450 activation for PAM and acrolein 
detoxification combined with the uncoupled catalytic cycle may be accountable to form extra 
amounts of oxyradicals that need to be neutralized (Dumontet et al., 2001; Harskamp et al., 
2012; Oboh and Ogunruku, 2010). The burst of superoxide induced by CP that cannot be 
efficiently eliminated through SOD activity is promptly buffered by the GSH (Aquilano et 
al., 2014). The electrophilic acrolein binds to GSH and reduces their availability inside the 
cells, hence impairing the antioxidant glutathione dependent-system and also increasing free 
radical generation (Peña-Llopis et al., 2002; Singh et al., 2014). 
The activity of Se-GPx is an important alternative to counteract harmful electrophiles 
produced during oxidative damage (Djordjevic et al., 2011) and is a key enzyme that 
detoxifies H2O2 and converts lipid hydroperoxydes to non-toxic alcohols (Charushila and 
Subodhini, 2015). The present results demonstrate that Se-GPx was unaffected at any of the 
CP levels to which worms were exposed to (Figure 3.4C). In contrast, N. diversicolor 
exhibited a clear induction of that enzyme when specimens were exposed to CisPt, as an 
offset of CAT activity decrease (Fonseca et al., 2017), once both enzymes are associated to 
enzymatic hydrogen peroxide scavenging (Cozzari et al., 2015). As in the present study CAT 
activity was not inhibited, it may be hypothesized that the activation of Se-GPx was not 
particularly relevant to counteract severe oxidative challenge. Notwithstanding, T-GPx is 
also recognized as the most important enzymatic reductor agent of lipid peroxides and 
emerges as a compensatory response in cases where SOD activity is inhibited (Aquilano et 
al., 2014). In contrast, the excess of non-neutralized oxyradicals, such as superoxide, may 
lead to exhaustion or inhibition of the defense system culminating in T-GPx inactivation, as 
observed in worms exposed to 500 and 1000 ng L-1 (Figure 3.4D). Thus, once T-GPx activity 
decreased, more hydrogen peroxide is accumulated in the cell to the point of causing 
oxidative damage and activation of inflammatory pathways (Yu et al., 2006). T-GPx activity 
inhibition also occurred in the digestive gland of the clam Ruditapes phillipinarum exposed 
to the antiepileptic carbamazepine and the antibiotic novobiocin, as a reflection of pro-
oxidant forces overcoming antioxidant defenses (Aguirre-Martínez et al., 2013). 
GST is involved in the Phase II biotransformation metabolism by catalyzing the 
nucleophilic attack of GSH onto highly electrophilic compounds, thus denoting an important 
role in homeostasis as well as in detoxification and clearance of the drugs ( Hayes et al., 
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2005; Faria et al., 2009; Aguirre-Martínez et al., 2013). Such enzyme can reduce lipid 
hydroperoxides together with GPx, and is related to protection against apoptosis (Prabhu et 
al., 2004). Several studies have pointed out its induction in aquatic invertebrates after 
pharmaceuticals exposure as an outcome of its activation and antioxidant role (Martín-Diaz 
et al., 2009; Aguirre-Martínez et al., 2013; Buffet et al., 2014; Maranho et al., 2014; Aguirre-
Martínez et al., 2016a). The mismatch between our results and those reported may be related 
to different patterns of response associated to the drug´s MoA and disparities across species 
regarding their defensive systems to metabolize xenobiotics (Sun and Zhou, 2008; Faria et 
al., 2009; Cozzari et al., 2015). No CP immunotoxicity was observed in the aquatic 
gastropod Lymnaea stagnalis even at therapeutic exposure levels, which was suggested to 
be related to the lack of appropriate converting enzymes of the pro-drug (Boisseaux et al., 
2017). Contrarily, polychaetes N. diversicolor exhibited a sharp decline in the 
biotransformation system in a 14-day bioassay conducted with the electrophilic CisPt, which 
resembles the highly electrophilic binding to the drug (Fonseca et al., 2017). Nevertheless, 
Gonzalez-Rey and Bebianno (2011) observed a significant decrease of GST activity in 
mussels Mytilus galloprovincialis exposed to ibuprofen (250 ng L-1), corroborating the data 
regarding the polychaete Diopatra neapolitana, in systems containing carbamazepine (3 µg 
L-1) (Pires et al., 2016b). 
Lipid peroxidation is initiated by the attack on fatty acids of biomolecules that 
possess sufficient reactivity to abstract a hydrogen atom from methylene carbon in the side 
chain (Halliwell and Chirico, 1993). Cellular lipids are the primary targets of generated ROS 
and subsequently LPO occurs, as in human cells exposed to hydroxyl-cyclophosphamide 
(Dumontet et al., 2001). Morphological changes were observed in type II-alveolar rats´ 
epithelial cells as a result of oxidative stress (e.g. decrease in SOD and glutathione reductase 
activities) and an enhancement of LPO occurs after 7 days of exposure to 150 mg CP kg-1 
body weight (Sulkowska et al., 1998). LPO is one of the main toxic effects caused by CP 
and responsible for several side effects during chemotherapy (Sulkowska et al., 1998) due 
to the production of the reactive aldehyde acrolein formed by β-elimination of 
aldophosphamide. Besides an important component produced by CP for cytotoxicity in 
cancer cells, this metabolite is also known as an overall secondary reactive species-product 
of LPO that triggers further chain reaction (Dumontet et al., 2001; Conklin 2004; Singh et 
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al., 2014). The increased levels of LPO by-products at the higher CP levels (500 and 1000 
ng L-1) (Figure 3.6) may be a result of an inefficient biochemical antioxidant defense system 
(Gonzalez-Rey and Bebianno 2011; Freitas et al., 2016; Pires et al., 2016a; Fonseca et al., 
2017), depicted by the depletion of SOD, T-GPx and GST activities, as indicated in the first 
axis of the PCA (Figure 3.7). Besides enzymes activity suppression, chemotherapy treatment 
produce additional ROS generation (Conklin, 2004), which may lead to DNA damage, 
mutations and apoptosis to normal growing cells, such as observed in marine non-target 
species exposed to cisplatin and methotrexate (Moreira et al., 2016; Fonseca et al., 2017).  
CP has bifunctional and SN1 molecular properties, with two reactive moieties 
towards bases of opposite DNA double strands (Anderson et al., 1995). The major alkylating 
agent following CP metabolism is PAM, which undergoes spontaneous hydrolysis to form 
reactive aziridinium intermediate species, that binds to nucleophilic N7-position of guanine 
in DNA. Alkylation to oxygen atoms of DNA, especially at the O6-position of guanine, are 
also generated at lower frequency than N-alkyl adducts, however its biological relevance is 
even greater considering the readily mispair of bases during DNA replication (Fu et al., 
2012). The array of lesions caused by CP alkylation impair genome integrity by inducing 
mutagenesis, besides DNA replication and eventual responsive signaling for cell death if 
DNA repair mechanisms are not efficient (Deans and West, 2011; Fu et al., 2012). DNA 
damage caused by CP is widely described in vertebrates cells, in which administration by 
therapeutically treated-patients and rats exposed to this drug showed gene mutations, sister 
chromatid exchange, DNA adducts, DNA-DNA and DNA-protein crosslinks in somatic 
cells, especially by the ultimate crosslinking metabolite PAM (Crook et al., 1986; 
Codrington et al., 2004). Few studies were so far conducted to access genotoxicity responses 
to anticancer drugs considering in vivo uptake by marine organisms (Parrella et al., 2015; 
Trombini et al., 2016a; Fonseca et al., 2017). In the present study, results showed a 
significant increase in DNA damage in CP-treated animals compared to controls (Table 3.2). 
Animals exposed to CP, particularly to 1000 ng L-1, had a significantly higher density of 
DNA in the tail compared to controls (CT14) (p < 0.05).  The grade of DNA damage was 
similar among CP treatments, although the lowest and highest concentrations indicated more 
burden of mid damage. 
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 DNA damage caused by anticancer drugs were addressed in other aquatic biological 
models, at levels ranging from low ng L-1 to µg L-1: the bivalve mollusc Mytilus 
galloprovincialis, exposed to cisplatin (Trombini et al., 2016a); the microcrustaceans 
Ceriodaphnia dubia and Daphnia magna, exposed to 5-FU, capecitabine, cisplatin, 
doxorubicin, etoposide and imatinib (Parrela et al., 2014a, 2015); and ZFL cell lines of the 
fish Danio rerio to the tyrosine kinase inhibitor imatinib (Novak et al., 2016). However, the 
14-day exposure of N. diversicolor to the alkylating agent cisplatin (Fonseca et al., 2017) 
yielded no genotoxicity effect at a similar range of concentrations. Cytotoxic metabolites of 
CP are transported and diffused into cells interacting with DNA sites after prodrug enzymatic 
activation, certified with the increasing DNA damage over increasing CP levels, however, 
this needs to be confirmed with CP levels accumulated in the worms.  
3.5 Conclusions 
The present study highlights the cytotoxic effects of the antineoplasic drug CP on 
normal proliferative cells of polychates, by binding to DNA and interfering in antioxidant 
status. Chronic exposure of polychaetes N. diversicolor to CP levels of 500 and 1000 ng L-1 
in seawater led to an inhibition of the antioxidant enzymes activity, stimulating LPO by-
products and DNA damage. The analysed biomarkers suggest that the prodrug CP is 
probably metabolically activated by N. diversicolor into PAM and acrolein, respectively 
responsible for the antineoplastic properties and toxic effects observed, nonetheless, this 
needs to be confirmed. 
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 Chapter 4  
Impacts of tamoxifen exposure to 
Nereis diversicolor  
Prepared for submission to: 
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Bebianno, M.J.. Impacts of in vivo and in vitro exposures to tamoxifen: comparative effects 
on human cells and marine organisms
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Abstract 
Tamoxifen (TAM) is a first generation-SERM administered for hormone receptor-
positive (HER+) breast cancer in both pre- and post-menopausal patients and may undergo 
metabolic activation in organisms that share similar receptors and thus face comparable 
mechanisms of response. The present study aimed to assess whether environmental trace 
concentrations of TAM are bioavailable to the deposit feeder N. diversicolor (0.5, 10, 25 and 
100 ng L-1) after 14 days of exposure. Behavioural impairment (burrowing kinetic), 
neurotoxicity (AChE activity), oxidative stress (SOD, CAT, GPXs activities), 
biotransformation (GST activities), oxidative damage (LPO) and genotoxicity (DNA 
damage) were assessed. TAM exerted a remarkable oxidative stress and damage at the 
lowest concentration (0.5 ng L-1), whereas significant genotoxicity was reported at the 
highest exposure level (100 ng L-1).  
4.1 Introduction 
In recent years, the occurrence of pharmaceuticals in the aquatic environment is 
recognized as one of the worldwide emerging issues regarding environmental quality and 
human health (Hereber. 2002). Increasing consumption of medicines leads to the continuous 
load of pharmaceuticals´ parent compounds and its metabolites into sewage and WWTPs, 
where low removal efficiencies have been reported (Hernando et al., 2006; Furuhagen et al., 
2014; Daughton, 2016; Pereira et al., 2017). Therefore, it is well established that several 
hundreds of pharmaceutical compounds are ubiquitous in WWTPs effluents, ground and 
surface waters, ultimately reaching estuarine and marine ecosystems (Frédéric and Yves, 
2014; Verlicchi and Zambello, 2014). 
Among the variety of pharmaceuticals classes released into the aquatic environment, 
anticancer drugs are one of the critical groups that raise concern regarding the 
ecotoxicological potential risk of long-term exposure to non-target organisms (Rowney et 
al., 2009; Besse et al., 2012; Booker et al., 2014). Overall, the MoA of these molecules rely 
on the interaction with DNA, cellular growth factors, proteins and signaling pathways that 
lead to apoptosis, thus promoting the tumour cell death (Gačić et al., 2014). Nevertheless, 
detrimental effects of anticancer drugs are not restricted to the highly proliferative cells or 
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onto cancer drivers, thus presenting cytotoxic, mutagenic, carcinogenic and teratogenic 
potential to all normal growing cells (Mater et al., 2014; Parrella et al., 2014a).  
Endocrine therapy is an alternative anticancer treatment that uses selective 
mechanisms of interaction with cancer targets, applied individually or in combination with 
cytotoxic molecules (Hoskins et al., 2009). It consists of the administration of a structurally 
diverse group of compounds that binds to the estrogen receptors α (ERα) and β (ERβ), and 
may produce estrogen agonist or antagonist effects, depending of the targeted tissue 
(Goldstein et al., 2000; Paterni et al., 2014). These molecules are referred as selective 
estrogen receptor modulators (SERM) (Goldstein et al., 2000; Rodenas et al., 2015; An, 
2016). The antagonist effect following the formation of estrogen receptor-SERM complexes 
is crucial for the management of hormone-dependent breast cancer and tumour cell survival 
(Goldstein et al., 2000; Zheng et al., 2007; Criscitiello et al., 2011). 
Tamoxifen (TAM) is a first generation-SERM administered for hormone receptor-
positive (HER+) breast cancer in both pre- and post-menopausal patients (Goetz et al., 
2007). Its antitumour ability derives from the antagonism towards the proliferative action of 
estrogen through competitive binding to ERs (Goldstein et al., 2000). As a pro-drug, TAM 
requires a complex metabolic activation to elicit its designed pharmacological activity 
(Kisanga et al., 2005). The 4-hydroxytamoxifen and 4-hydroxy-N-desmethyltamoxifen 
(endoxifen) are the main products of hepatic oxidation, elicited by CYP2D6 and CY3A4, 
with high anti-estrogen potential in humans (Johnson et al., 2008; Murdter et al., 2011) 
(Figure 4.1). Since pharmaceuticals active compounds are designed to have a specific MoA, 
targeting a specific metabolic and molecular pathway in humans, their biological activity 
may occur in organisms that share similar receptors and face comparable mechanisms of 
responses (Fent et al., 2006a). Conservation of biomolecules during evolution may trigger 
similar responses of chemicals in different non-targeted biological systems (Franzellitti et 
al., 2013; Zhang et al., 2017). Although organisms may lack homologues of estrogen 
receptors, they may contain genes for estrogen-related receptors (ERRs) that, according to 
Borgatta et al. (2015) are structurally close to human ERα and ERβ.  
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Figure 4.1: Metabolic pathways of tamoxifen in humans, following activation by 
cytochrome P450. 
Assumptions based on physico-chemical properties indicate that TAM has a high 
hydrophobic potential (Kow = 6.3), thus prone to adsorb to organic particles (Orias et al., 
2015) and settle onto bottom sediments. However, once in coastal areas, TAM as other 
pharmaceuticals molecules, can be subject to physico-chemical and biological conditions 
different from those found in freshwater environments (e.g. salinity, pH, temperature, 
turbidity, organic compounds, microbial population) and thus TAM may present  different 
chemical behaviour and unexpected partition over water, suspended particles and sediments, 
therefore a distinct persistence (Weigel et al., 2002; Lara-Martín et al., 2014).  
Ecotoxicity assays conducted with TAM, in freshwater and marine species, showed 
inhibition in the larval development of the sea urchin Spherechinus granularis (Pagano et 
al., 2001), a decrease in egg production of the fish Tautogolabrus adspersus  (Mills et al., 
2015), and an alteration of vitellogenin gene expression in the fish Sparus aurata L. (García-
Hernández et al., 2016) (See details in Table 4.1). These effects were detected at a 
concentration range from ng L-1 to µg L-1, encompassing TAM concentrations detected in 
aquatic compartments (Table 4.1). Despite the increasing efforts devoted to comprehend the 
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risks of TAM occurrence in aquatic compartments, there is still a lack of environmental 
concentrations screening in coastal and marine ecosystems, as well as information around 
its bioavailability and potential routes of exposures that may derive toxicological effects to 
non-target species (Thomas and Hilton, 2004; Roberts and Thomas, 2006; Lara-Martín et 
al., 2014).  
In light of the trend of increasing concentrations of anticancer drugs in the aquatic 
environment, even though below human therapeutic doses, it is important to understand 
whether pharmaceuticals are likely to pose a risk to the biota via similar metabolic pathways 
detected in humans (Furuhagen et al., 2014; Mater et al., 2014). Estrogen receptor 
expression varies across species and can be differentially expressed according to tissues 
(McGinnis and Crivello, 2011). Human cell lines such as the retinal pigment epithelium 
(RPE) cell line have shown to express ER subtypes (Wang et al., 2015; Koulisis et al., 2016), 
in contrast to cervical carcinoma HeLa cells, in which ER does not mediateestrogen 
responsive reporter expression (Maminta et al., 1991; Shanle and Xu, 2010; Klinge, 2015;).  
Polychaetes are sediment dwelling organisms from estuarine and marine benthic 
zones which possess high ecological relevance, besides being an important component of an 
ecotoxicological toolbox to assess the impact of contaminants in sediments due to their life 
habits that provide a constant contact with chemicals adsorbed onto particles and interstitial 
water (Freitas et al., 2015). Putative detrimental effects of anticancer drugs in sediments 
have been depicted through biochemical impairments in the polychaete N. diversicolor, 
exposed to the cytotoxic drug cisplatin (0.1 to 100 ng Pt L-1) (Fonseca et al., 2017) and 
cyclophosphamide (10 to 1000 ng L-1) (Fonseca et al., 2018), and the amphipod Corophium 
volutator exposed to the drug methotrexate (1 to 1000 ng L-1) (Moreira et al., 2016). Due 
the paucity of research to effects of TAM to marine organisms, particularly considering their 
routes of uptake, one of the aims of the present study was to investigate whether 
environmental trace concentrations of TAM are bioavailable to the deposit feeder N. 
diversicolor. The approach consisted of a 14-day assessment of behavioural impairment 
(burrowing kinetic impairment), neurotoxicity (AChE activity), oxidative stress (SOD, 
CAT, GPXs activities), biotransformation (GST activities), oxidative damage (LPO) and 
genotoxicity (DNA damage). Organisms were exposed to a range of concentrations that 
encompass environmental relevant levels and those considered a worst-case scenario
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 Table 4.1: TAM Concentrations in water (ng L−1), suspended solids and sediments (ng g−1) from ground, riverine and marine waters. 
Study Area 
Groundwater River  Marine  
Reference 
 Surface Water Suspended Solids Sediment Seawater Suspended Solids Sediment 
France - <5.8 - 25  - - - - - Coetsier et al. (2009) 
Japan - - 658 0.042 - - - Azuma et al. (2017) 
Germany 6 - 16.5  - - - - - - Reh et al. (2013) 
England - 27 - 212  - - - - - Roberts and Thomas (2006) 
England - <10 - - - - - Ashton et al. (2004) 
England - 13 - 71  - - - - - Hilton and Thomas (2004)  
England - <10 - 23  - - - - - Hilton et al. (2003) 
Spain - 12.4 - 26.8  - - - - - López-Serna et al. (2012) 
Spain 11.2 - 223  - - - - - - López-Serna et al. (2013) 
Spain - 12 - 38 - - - - - Ferrando-Climent et al. (2014) 
Spain - 0.5 - 25  - - - - - Franquet-Griell et al. (2017) 
USA - - - - - 8 - 44 7 Lara-Martín et al. (2014) 
USA - n.d. - 11.2   - - - - - Lara-Martín et al. (2015) 
USA - - - - 93 - - Nödler et al. (2014) 
China - 0.01 - 1.23  - - - - - Zhao et al. (2015) 
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4.2 Materials and Methods 
4.2.1 Chemicals 
Tamoxifen analytical standard (CAS 10540-29-01) was purchased from Sigma-
Aldrich (Portugal). For safety handling of the drug, the experimental work was performed 
using class II biological safety cabinet, with appropriate clothing (open-back, impervious 
chemotherapy protection gown, double powder-free latex gloves and safety goggles). Since 
TAM is not readily soluble in water, the stock solution was prepared in the carrier solvent 
dimethyl sulfoxide (DMSO). Experimental solutions were prepared from sequential 
dilutions in ultrapure Milli-Q water, with a final concentration of 0.001% (v/v) DMSO in 
order to avoid a solvent toxic effect.  
4.2.2 Experimental design 
Polychaetes N. diversicolor and sediment samples were collected in an intertidal 
mudflat in Mira River Estuary (SW, Portugal), during low tide, and transported alive to the 
laboratory. Sediment grain size distribution and organic matter content were determined 
according to methods described by Royse (1970) and Gross (1971) (see Fonseca et al., 
2018). Animals were maintained in glass aquaria filled with aerated natural seawater 
(salinity 35) and sediments from the site of origin, during 5 days before testing. A total of 
75 polychaetes was randomly selected and added to each treatment, in a triplicate design (25 
animals per aquaria), in 10-L glass aquaria containing sediments and seawater (1:4 ratio, 
respectively). Specimens were unexposed: controls (CT0 - day 0; and CT14 - day 14) and 
exposed to DMSO (0.001%), and to TAM (0.5, 10, 25 and 100 ng L-1) for 14 days. 
Experimental set-up was kept under constant aeration and light period (12:12 hours), and 
physico-chemical parameters registered (pH 7.92 ± 0.2; temperature 19 ± 1°C; salinity 35 ± 
1). During the experiment, water was carefully renewed every 48 hours avoiding sediment 
resuspension, with addition of DMSO (0.001%) and TAM concentrations into water column 
aftermath. Animals were not fed during the bioassay.  
For burrowing and comet assays, specimens were immediately handled and managed 
for respective analysis, while those regarding biochemical end-points (AChE, SOD, CAT, 
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GST, GPx, LPO) were rinsed with clean seawater and stored at -80 °C until further use. For 
the DNA damage analysis coelomic cells of N. diversicolor (5 specimens per aquaria, in 
triplicate; total of 15 organisms per treatment) were extracted from the posterior region of 
the polychaete body into 20 µL of PBS buffer with a 0.5 mL-syringe fitted with hypodermic 
needle (adapted from Lewis and Galloway 2008).  
4.2.3 Burrowing assay 
The behavioural endpoint of the burrowing assay was verified only over the exposure 
of N. diversicolor. Polychaetes from control conditions, DMSO and TAM-exposed were 
submitted to a burrowing test after the 14-days bioassay, according to Fonseca et al. (2017). 
Polychaetes (5 specimens per aquaria, in triplicate; total of 15 organisms per treatment) were 
carefully and individually displaced from their test containers and transferred to 150 mL-
plastic flasks, filled with natural seawater and 5 cm of sediments. The vertical position of 
polychaetes in sediment column was recorded every two minutes, to assess the time for fully 
burrowing in the 30 min-assay. The results are expressed as the percentage (%) of un-
burrowed specimens, over time (min).  
4.2.4 Biochemical Analysis 
Total proteins 
Total proteins concentrations (mg protein g−1 tissue) were determined according to 
the method described by Bradford (1976) adapted for microplate reader, using bovine serum 
albumin (BSA) as a standard. 
Neurotoxicity 
AChE activity was determined in whole tissues of N. diversicolor (2 specimens per 
aquaria, in triplicate; total of 6 organisms per treatment). Samples were individually 
homogenized in 100 mM Tris-HCl buffer (pH 8.0) with addition of 0.1% Triton, following 
centrifugation at 12,000 g, for 30 min, at 4 °C. Supernatants were split into aliquots for total 
protein determination (Bradford, 1976) and AChE activity was analysed using the method 
of Ellman et al. (1961) adapted to microplate reader. Briefly, 50 μl of non-diluted samples, 
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or blank solution, were incubated with 200 μl of 0.75 mM DTNB solution (Sigma) in 0.1 M 
Tris-HCl buffer, pH 7.5. The reaction started by the addition of 50 μl of 3 mM ATC (Sigma), 
following incubation for 10 min at room temperature. Changes in absorbance were recorded 
over 5 min at 405 nm, and results are expressed as ATC.min-1 mg-1 protein. 
Antioxidant enzymes 
Antioxidant enzymes activities were determined in whole tissues of N. diversicolor 
(2 specimens per aquaria, in triplicate; total of 6 organisms per treatment). Samples were 
individually homogenized in 20 mM Tris-HCl buffer (0.5 M sucrose; 0.075 M KCl; 1 mM 
DTT; 1 mM EDTA; adjusted to pH 7.6 with HCl), according to the protocol described by 
Geret et al. (2002). Homogenates were centrifuged at 500 g, for 15 min, at 4 °C, and the 
supernatants obtained centrifuged again (12,000 g, 45 min, 4 °C). Enzymatic activities were 
analysed in the cytosolic fraction. SOD activity was assessed by measuring the decrease of 
absorbance of the substrate cytochrome-c by xanthine oxidase/hypoxanthine system, at 550 
nm (McCord and Fridovich 1969), and the results are expressed as U mg-1 protein. CAT 
activity was evaluated through the decrease of absorbance originated by hydrogen peroxide 
(H2O2) consumption at 240 nm, according to Greenwald (1985). GPX activity was measured 
at 340 nm by using cumene hydroperoxide and H2O2 as substrates for T-GPx and Se-GPx, 
respectively (adapted from Lawrence and Burk, 1976). The activity of CAT, Se- and T-GPx 
are expressed in nmol min-1 mg-1 protein.  
Biotransformation enzyme activity 
The cytosolic fraction for the determination of GST activity was obtained according 
the protocol described in 2.3.2. Measurement of this biotransformation enzyme activity was 
conducted in whole specimens of N. diversicolor (6 organisms per treatment). Reaction 
mixture undergoes by the conjugation of 0.2 mM reduced glutathione (GSH) with 0.2 mM 
CDNB (molar coefficient of extinction = 0.6 mM-1 cm-1) in a reaction mixture of 0.2 M 
KH2PO4/K2HPO4 buffer (pH 7.9), at 340 nm (adapted from Habig et al., 1974). GST activity 
is determined in nmol min-1 mg-1. 
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Oxidative damage 
Polychaetes N. diversicolor (6 organisms per treatment) were individually 
homogenized in a Tris–HCl buffer (20 mM, pH 8.6) and BHT (100:1 µL, respectively). The 
resulting homogenates were centrifuged, for 45 min at 30,000 g at 4 °C, in order to obtain 
the cytosolic fraction. Aliquots of supernatants were used for the quantification of total 
proteins (Bradford, 1976) and determination of oxidative damage (Erdelmeier et al., 1998), 
adapted for microplate reading. The absorbance of LPO by-products, the malondialdehyde 
(MDA) and (2E)-4-hydroxy-2-nonenal (4-HNE), was measured at 586 nm and expressed as 
nmol MDA + 4-HNE mg−1 protein.  
4.2.5 Genotoxicity  
Genotoxicity was estimated by the alkaline Comet assay, as described in Fonseca et 
al. (2018). Briefly, cells collected from polychaetes and mussels were centrifuged at 3000 
rpm (3 min, 4 °C), and resulting pellets suspended in 0.65 % low melting point agarose 
(LMA, in Kenny's salt solution; 0.4 M NaCl, 9 mM KCl, 0.7 mM KH2PO4, 2Mm NaHCO3, 
1000 ml Milli-Q water). Subsequently, cells were smeared in duplicate on microscope slides, 
coated with 0.65 % normal melting point agarose (NMA) in Tris-acetate EDTA. To allow 
membrane permeability and release of DNA, slides were immersed in lysis buffer (100 mM 
EDTA, 2.5 M NaCl, 10 mM Tris, 1% Triton X-100, 10% Dimethylsulfoxide,1% Sarcosil, 
pH 10, 4 °C), for at least 1 h, and placed in a horizontal electrophoresis box. Cells were 
exposed to alkali buffer (300 mM NaOH, 1 mM EDTA, adjusted at pH 13, 4 °C) over 15 
min to allow DNA unwinding. Electrophoresis current was set up at 25 V and 300 mA, over 
5 min, following slides neutralization (0.4 mM Tris, pH 7.5). Cells were stained with 4,6-
diamidino-2-phenylindole (DAPI, 1 mg ml-1) and analysed with an optical fluorescence 
microscope Axiovert S100 (total magnification of ×400). The amount of DNA in the comet 
tail (DNA tail %) was determined by the software Komet 5.5 (Kinetic Imaging Ltd) in 50 
cells per sample (25 in each duplicate). Results are expressed as mean ± standard deviation 
(S.D.). 
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4.2.6 Statistical analysis 
Statistical analysis was carried out using the Statistica 8.0 software (Statsoft Inc., 
2007, USA). The results were compared using parametric tests (ANOVA, followed by the 
Tukey’s test), or non-parametric equivalent test (Kruskal-Wallis), according to data 
distribution and variances homogeneity (Shapiro-Wilk and Levene's tests, respectively). 
Results were significant when p < 0.05.   
4.3 Results 
4.3.1 Burrowing behaviour 
The percentage of polychaetes from CT0, CT14 and exposed to DMSO buried were 
100%, 90% and 90%, respectively, within 6 minutes of bioassay. In contrast, organisms 
exposed to the different TAM concentrations showed a general increase in burrowing time 
with the increase of TAM concentrations exposure. Polychaetes treated with 25 ng L-1 and 
100 ng L-1 failed to burrow after 4 minutes and 26% and 53% of polychaetes, respectively, 
remained unburied (Figure 4.2). 
 
 
Figure 4.2: Percentage of unburied N. diversicolor over time (minutes) in controls (CT0, 
CT14) and exposed to DMSO and to TAM concentrations (0.5, 10, 25, 100 ng L-1). Lines 
with symbols indicate the behaviour during the 30-min experiment. 
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4.3.2 AChE activity  
No differences in AChE activity were detected among controls (i.e. CT0, CT14) and 
DMSO (p > 0.05) (Figure 4.3). Polychaetes exposed to TAM showed an induction of AChE 
activity, except for those exposed to 10 ng L-1.  
 
Figure 4.3: N. diversicolor AChE activity (mean ± S.D.) (ATC.min-1 mg-1 protein) in 
unexposed (CT0, CT14) and exposed to DMSO and to TAM concentrations (0.5, 10, 25 and 
100 ng L-1). Different letters indicate significant differences among treatments (One-way 
ANOVA; p < 0.05). 
 
4.3.3 Antioxidant enzymes responses 
Overall, enzymatic activities of unexposed specimens (i.e. CT0, CT14) and exposed 
to DMSO were similar (p > 0.05), with the exception of T-GPx that indicated an increase in 
DMSO exposed group. In polychaetes exposed to the lowest TAM concentration (i.e. 0.5 ng 
L-1), SOD activity increased compared to all other treatments (p < 0.05) (Figure4.4-A). 
Although not significant (p > 0.05), there was an increasing trend of SOD activity in the 
other TAM concentrations. Regarding CAT activity, a significant inhibition occurred at the 
highest TAM concentration compared to control conditions (p < 0.05) (Figure 4.4-B). The 
activity of Se-GPx and T-GPx, like for SOD, also increased in polychates exposed to 0.5 ng 
L-1 of TAM (p < 0.05) (Figure 4.4-C and 4.4-D) (2-fold compared to controls).  
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Figure 4.4: N. diversicolor antioxidant enzymes activities (mean ± S.D.) expressed in 
unexposed polychaetes (CT0, CT14) and exposed to DMSO and to a range of TAM 
concentrations (0.5, 10, 25 and 100 ng L-1): (A) SOD, (B) CAT, (C) GPx Se-dependent, (D) 
T-GPx. Different letters indicate significant differences among treatments (One-way 
ANOVA; p < 0.05).  
 
4.3.4 Biotransformation enzyme activity 
Relatively to GST activity, no significant alteration was observed among treatments 
(p > 0.05) (Figure 4.5). 
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Figure 4.5: N. diversicolor GST activity (mean ± S.D.) in unexposed (CT0, CT14) and 
exposed to DMSO and to TAM concentrations (0.5, 10, 25 and 100 ng L-1) Absence of letters 
indicate no differences among treatments (One-way ANOVA, Kruskal-Wallis; p > 0.05). 
 
4.3.5 Oxidative damage 
LPO levels in polychaetes controls and exposed to DMSO were similar (p > 0.05). 
In contrast, the exposure of polychaetes to TAM induced the generation of LPO by-products 
since there was a similar increase of MDA + 4HNE concentrations in all of exposed animals 
compared to controls (p < 0.05; Figure 4.6). 
 
Figure 4.6: N. diversicolor LPO levels (mean ± STD) (MDA+ 4-HNE nmol.mg-1 protein) 
in unexposed (CT0, CT14) and exposed to DMSO and to different TAM concentrations (0.5, 
10, 25 and 100 ng L-1). Different letters indicate significant differences among treatments 
(One-way ANOVA; p < 0.05). 
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4.3.6 Genotoxicity 
No significant changes in % of DNA tail were detected on coelomocytes from control 
conditions (CT0, CT14 and DMSO) (p > 0.05; Figure 4.7). In TAM-treated polychaetes, 
DNA damage was only addressed in specimens exposed to the highest drug concentration 
(100 ng L-1) (p < 0.05; Figure 4.7). 
 
Figure 4.7: DNA damage (mean ± standard deviation) in coelomocytes of polychaetes N. 
diversicolor unexposed (CT0, CT14) and exposed to DMSO and to different TAM 
concentrations (0.5, 10, 25 and 100 ng L-1). Different letters indicate significant differences 
among treatments (One-way ANOVA; p < 0.05). 
 
4.4 Discussion 
Specific physico-chemical properties of pharmaceuticals are known to provide 
predictable behaviour and fate in aquatic compartments. The high log Kow and low water 
solubility of TAM suggest a potential removal from wastewater through drug adsorption 
onto sewage sludge and sediments. However, detection of TAM in WWTPs effluents 
(concentrations up to 369 ng L-1) (Roberts and Thomas, 2006) confirm its low removal 
efficiency (i.e. 17 to 43%) and drug recalcitrance over conventional technologies that use 
sorption processes (Fernando-Climent et al., 2014). Once released in the aquatic 
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environment, besides its residence in water column, pharmaceuticals compounds also sorb 
onto suspended organic matter, clay, sediments and microorganisms, that eventually settle 
in the bottom areas (Silva et al., 2011; Zenker et al., 2014; Rocha et al., 2015). Therefore, 
differential uptake, trophic transfer and bioaccumulation are experienced by aquatic species 
subjected to different ways of exposure, via water or sediment contact, although there is still 
a lack of information around TAM´s bioavailability, that may derive toxicological effects to 
non-target species (Table 4.2) (Chapman and Wang, 2001; Torres et al., 2009; Yamamoto 
et al., 2009; Du et al., 2014; Ribeiro et al., 2015). 
The present findings indicated that SOD and Se-GPx activities significantly 
increased in polychaetes exposed to the lowest TAM concentration (0.5 ng L-1) (p < 0.05) 
(Figure 4.2). SOD upregulation illustrates the prompt of the antioxidant system to overcome 
those toxic by-products, by means of converting superoxide radical into less toxic hydrogen 
peroxide (H2O2), following detoxification into water and oxygen by GPx´s (Van der Oost et 
al., 2003; Gonzalez-Rey and Bebianno, 2014). At the lowest TAM concentration, GPx may 
have exerted a critical compensatory mechanism over the unchanged CAT activity (Cozzari 
et al., 2015; Marchi et al., 2017). The non-linear dose response characterized by the lower 
dose stimulation (0.5 ng L-1) observed in SOD and Se-GPx activities (Figure 4.4), is referred 
as hormesis and may include mechanisms to overcompensate alterations in homeostasis and 
adaptive response based on inducible repair processes (Chapman, 2002; Hoffmann, 2009). 
In other words, a small exposure to a stressful stimulus increases the resistance of the cell or 
organism to a moderate or severe level of stress (Arumugam et al., 2006; Hoffmann, 2009). 
Besides repairing any damage, organisms also reduce background damage more effectively 
(Chapman, 2002). The hormetic curve is described as non-monotonic and biphasic shape, in 
which effects at low doses are opposite to those at high doses (Hoffmann, 2009). This kind 
of relationship have been described from bacteria to vertebrates, as an outcome at 1000 
different environmental stressors (Chapman, 2002; Mater et al., 2014), and is also attributed 
to the response of N. diversicolor exposed to the lowest CP concentration (10 ng L-1) 
(Fonseca et al., 2018).  
In the case of TAM administration to human patients, an increase in enzymatic 
activity was registered for choline acetyltransferase, accountable for the synthesis of the 
acetylcholine neurotransmitter critical for synapses (Silva et al., 2000). In mammalian brain, 
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TAM acts as an ER agonist and exerts estrogen-like effects associated to modulation of 
neuroprotection and increase of human cognition, attention and verbal skills (Dicko et al., 
1999; McEwen and Alves, 1999; Simpkins et al., 2009; Newhouse et al., 2013). Besides the 
beneficial effects of TAM in human neuroactivity, there are still confounding factors in the 
mammalian group itself related to features of hormonal status, age, tissue-specific activation 
of ERs, and whether ERs possess ability to bind estrogens or anti-estrogens at low 
concentrations (Newhouse et al., 2013; Lv et al., 2017). At a concentration range from 0.1 
to 50 µg L-1, TAM was unable to alter AChE activity in the freshwater clam Corbicula 
fluminea and disagree with the present observations, reinforcing that its role as a receptor-
estrogen modulator in invertebrates is far from clear (Aguirre-Martínez et al., 2018)  
The biotransformation enzyme, GST, conjugates reactions of active electrophilic 
metabolites or their parental compounds with reduced glutathione (GSH), enabling its 
transformation to more extractable hydrophilic metabolites (Van der Oost et al., 2003; Luis 
et al., 2016). In addition, GST provides protection against ROS, playing a critical role in the 
defence against oxidative damage and peroxidative products of DNA and lipids (Nuwaysir 
et al., 1996). However, in human liver, TAM is extensively metabolized by phase I 
cytochrome P450 and phase II sulfotransferases (SULTs) and UDP-
glucoronosyltransferases (UGTs) (Kiyotani et al., 2012), whereas the mechanism by which 
TAM affects GST expression is poorly studied. According to Nuwaysin et al. (1996), TAM 
administration at relevant clinically therapeutic doses produce significant suppression in 
GST mRNA expression in rat liver, resembling the outcomes associated to cisplatin MoA 
(Fuertes et al., 2003). Herein, the activity of GST did not change in polychaetes exposed to 
any TAM-concentration, in contrast to the significant inhibition in N. diversicolor specimens 
exposed to cisplatin at 100 ng Pt L-1 (Fonseca et al., 2017 - Chapter 2). In the present case, 
either TAM metabolism may not be involved in GST phase II enzyme, or the concentration 
range applied in the bioassay was not enough to trigger this detoxification pathway. 
In this study, TAM induced LPO in polychaetes exposed to all concentrations (Figure 
4.6). TAM embeds itself in the lipid membranes and generates superoxide, which causes 
LPO and subsequent 4-HNE formation, following activation of caspase-3 cascade and cell 
death (Bekele et al., 2016). Such mechanism supports the contribution of oxidative damage 
on killing cancer cells during TAM therapy. Interferences in the oxidative damage may be 
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attributed either to the metabolic activation of TAM in N. diversicolor, following production 
of ROS, and/or by oxidative stress generated by TAM molecule intrusion in the lipid bilayer, 
which does not depend on the prodrug metabolism neither ERα expression and its activation 
(Trachootham et al., 2009; Lushchak, 2011; Bekele et al., 2016).  
Accordingly, the noteworthy DNA damage herein revealed in specimens exposed to 
the highest TAM concentration may be particularly linked to activation of prodrug at such 
great drug levels (Figure 4.7), since the conversion of TAM into its intermediary putative 
active metabolite α-hydroxytamoxifen is a pre-requisite for DNA covalent binding and 
adducts formation (Boocock et al., 2002), as reported in human peripheral blood 
lymphocytes and MCF-7 cells using alkaline Comet Assay (Wozniak et al., 2007). Such 
explanation is plausible considering that the antioxidant disruption elicited in polychaetes 
from 100 ng L-1 treatment only occurred through inhibition of CAT activity in addition to 
levels of LPO by-products, at the same grade of oxidative damage generated in all tested 
TAM concentrations. In other words, different mechanisms are involved in DNA damage at 
the highest TAM concentration. 
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Table 4.2: Ecotoxicological effects of TAM reported in coastal and marine species. 
Taxon Species 
Concentration                   
range (ng L-1)a 
Time (d)b Parameter Effect Reference 
Microalgae Isochrysis galbana 1 - 5 × 108  4 Growth inhibition EC50 = 3.5 × 107  Aguirre-Martínez et al. (2016a) 
Bivalve Mollusc Ruditapes phillipinarum  100 - 50000 14 
Oxidative stress, 
oxidative damage, 
genotoxicity, 
oxidative damage 
100: *↑ EROD, LPO;  
     *↓GPx, DBF;   
1000: *↑ EROD, GPx, GR, LPO, DNA; 
*↓ DBF, GST;    
   10000: *↑ EROD, GPx, LPO;  
*↓DBF                                                        
50000:  *↑ EROD, GPx, GR, LPO;  
    *↓ AChE, GST, DBF  
Aguirre-Martínez et al. (2016a) 
Echinorderm 
Paracentrotus lividus 10 - 109  1b Fertilization EC50 = 1.5 × 107 Aguirre-Martínez et al. (2016a) 
  10 - 109  2 Larval Development EC50 = 1 × 109   
  10-8 - 10-6 M 0.5b Fertilization 1 × 10-7 M: *↓ Pagano et al. (2001) 
  10-8 - 10-6 M 0.5b Offspring Quality 1 × 10-6 M: *↓   
Spherechinus granularis 10-8 - 10-6 M 3 Larval Development 1 × 10-6 M: Embryotoxicity *↑   
Strongylocentrotus purpuratus - 4 Larval Development EC50 = 50 Roepke et al. (2005) 
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Fish 
Tautogolabrus adspersus 5 × 105 - 5 × 106a 17 Egg production 5 × 105: *↓ Mills et al. (2015) 
Sparus aurata L. 100000a 25 Gene expression Vitellogenin *↑ García-Hernández et al. (2016) 
  100000a 25 Gene expression 
Immune response (ilb1, tnfa, 
tgfb1,mhc1a, tlr9)  *↑ 
  
  100000a 25 Sperm concentration *↑   
  100000a 25 Sperm motility *↑   
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4.5 Conclusions 
Our present findings confirmed that the prodrug TAM elicits detrimental 
impacts in N. diversicolor, at environmental realistic concentrations, by means of a 
hormetic trend of responses. These results highlight the risks to which coastal species 
are chronically subjected. Although the lack of evidence regarding nuclear ERs-like 
expression in N. diversicolor, which would enable drug metabolic activation and 
apoptotic outcomes, the generation of oxidative stress, membrane damage, and 
genotoxicity were registered, and could have been attributed to the direct contact of 
prodrug to cytoplasmic membrane. In this sense, it is relevant to determine whether 
TAM acts as an agonist and antagonist in the tissue of analysis, and to which extent 
the presence of ERs is crucial for cell growth inhibition in non-target organisms.  
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 Chapter 5  
Effects of mixtures of anticancer 
drugs in the benthic polychaete 
Nereis diversicolor  
 
Prepared for submission to: 
 Fonseca, T.G., Abessa, D. M. S., Bebianno, M.J. Effects of mixtures of 
anticancer drugs in the benthic polychaete Nereis diversicolor
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Abstract 
The increasing consumption of anticancer drugs through single and/or 
combinatory chemotherapy administration worldwide raised concern regarding their 
toxicity burden towards non-target species, particularly in the coastal zone. The 
toxicity of tertiary mixtures involving the drugs cisplatin (CisPt), cyclophosphamide 
(CP) and tamoxifen (TAM), at an increasing range of concentrations (Mixtures A, B, 
C, and D), was determined in the marine polychaete Nereis diversicolor by analyzing 
different endpoints like the effects on burrowing behaviour, neurotoxicity 
(acetylcholinesterase – AChE - activity), antioxidant enzymes (superoxide dismutase 
(SOD), catalase  (CAT), selenium dependent glutathione peroxidase (Se-GPx) and 
total glutathione peroxidases (T-GPx) activities), biotransformation metabolism 
(Glutationne-S-transferases  (GST), lipid peroxidation (LPO) and genotoxicity (DNA 
damage). The effects obtained from the exposure to mixtures were compared to those 
of the same concentration of the single-drugs. Regarding SOD activity, TAM showed 
an antagonist effect over CisPt and CP in mixtures C and D. However, in Mix D, there 
was a synergistic effect of TAM and CisPt that resulted in the sharp inhibition of CAT 
activity, and an additive interaction of CisPt and CP on the Phase II biotransformation 
enzyme. Even at low concentrations, the drugs present in Mix A also suppressed 
polychaetes´ GST activity, although different from the respective single-drug 
responses, in addition to a protective mechanism of hormesis detected by T-GPx 
activity induction not sufficient to avoid oxidative damage and mid-grade DNA 
damage. Due to the absence of burrowing impairment in Mix A, mechanisms involved 
in neurotoxicity were other than the one driven by AChE alterations. At the 
intermediary concentrations (Mix B and C), only LPO occurred, as a potential effect 
of TAM interaction over cellular membranes. Despite the range of concentrations 
tested, the sediment dweller N. diversicolor showed to uptake and metabolize the 
anticancer compounds in combination indicating that mixtures may act differently 
according to the dose of the individual drugs. These findings show that single 
compound toxicity data are not enough to predict aquatic toxicity such as anticancer 
drug mixtures.  
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5.1 Introduction 
It is well established that aquatic organisms are exposed to multiple stressors, 
containing complex mixtures of chemicals, among them pharmaceutical residues and 
their respective metabolites (González-Ortegón et al., 2016; Thrupp et al., 2018). 
Despite the fact that pharmaceuticals are jointly discharged into water bodies via 
effluents from hospitals and household WWTPs, with limited efficiency to remove 
complex molecules, or directly from the sources, as is the case of developing countries, 
environmental risk assessment still relies on the impact of individual substances 
(Altenburger et al., 2000; Fent et al., 2006a; Santos et al., 2010). The assessment of 
ecotoxicological impacts elicited by combined effects of pharmaceuticals in mixtures 
is still an incipient topic of research, particularly regarding coastal and marine 
organisms. 
Evidence suggests that some drugs interact at environmentally relevant levels 
in a given mixture, conferring unexpected toxicity effects not predicted based on 
individual concentrations, by virtue of interactions among their modes of action 
(MoAs) (Cleuvers, 2004; Pomati et al., 2008; Trombini et al., 2016b). Almeida et al. 
(2018) showed that the antiepileptic carbamazepine (CBZ) or the anti-histaminic 
cetirizine (CTZ) combined with Cd elicited different biochemical responses in marine 
clams Ruditapes philippinarum compared to the drugs alone, in a 28-day bioassay. 
GST activity and levels of LPO by-products were similar between individuals from 
controls and those exposed to the mixture CBZ + Cd, whereas the single exposure to 
CBZ caused oxidative stress and damage. On the other hand, CBZ combined with Cd 
inhibited GST activity, while individual exposure to this drug did not cause 
biochemical alterations. A 6 h-exposure of the Pacific oyster Cassostrea gigas to a 
mixture containing ibuprofen (5 µg L-1) and the herbicides diuron (5 µg L-1) and 
isoproturon (5 µg L-1) caused a significant inhibition of phagocytosis (50%) and a 20% 
reduction in the catecholase phenoloxidase activity, in contrast to the absence of 
effects on exposure only to diuron (Luna-Acosta et al., 2012).  
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The therapeutic purpose and MoA of mixtures of drugs are important 
parameters of concern, such as their respective individual concentrations (Trombini et 
al., 2016b). It is crucial to consider the potential toxic mechanisms underlying drugs´ 
MoA and the complexity of responses in aquatic species, particularly those produced 
by hazardous therapeutic classes (Pomati et al., 2008; Toolaram et al., 2014). In this 
context, the anticancer drugs applied in conventional chemotherapies arise as an 
incipient environmental concern given their overall design to ultimately interrupt 
tumour cell proliferation and provoke cells’ death (Johnson et al., 2008; Xie, 2012; 
Toolaram et al., 2014). Such therapeutic class comprise a wide array of subgroups, in 
which molecules exert cytotoxic activity through a range of mechanisms, including 
disruption of DNA transcription, replication and synthesis; significant generation of 
reactive oxygen species (ROS) following biochemical alterations and cellular damage; 
modulation of kinases and inactivation of vital proteins; interaction with microtubules 
or tubulins in order to disrupt mitotic spindle, among others (Conklin, 2004; Gorrini 
et al., 2013; Toolaram et al., 2014; He et al., 2016). Since these “targets” are not 
specific drivers of tumour proliferation, normal growing cells are also affected, with 
cytotoxic, genotoxic and mutagenic outcomes (Zounková et al., 2007; Caley and 
Jones, 2012; Heath et al., 2016). Particularly regarding the administration of these 
pharmaceuticals, chemotherapy regimens combine multiple anticancer drugs with 
distinct MoAs, in order to provide an additive or synergistic activity, thus achieving 
clear rationale cytotoxic effects and overcome patients´ resistance (Tkaczuk, 2009; Shi 
et al., 2012; He et al., 2016). To mitigate potential increases in toxicity, the 
combination approach to treatment frequently involves using lower doses of 
chemotherapeutic agents than would typically be considered optimal (Tkaczuk, 2009). 
Consequently, excreted residues consist of mixtures of these therapeutic compounds 
and their by-products (Parrella et al., 2014a).  
A vast array of pharmaceuticals with anticancer purposes were detected in 
freshwater and marine compartments at concentrations from sub-ng to ng L-1 (Thomas 
and Hilton, 2004; Buerge et al., 2006; Zuccato et al., 2006; Ortiz de García et al., 
2013; Česen et al., 2015; Franquet-Griell et al., 2017). Regardless of being present at 
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very low levels, anticancer agents cause subtle effects in non-target aquatic organisms 
under chronic exposure, via similar toxic mechanisms reported in targeted biological 
models (Moreira et al., 2016; Trombini et al., 2016b; Fonseca et al., 2017, 2018), thus 
highlighting that ecotoxicological data of aquatic species should not be merely based 
on acute toxicity determinations (Brezovsek et al., 2014; Elersek et al., 2016). 
Although knowledge regarding toxicity elicited by mixtures of anticancer drugs is 
growing, there is still a caveat around the potential responses in marine species. 
Once in the aquatic environment, pharmaceuticals undergo hydrodynamic, 
biological and chemical processes over the water course until they reach the marine 
environment, where the gradient of salinity and pH, microbial population, among 
others, may provide differential partitioning of pharmaceuticals compounds and 
contribute to their aggregation and settling onto sediments (Yamamoto et al., 2009; 
Du et al., 2014; Ribeiro et al., 2015). Sediment dwelling species are then constantly 
exposed to complex pharmaceuticals mixtures, either by bulk sediments dermal 
contact and ingestion, such as through interstitial water, depicting important routes of 
exposure to benthic biota. Altogether, factors that must not be neglected in these 
combinatory approaches are the range of concentrations present in mixtures, 
differences in bioavailability and routes of drug uptake, presence of biologically 
relevant targets of the drug and reasonable interactions between them (Escher and 
Hermens, 2002; Parrella et al., 2014a; Brezovsek et al., 2014) .  
Cisplatin (CisPt) is a platinum-based anticancer agent mainly applied to treat 
ovarian, colorectal, head and lung cancers, by inducing covalent linkages with DNA 
and generation of interstrand crosslinks (see Chapter 2). Although also acting on DNA, 
cyclophosphamide (CP) consists of an alkylating mustard that requires metabolic 
activation to exert its cytotoxic purpose by forming covalent adducts (Emadi et al., 
2009) (see also Chapter 3). Tamoxifen is a selective estrogen-receptor modulator 
(SERM) prescribed for therapy of breast cancer with the purpose to antagonize the 
proliferative action of estrogen through competitive binding to its respective receptor 
(ER) (Goldstein et al., 2000; Besse et al., 2012)  (see also Chapter 4).  
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Because these anticancer drugs have been traditionally applied worldwide in 
single and combinatory chemotherapy during decades, they were chosen for the 
present mixture toxicity assessment aimed to determine the effects exerted in an 
ecological representative species from marine benthos, the polychaete Nereis 
diversicolor. Mixtures consisted of an increasing range of concentrations and exposure 
took over 14 days. The objective of the present chapter was to assess the effect of 
mixtures of CisPt, CP and TAM on a multibiomarker approach, including behavioural 
impairment in burrowing activity; neurotoxicity (AChE activity); antioxidant 
enzymes, namely the superoxide dismutase (SOD), catalase (CAT) and glutathione-
peroxidases (Se-GPx and T-GPx); the biotransformation phase II enzyme, glutathione-
S-transferase (GST); lipid peroxidation (LPO); and genotoxicity (DNA damage). 
Secondly, results on the effects obtained of the mixtures exposures were compared to 
their individual effects previously determined in N. diversicolor (Fonseca et al.2017; 
2018).  
5.2 Materials and Methods 
5.2.1 Chemicals 
The analytical standards of cis-platinum (II) diamine dichloride (CisPt) (CAS 
15663-27-1), cyclophosphamide monohydrate (Cytoxan) (CAS 0768) and tamoxifen 
(CAS 10540-29-01) were purchased from Sigma-Aldrich (Portugal). Stock solutions 
of each chemical were prepared in ultrapure Milli-Q water, except for that of TAM 
that due to its low water solubility was first dissolved in the carrier solvent dimethyl 
sulfoxide (DMSO). Experimental solutions of pharmaceuticals were individually 
prepared from serial dilutions of respective stock solutions (CisPt 123.07 mg Pt L−1; 
CP 40 mg L-1; TAM 100 mg L-1) in ultrapure Milli-Q water. Aliquots of 100 µL of 
each pharmaceutical solution, at respective concentrations, were added and mixed in 
microtubes, following subsequent seed into respective treatment tanks. In order to 
avoid toxic effects derived from solvent, a final concentration of 0.001% (v/v) DMSO 
was set up in test aquaria (Fonseca et al., 2017, Chapter 4). Since dermal exposure is 
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considered to have the predominant role in the uptake of anticancer agents by health 
care workers, drugs herein studied were safety handled using class II biological safety 
cabinet, with appropriate clothing (open-back, impervious chemotherapy protection 
gown, double powder-free latex gloves and safety goggles). 
5.2.2 Experimental setup  
Polychaetes N. diversicolor were handpicked during summer, at the intertidal 
estuarine mudflat in Mira River estuary (Vila Nova de Milfontes, Portugal), following 
their transport to the laboratory with sediments and water from the site of origin. 
Sediments treatment and characterization were performed according to Fonseca et al. 
(2017, 2018, See Chapters 2 and 3). Grain size distribution was composed 
predominantly by silt and clay (73% of particles <63 µm), following fine sand (23%), 
and organic matter content of 7.8%. Polychaetes were acclimated for five days in 
aerated aquaria filled with natural filtered seawater (salinity 35) from the Ria Formosa 
lagoon (Faro, Portugal) and sediments from the sampling site. Specimens of N. 
diversicolor were placed in 10-L glass aquaria, in triplicate, containing sediment and 
water (1:4), under constant aeration, controlled temperature (19 ± 2°C), salinity (35 ± 
1.8) and light period (12:12 hours). 
Seawater was carefully renewed every 48 hours, avoiding sediment 
resuspension, following addition of pharmaceutical mixtures into water column. 
Polychaetes were exposed for 14 days to four tertiary drug combinations, including 
CisPt + CP + TAM, at increasing concentrations (ng L-1), respectively: Mix A: 0.1 + 
10 + 0.1; Mix B: 10 + 100 + 10; Mix C: 100 + 500 + 25; Mix D: 100 + 1000 + 100 ng 
L-1. Concentrations studied were selected according to environmental levels reported 
in water bodies and worst-case scenarios of pharmaceutical pollution. Along with 
drug-exposed treatments, controls of seawater (day 0, before systems contamination: 
CT0; day 14: CT14) and solvent (0.001% DMSO) were set up. Seventy-five 
polychaetes were distributed per treatment (25 per aquarium). Animals used in the 
burrowing and comet assays were immediately handled for respective analysis, while 
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those regarding biochemical end-points were rinsed with clean seawater and stored at 
-80 °C until further use.  
5.2.3 Burrowing Assay 
At the first (CT0) and 14th days (CT14; DMSO; MIX A, B, C and D) of the 
bioassay, fifteen animals were removed from each exposure treatment (5 per 
aquarium) and individually placed in 150 mL-plastic containers, filled with natural 
seawater and 5 cm of clean sediments. Worms were submitted to a burrowing test 
according to Fonseca et al. (2017) (Chapter 2), over a period of 30-minutes. The 
position of the polychaetes was recorded every two minutes, to assess the time for fully 
burrowing. The results are expressed as the percentage (%) of unburied specimens, 
over time (min).  
5.2.4 Biochemical analysis  
Neurotoxicity 
For determination of AChE activity, polychaetes were individually 
homogenized (2 specimens per replicate; total of 6 organisms per treatment) in 100 
mM Tris-HCl buffer (pH 8.0) and 0.1% Triton. The homogenates were centrifuged at 
12,000 g, for 30 min, at 4 °C, and further separated in aliquots for total protein 
determination (Bradford, 1976) and AChE activity analysis (Ellman et al., 1961). The 
product of acetylcholine (ATC) cleavage by AChE was determined at 405 nm (Ellman 
et al., 1961; Colovic et al., 2013), and enzymatic activity expressed as ATC.min-1 mg-
1 protein. 
Antioxidant and biotransformation enzymes activities  
Procedures regarding tissue preparation and enzymatic analysis were 
previously detailed in Fonseca et al. (2018). Whole organisms (2 specimens per 
aquaria, in triplicate; total of 6 organisms per treatment), were homogenized in 20 mM 
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Tris-HCl buffer (0.5 M sucrose, 0,075 M KCl, 1 mM DTT, 1 mM EDTA, pH 7.6), 
following cytosolic fractioning obtained by serial centrifugations, according to 
Fonseca et al. (2018) (Chapter 3). Supernatant aliquots (150 µL) were separated for 
further determination of antioxidant enzymes (SOD and CAT) and biotransformation 
(GST) activities, normalized by total proteins concentration (mg protein g-1 tissue) by 
using bovine serum albumin (BSA) as standard (Bradford, 1976). Absorbance of SOD 
activity was measured at 550 nm and results expressed as U mg-1 protein (McCord and 
Fridovich, 1969). Absorbance regarding CAT activity was measured at 240 nm 
(Greenwald, 1985) and results expressed as nmol min-1 mg-1 protein.  
GST activity was measured at 340 nm, by the conjugation of 0.2 mM reduced 
glutathione (GSH) with 0.2 mM CDNB in a reaction mixture of 0.2 M KH2PO4/K2PO4 
buffer (pH 7.9) (adapted from Habig et al., 1974), and results expressed in nmol CDNB 
min-1 mg-1 protein. Total GPX activity was measured in a microplate reader, at 340 
nm, based on the method adapted from Lawrence and Burk (1976). The reaction 
consists in the reduction of oxidized glutathione linked to the oxidation of NADPH in 
the presence of excess glutathione reductase. Cumene hydroperoxide and H2O2 were 
used as substrates for T-GPx and Se-GPx, respectively. Results are expressed in nmol 
min−1 mg−1 protein. 
Oxidative damage 
Levels of LPO by-products were measured in whole organisms (2 specimens 
per aquaria, in triplicate; total of 6 organisms per treatment), through malondialdehyde 
(MDA) and 4-hydroxyalkenals (4-HNE) absorbances measured at 540 nm adapted 
from the method of Erdelmeier et al. (1998).  Results are expressed in nmol MDA + 
4-HNE mg−1 protein.  
5.2.5 Genotoxicity assay 
Genotoxicity assessment conducted with alkaline Comet assay in N. 
diversicolor coelomocytes was previously detailed in Fonseca et al. (2018) (Chapter 
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3). Briefly, collected cells were centrifuged at 3000 rpm (3 min, 4 °C), and resulting 
pellets suspended in 0.65 % low melting point agarose (LMA). Cells were smeared on 
microscope slides, following immersion in lysis buffer, for at least 1 h. Slides were 
placed in a horizontal electrophoresis box aftermath, and immersed in alkali buffer 
allowing DNA to unwind. Electrophoresis current was set up at 25 V and 300 mA, 
over 5 min, following slides neutralization (0.4 mM Tris, pH 7.5). Cells were stained 
with 4,6-diamidino-2-phenylindole (DAPI, 1 mg ml-1) and analysed with an optical 
fluorescence microscope Axiovert S100 (total magnification of ×400). DNA in the 
comet tail (DNA tail %) was determined in 50 cells per sample (25 in each duplicate) 
(Komet 5.5 - Kinetic Imaging Ltd). Results are expressed as mean ± standard deviation 
(S.D.). In addition, cells were also categorized for the frequency of DNA damage 
grade, according to the criteria used by Jo (2014). Damage is determined zero or 
minimal when it is DNA in tail is lower than 10%; low damage from 10-25%; mid 
damage from 25-50%; high damage from 50-75%; and extreme damage >75%.  
5.2.6 Statistical analysis 
Data were tested for normality (Shapiro-Wilk test) and homogeneity of 
variances (Levene´s test) in order to determine whether they satisfy the assumptions 
associated with parametric tests, then the one-way analysis of variance (ANOVA) or 
the non-parametric Kruskal-Wallis were applied. Tukey´s or Dunn´s post-hoc tests 
were performed to compare treatment effects. Results were significant when p< 0.05. 
Burrowing behavioural data was analysed by linear regression. Principal Component 
Analysis (PCA) was applied to evaluate the relationship among biomarkers responses 
and between pharmaceuticals levels. Statistical analysis was carried out using the 
Statistica 8.0 software (Statsoft Inc., 2007, USA). 
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5.3 Results  
5.3.1 Burrowing behaviour  
Results of burrowing bioassay are shown in Figure 5.1. A similar behavioural 
profile was addressed for polychaetes collected from control, DMSO and those from 
the highest-concentration mixture (Mix D), in a way that 100% of individuals were 
buried within 2 (CT14, DMSO, Mix D) and 4 minutes (CT0). On the other hand, no 
trends of behaviour could be depicted for the remaining treatments. Polychaetes 
exposed to the Mixture A and B failed to burrow after 2 minutes of the bioassay, thus 
resulting in 33% and 13% of organisms left unburied until the end of analysis. 
Regarding polychaetes exposed to Mixture C, 26% of individuals remained at the 
sediment surface.  
 
Figure 5.1: Burrowing behaviour of N. diversicolor from control conditions (CT0; 
CT14; 0.01% DMSO) and exposed to a combination of anticancer drugs, at increasing 
concentrations (Mix A, B, C and D). Results were expressed as percentage of unburied 
organisms over time (lines with symbols).  
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5.3.2 Biochemical analysis 
Neurotoxicity 
AChE activity did not change among controls (p > 0.05). Polychaetes exposed 
to Mixture A and C exhibited similar AChE activity compared to the unexposed 
organisms. Conversely, neurotoxicity was detected in mixtures B and C, by means of 
a 2- and 3-fold inhibition of AChE activity (p < 0.05) (Figure 5.2). 
 
Figure 5.2: AChE activity (mean ± S.D.) (ATC.min-1.mg-1 protein) (mean ± S.D.) in 
N. diversicolor unexposed (CT0; CT14; 0.01% DMSO) and exposed to a combination 
of anticancer drugs, at increasing concentrations (Mix A, B, C and D), over 14 days. 
Different letters indicate significant differences among treatments (One-way ANOVA; 
p < 0.05). 
Antioxidant and biotransformation enzymes 
Activity of antioxidant enzymes were similar between controls and indicated 
that the percentage of solvent concentration applied to prepare the mixtures of 
pharmaceuticals solutions provided no significant effects in N. diversicolor. Although 
a slight trend of increase was depicted in SOD activity, over the increasing 
concentrations of the mixtures, no significant alterations were detected (p > 0.05) 
(Figure 5.3-A). In contrast to SOD, there was a decreasing trend of the CAT activity 
in the polychaetes exposed to the mixture containing the highest drugs concentrations 
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(i.e. Mix D), CAT activity was significantly inhibited 12-fold when compared to the 
other mixtures (p < 0.05) (Figure 5.3-B). No significant impairments in Se-GPx were 
addressed in control conditions neither in drug-treated polychaetes, in contrast to T-
GPx, induced in individuals exposed to Mix A (p < 0.05). 
 
Figure 5.3: Antioxidant enzymes activities (mean ± S.D.) of (A) SOD, (B) CAT, (C) 
Se-GPx and (D) T-GPx (mean ± S.D.) in N. diversicolor unexposed (CT0; CT14; 
0.01% DMSO) and exposed to increasing concentrations of mixtures of anticancer 
drugs (Mix A- D), over 14 days. Different letters indicate significant differences 
among treatments (One-way ANOVA; p < 0.05). 
Regarding GST activity, a bell-shaped response profile was displayed (Figure 
5.4). A significant 2-fold inhibition of GST activity was detected in polychaetes 
exposed to the lowest mixture concentration (i.e. Mix A), followed by an increase until 
Mix C and ultimately decreasing at the highest mixture concentration (Mix D), similar 
to Mix A (p < 0.05). 
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Figure 5.4: GST activity (mean ± S.D.) in N. diversicolor unexposed (CT0; CT14; 
0.01% DMSO) and exposed to increasing concentrations of mixtures of anticancer 
drugs (Mix A-D), over 14 days. Different letters indicate significant differences among 
treatments (One-way ANOVA; p < 0.05). 
Oxidative damage 
Levels of LPO by-products were similar among controls (p > 0.05) (Figure 
4.5). Conversely, in polychaetes exposed to the mixtures, LPO significantly increase 
in the presence of mixtures with Mixtures A and C having LPO levels 2-fold higher 
than controls. The highest oxidative damage was detected in polychaetes exposed to 
Mixtures B and D (3-fold higher than controls) (p < 0.05).  
 
Figure 5.4: Lipid Peroxidation (LPO) levels (mean ± STD) (MDA+ 4-HNE nmol.mg-
1 protein) in N. diversicolor unexposed (CT0; CT14; 0.01% DMSO) and exposed to 
increasing concentrations of mixtures of anticancer drugs (Mix A-D), over 14 days. 
Different letters indicate significant differences among treatments (One-way ANOVA; 
p < 0.05). 
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5.3.3 Genotoxicity 
No significant differences were reported in DNA tail (%) among control 
conditions and groups exposed to pharmaceutical mixtures (Table 5.1). However, 
according to the grading of DNA damage in coelomocytes, unexposed polychaetes 
showed minimal or low damage along the 14-day exposure period (95.6 to 98.8%), 
whereas those exposed to Mix A indicated the highest level of mid damage (57.1%), 
followed by Mix C, B and D (Table 5.1). In the present study, no extreme DNA 
damage was reported. 
Table 5.1: Genotoxicity in polychaetes N. diversicolor unexposed (CT0; CT14; 0.01% 
DMSO) and after 14 days of exposure to mixtures (Mix A-D), expressed as percentage 
of DNA in tail (mean ± SEM). Frequency of coelomocytes distributed by grade of 
DNA damage (%) (i.e. minimal to mid). 
Treatment DNA Tail (%) 
DNA Damage grade 
Minimal Low Mid 
Control 
CT0 9.49 (± 3.3) 60.1 36.7 3.2 
CT14 7.6 (± 1.8) 67.2 31.6 1.2 
DMSO 10.8 (± 1.78) 53.8 41.8 4.4 
Mixtures 
A 14.2 (± 3.3) 7.9 35 57.1 
B 12.85 (± 2.9) 7.9 45.1 47 
C 12.3 (± 6.6) 7.3 52 40.7 
D 11.3 (± 3) 5.9 52.6 41.5 
5.3.4 Principal Component Analysis  
Integration of biomarkers responses regarding organisms exposed to 
pharmaceuticals in mixtures is depicted in Figure 5.6. PCA of the data explained 81% 
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of variance, in which PC1 and PC2 corresponded to 53.3% and 27.7%, respectively. 
According to Durou et al. (2007), correlation coefficients are significant when they are 
higher than √d/n (i.e. d is the number of principal components; n the number of 
variables), thus equal to 0.35 for this data analysis.  In PC1, positive correlations were 
registered for CAT, GST and AChE activities, jointly with loading contributions of 
control conditions (CT0, CT14 and DMSO) and Mix C, which indicates the high 
expression range of these enzymes. In contrast, PC1 exhibited a negative correlation 
regarding Se-GPx, T-GPx, LPO and DNA damage explaining the effects on these 
endpoints in individuals exposed to Mix A, B and D.  
Regarding PC2, the variables of significant positive distribution are 
represented by SOD, Se-GPx and GST enzymes, grouping individuals exposed to 
DMSO control condition and Mix B, C and D. Interpretations of this axis suggest 
higher levels of these enzymatic activities compared to the other groups present in the 
negative axis, although no significative differences were observed and no clear 
elucidations could be concluded. On the other hand, the induction of GPx-T activity 
in individuals exposed to Mix A and the clear inhibition of CAT activity in those 
exposed to Mix supported the separation of both treatment groups in PC2, and negative 
correlations attributed to both variables.  
Integrating biomarkers responses from mixtures and individual exposure data 
of anticancer drugs (Chapter 2, 3 and 4) on a PCA analysis results were distributed in 
three main axes (PC1, PC2 and PC3), which accounted for 74.3% of variance. Figure 
4.7-A shows the plot of PC1 and PC2 that respectively represent 41% and 18.5% of 
the total variance. The correlation coefficient for this dataset was 0.61. Therefore, PC1 
illustrated a significant positive correlation between the antioxidant status, defined by 
SOD, CAT, Se-GPx and T-GPx, jointly with the biotransformation enzyme GST. 
Loadings concerning polychaetes exposed to pharmaceuticals in mixtures are 
distributed on higher scores of the negative PC1, particularly regarding the group D 
(Figure 5.7-A) in comparison to control groups closer to the origin, thus indicating a 
general trend of inhibition in these biochemical markers in mixture-exposed 
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individuals. Due to the high scores in the positive axis of PC1, biomarkers effects from 
the singular exposure to CisPt (Chapter 2) showed substantial distance from those 
registered for the other anticancer drugs, particularly attributed to the higher baseline 
values addressed in enzymatic activities. Interestingly, PC1 also illustrated a 
relationship between the effects of TAM- and CP-treated groups with those under the 
mixtures. In addition, exposure of pharmaceuticals mixtures A, B and D showed a 
similar contribution in PC1 regarding enzymes activities, which corroborates to 
responses observed at the highest CP concentration (1000 ng L-1). 
According to biomarkers´ loadings in drug-treated groups, animals exposed to 
CisPt seemed to fail to contribute in mixtures´ toxicity, at any of the concentrations 
tested. Likewise, the lowest level of TAM (0.5 ng L-1), which individually induced 
higher activity of SOD, CAT and GST during its single exposure (Chapter 4), was not 
able to elicit enzymatic alterations within Mix A. Moreover, PC2 exhibited a 
significant positive correlation between Se-GPx and T-GPx, activities related to effects 
from individuals exposed to Mix A, particularly attributed to the sharp induction 
reported in T-GPx activity (Figure 3-D). Once again, biochemical responses of Mix A 
show a disagreement with the effects reported for pharmaceuticals individually 
exposed, as can be seen by the opposite distribution of treatments. PC3 explained 
14.8% of the total variance (Figure 5.7-B) in which a significant positive loading was 
attributed to LPO. In this biplot, individuals exposed to CP showed a range of MDA 
products higher than that registered in the other singular and mixture exposures.  
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Figure 5.5: PCA biplot of PC1 vs. PC2 integrating biomarkers responses (  AChE, 
SOD, CAT, Se-GPx, T-GPx, GST, LPO, DNA damage) from polychaetes N. 
diversicolor unexposed and exposed to different mixtures concentrations of anticancer 
drugs (  Mix). 
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Figure 5.6: PCA biplot from (A) PC1 vs. PC2 and (B) PC1 vs. PC3 integrating 
biomarkers responses (  AChE, SOD, CAT, Se-GPx, T-GPx, GST, LPO, DNA 
damage) in polychaetes N. diversicolor from bioassays conducted with singular 
exposure of anticancer drugs in (  CisPt;  CP;  TAM) and in combination (  
Mix), at different concentrations jointly with control conditions. 
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5.4 Discussion 
Anticancer drugs have been applied for about sixty years in chemotherapy 
treatments worldwide, but since then the outlook of non-communicable diseases 
indicates an increase in cancer incidence for the next decades, trends of consumption 
of these specialized medicines are also estimated to rise, as do their excretion on 
waterways and the consequent impact to water resources (López-Gómez et al., 2013; 
Toolaram et al., 2014; Torre et al., 2015). Data regarding marine ecotoxicological 
effects of pharmaceutical mixtures have been mainly conducted with non-steroidal 
anti-inflammatories, analgesics, fungicides, antiepileptics, beta-blockers, anti-
depressants and blood lipid lowering drugs, whereas concerns directed to the issue of 
anticancer drugs has shown to be incipient (Canesi et al., 2007; Luna-Acosta et al., 
2012; Gonzalez-Rey et al., 2014; González-Ortegón et al., 2016; Pires et al., 2016a; 
Trombini et al., 2016b).  
Cancer cells have an aberrant metabolism (Che et al., 2016) characterized by a 
highly oxidant intracellular environment in which critical ROS-sensitive signaling 
pathways act as drivers and regulators for tumour proliferation (Trachootham et al., 
2009; Liou and Storz, 2010). Therefore, the pharmacologic rationale of anticancer 
drugs relies on the induction of irreparable damages, cell cycle arrest or death, either 
through the ability to exceed threshold levels of intracellular ROS and/or by 
suppressing antioxidant defenses (Liou and Storz, 2010; Gorrini et al., 2013). SOD 
activity plays an important role by the dismutation of superoxide anion (O2∙-) into 
hydrogen peroxide (H2O2), a critical messenger of antiapoptotic mechanisms and 
tumour proliferation (Sarsour et al., 2008). Although assumed as a target for cytotoxic 
purpose, no alterations in SOD activity were addressed in polychaetes tested in 
mixtures. In Mix C and D, the absence of changes in SOD could be associated to the 
antagonistic potential of TAM over CisPt and CP, once both drugs were accountable 
for its inhibition in polychaetes under single-drug exposure (Figure 5.8). According to 
the PCA (Figure 5.7) and the overall effects illustrated in Figure 5.8, the profile of 
antioxidant system (i.e. SOD, CAT, Se-GPx and T-GPx activities) of polychaetes 
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exposed to Mix C and D were mainly driven by the responses reported in the bioassay 
conducted only with TAM.  
When CisPt and CP were exposed individually, both were able to induce and 
inhibit T-GPx, respectively, while in combination their effects were cancelled (Figure 
5.8). Antagonism is generally defined by the interaction between two or more drugs 
resulting in an overall effect intensity lower than any of the drugs alone (Becker, 
2011); a toxicity in mixture lower than the sum of the individual effects (Láng and 
Kőhidai, 2012), although Chou et al. (2010) infer that drugs interactions should not be 
limited to a simple arithmetic sum and the shape of dose-effect curve must be 
considered. Antagonistic effects on growth inhibition were addressed in the freshwater 
ciliate Tetrahymena pyriformis exposed to binary mixtures involving diclofenac, 
ibuprofen, metoprolol and propranolol and predominate at the highest concentrations 
due to the potential competitive inhibition between the two pharmaceuticals acting on 
the same molecular target (Láng and Kőhidai, 2012). Although the designed 
pharmacological MoA of TAM diverges from the cytotoxicity of CisPt and CP, studies 
have shown that TAM may also elicit toxic effects in ER-negative cells, thus via a 
strategy disregarding the anti-estrogenic pathway (Scripture and Figg, 2006). 
According to Becker (2011), pharmacokinetic interactions between administered 
drugs alter one´s delivery to its respective target, due to changes in absorption, 
distribution, and elimination, which may change the interaction toward specific 
pathways and receptors, thus its ultimate efficacy (Scripture and Figg, 2006; Becker, 
2011). Interactive outcomes provided by the tertiary mixtures may have altered the 
uptake of the cytotoxic agents by the cells via changes in structure or function of 
proteins involved in drug transport delivery. In the case of CisPt, the copper transporter 
proteins CTR1 are accountable for its accumulation, and impairments in this influx is 
linked to resistance (Dasari and Tchounwou, 2014; Ma et al., 2015). However, to the 
best of our knowledge, no studies have clarified an interaction of TAM or CP with this 
membrane protein. In fact, studies have highlighted that the combinatory 
administration of CisPt with the alkylating CP is more effective in clinical responses 
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than when managed individually, particularly in ovarian carcinoma (Neijit et al., 1984; 
Mcguire et al., 1996).  
Likewise, the adjuvant administration of CisPt with TAM led to an 
enhancement of cytotoxic and apoptotic effect in the ER-positive OSCC (oral 
squamous cell carcinoma) cells and concluded that the binary treatment could be a 
more effective alternative (Kim et al., 2007). In addition, TAM and CisPt have 
demonstrated synergistic action in the human melanoma cell line T-289 (Mcclay et al., 
1994; Nakata et al., 1995), similar to the results obtained in combinatory treatment of 
CP with TAM, showing a significant benefit in breast cancer patients (Abram et al., 
1988). Although the divergence in drug-combination outcomes, it is important to be 
aware that the range of concentrations applied herein are nearly 10-6 lower than those 
used in the chemotherapy, which may have triggered responses of multidrug resistance 
phenotype, drug efflux metabolism, or metabolism into less active metabolites and 
activation of kinases pathways according to the targeted tissue (Tan et al., 2014; Zhu 
et al., 2017). In the study of Goldenberg and Froese (1985), an antagonistic effect was 
registered at the co-administration of TAM with melphalan, suggesting that the former 
either inhibited the other´s influx and stimulated its efflux.  
In addition, the combination of TAM with the cytotoxic docetaxel, able to 
inhibit microtubule depolymerization, produces antagonist outcomes in ER-positive 
MCF-7 human cell lines, while in the ER-negative breast cancer cell lines the response 
is synergistic, thus indicating that mechanisms leading to drug resistance may diverge 
according to targeted tissues (Zhu et al., 2017). Toxicity predictions of binary mixtures 
failed to estimate growth inhibition in the green algae Pseudomonas subcapitata, 
underestimating the detrimental effects caused by 5-FU + CisPt and 5-FU + IM, and 
overestimating those of CisPt + ET (Bresovzec et al., 2014). Also, growth inhibition 
caused by 5-FU + IM on the cyanobacteria S. leopoliensis was lower than that modeled 
(Bresovzec et al., 2014). Therefore, besides the particular physico-chemical features 
of mixtures under study, some species may be more affected than others, which 
generates particular orders of susceptibility (Ortiz de García et al., 2014). Although 
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resistance to anticancer drugs is an issue of high interest for chemotherapy 
effectiveness, the mechanisms involved in the drug failure are also relevant for 
ecotoxicological approaches over non-target species. 
Figure 5.7: Biomarkers profile in N. diversicolor exposed to tertiary mixtures (A, B, 
C and D), according to the single-drug responses. Arrows ↓ indicate inhibition; arrows 
↑ induction; absence of arrows indicates effects similar to controls, in each single-drug 
bioassay. Green and red boxes indicate, respectively, similar and distinct effects in 
relation to the corresponding mixture. 
 
In contrast, the single-exposure of CisPt and TAM, conducted with the same 
Mix D concentrations, inhibited CAT activity by 57% and 51%, respectively, whereas 
in combination enzymatic decrease accounted for 90%, indicating synergistic effects 
on this enzyme. In addition, polychaetes exposed to this high set of concentrations 
experience a significant disruption of the first line of ROS scavengers by a severe 
Drugs (ng L-1) SOD CAT 
Se-
GPx 
T-GPx GST AChE LPO 
DNA 
Damage 
MIX A 
CisPt 0.1    ↓     
CP 10        ↑ 
TAM 0.5 ↑  ↑    ↑  
MIX B 
CisPt 10  ↓       
CP 100  ↑      ↑ 
TAM 10  ↓     ↑  
MIX C 
CisPt 100 ↓ ↓ ↑ ↑ ↓ ↓ ↑  
CP 500 ↓ ↑  ↓ ↓  ↑ ↑ 
TAM 25      ↑ ↑  
MIX D 
CisPt 100 ↓ ↓ ↑ ↑ ↓ ↓ ↑  
CP 1000 ↓   ↓ ↓  ↑ ↑ 
TAM 100  ↓    ↑ ↑ ↑ 
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inhibition of CAT activity (Figure 5.3). The significant inhibition of GST activity was 
similar to the response addressed in N. diversicolor under single exposure to 100 ng 
Pt L-1 CisPt and to 1000 ng L-1 CP (Fonseca et al., 2017, 2018), showing their additive 
interaction (Figure 5.8). In addition, Becker (2011) addressed that the most frequent 
and significant pharmacokinetic interaction between drugs is associated to the 
biotransformation metabolism. Even at low concentrations (Mix A) suppressed 
polychaetes´ biotransformation metabolism, although with no similarity to the 
respective single-drug responses (Figure 5.8). Indeed, PCA indicated in PC1 that 
biochemical responses addressed in specimens exposed to Mix A correspond to those 
reported for Mix D as well as those from single CP exposure (Figure 5.7). Although 
interferences in Mix D toxicity may also derive from CisPt´s MoA, PC1 loadings 
separate this group from the others in the positive side of axis, since the overall range 
of biomarkers responses are higher than those reported in any other experiment. It is 
well-known that the thiol groups in the cytoplasm, especially consisting of glutathione 
(GSH) may conjugate to electrophilic pharmaceuticals like CisPt and CP, forming 
adducts that provide their inactivation and detoxification (Vertuani et al., 2004; 
Galadari et al., 2017). Since GST catalyzes the conjugation of GSH with the reactive 
species acrolein and mono-aquacisplatin from CP and CisPt metabolism, its inhibition 
leads to hydroxyl radical formation and oxidative stress, able to trigger LPO (Basu et 
al., 2015; Siddik, 2003). Therefore, it seems that, once combined at low concentrations 
(Mix A), CisPt and CP may impair GST detoxification to the same extent that was 
observed at high concentrations (Mix D) and turn it insufficient to prevent membrane 
damage (Gonzalez-Rey et al., 2014) (Figure 5.5), as illustrated by the PCA dispersal 
pattern (Figure 5.6).  
Drugs at the low concentrations (Mix A) may be accountable for inducing 
significant levels of T-GPx activity (Figure 5.3-D) as a potential protective effect of 
hormesis promoted by responsive mechanisms facilitated at low concentrations, such 
as drug permeability (Alfarouk et al., 2015). In other words, although the balance of 
antioxidant status and mechanisms involved in toxicity vary among concentrations, 
the stress performed by Mix A could have prompted physiological protective 
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mechanisms to compensate a disruption in homeostasis (Calabrese and Baldwin, 
2001). A hormetic trend response was also depicted by the induction of SOD and Se-
GPx activities in the TAM single-exposure at 0.5 ng L-1 (Chapter 4), although such 
biochemical profile was offset in Mix A and not associated to the herein experienced 
hormesis. Likewise, CisPt at 0.1 ng Pt L-1 showed to disrupt T-GPx activity in 
polychaetes, by a significant decrease of the activity (Figure 5.8), (Chapter 2). T-GPx 
acts in the intracellular space together with CAT on the role of H2O2 breakdown by 
reducing it to water. Accumulation of this ROS contribute to the generation of 
hydroxyl radicals (OH∙) by Fenton reaction and have damaging effects on proteins 
function, DNA and lipids (Liou and Storz, 2010; Basu et al., 2015). In this sense, it is 
hypothesized that despite the activation of the antioxidant system in polychaetes 
submitted to Mix A, ROS were not sufficiently scavenged and detoxification was not 
enough to overcome injuries provided by LPO by-products (Pires et al., 2016a), 
culminating in mid-grade DNA damage at levels higher than those of the other 
mixtures (Table 5.1), as indicated by the positive correlation in PC1 joining T-GPx, 
LPO and DNA damage responses (Figure 5.6). In addition, the single exposure to 0.5 
ng L-1 of TAM induced high levels of oxidative damage (Chapter 4), suggested to be 
responsible for the levels of LPO by-products in this mixture (Figure 5.8).  
Despite the favorable anti-tumour properties, CisPt are also known to cause 
severe neurotoxicity as side effects in humans (Aljafari, 1995; Dasari and Bernard 
Tchounwou, 2014). The accumulation of platinum compounds and respective 
metabolites in the dorsal root ganglion of rats generates platinum-DNA adducts, 
known as key-steps to neurotoxicity (Kanat et al., 2017). According to Baig et al. 
(2014), CisPt molecular docking within the acyl pocket of AChE is permitted by the 
hydrophobic interactions and hydrogen bonds that play an equally important role in 
the drug´s correct positioning, thus allowing the inhibition of AChE. This also occur 
in the exposure of CisPt (100 ng Pt L-1) to N. diversicolor, along with the impairment 
to burrow (Fonseca et al., 2017 – See Chapter 2). However, even though organisms 
submitted to Mix D indicated the same neurotoxic profile, they showed an efficient 
burrowing capacity, in contrast to the expected results (Figure 5.1). Specimens 
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exposed to CP (1000 ng L-1) were fully buried by the end of the bioassay and indicated 
no alterations of AChE activity profile (Fonseca et al., 2018 – See Chapter 3). In this 
sense, according to the overall results, it is suggested that the mechanism involved in 
the burrowing impairment in Mix A was different from the one driven by AChE 
alterations. Therefore, further assessments around energy expenditures related to 
mitochondrial electron transport and lipid reserves are needed to better understand the 
mechanisms involved in burrowing interferences (Maranho et al., 2015). 
Progressively, findings around the toxicity or estrogenic assessment of 
mixtures have shown that combination of endpoints cannot be calculated by simply 
adding the effects of the individual components present in the mixture, especially if 
they have different dose-response curves (Fent et al., 2006a; Payne et al., 2000). 
Binary mixtures involving the drugs 5-fluorouracil (5-FU), cisplatin (CisPt), etoposide 
(ET) and imatinib (IM), at concentrations in a µg L-1 range, were accountable for the 
offspring reduction of the crustacean Daphnia magna, similar to single-exposures 
(Parrella et al., 2014a). Hence, drugs exerted detrimental effects at concentrations 
independent of the other anticancer agents present in the mixtures, confirming the 
predictive power of independent action (IA) model at lower concentrations (Cleuvers, 
2003; González-Ortegón et al., 2016), which roles out when the combined compounds 
have different MoAs. However, at higher concentrations, antagonist interactions 
occurred in mixtures containing IM as a potential sign of interference in the activity of 
ET and CisPt (Parrella et al., 2014c), revealing a clear demonstration that interactions 
with targeted receptors, influx and efflux transporters and expression of resistance 
pathways may vary according to the concentration and nature of chemicals present in 
the mixture.  
At the intermediary concentrations of Mix B and C, the anticancer compounds 
also triggered a significant oxidative damage in polychaetes, although no pronounced 
effects on neuroactivity, antioxidant and biotransformation metabolisms were 
detected. In these two mixtures, biochemical effects in polychaetes were similar to 
those reported in single-TAM exposures (10 and 25 ng L-1) (Chapter 4): no significant 
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changes in antioxidant outcomes were registered, although drugs elicited an ultimate 
response of LPO, potentially triggered by drugs interaction directly over cellular 
membrane. In fact, TAM is known to impair the lipid bilayer integrity that ultimately 
influence down-stream nuclear events (Cabot et al., 1997; Engelk et al., 2002; Bilge 
et al., 2013), disregarding the presence of ERs to trigger oxidative mechanisms 
recognized as important pathways for cell death (Bekele et al., 2016). Furthermore, 
besides the potential mechanisms associated to resistance against anticancer drugs in 
mixture, it is important to bear in mind that even that the target tissue under study 
express ERs, the mechanisms that mediates TAM over them may vary, culminating in 
estrogen agonist or antagonist, according to cell type (Sun et al., 2011; García-
Hernández et al., 2016). The effects of TAM and its MoA in aquatic species have been 
investigated in fish, although results showed that estrogenic or anti-estrogenic 
outcomes depend on the gender, concentration and tissue analysed (Sun et al., 2011).   
5.5 Conclusions  
In summary, some of the biological effects exerted by mixtures were in 
accordance to those previously reported for single-drug exposures, although 
corroborating only in specific endpoints, rather than similar to the whole set of 
biomarkers. Responses varied according to the range of concentrations assessed, but 
not in a strict dose-response manner. Although high levels of LPO by-products were 
reported in polychaetes exposed to all mixtures, mechanisms involved in the oxidative 
damage exerted at intermediary-drug levels (Mix B and C) seemed to stray from the 
oxidative stress pathway as reported in low-drug levels (Mix A). In addition, with the 
increase of drug concentrations in the mixture, the trend of effects was more similar to 
that observed in TAM single-exposure, suggesting an antagonist interaction of the 
cytotoxic CisPt and CP at their respective high doses and the dominance of TAM MoA 
over their cytotoxic potential in Mix C and D. Despite the range of low concentrations 
tested, the sediment dweller N. diversicolor showed to uptake and metabolize the 
mixture of anticancer compounds, indicating that the combined compounds may 
interact differently according to their doses. Therefore, our findings showed that single 
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compound toxicity data are not sufficient to predict the environmental risks offered by 
anticancer drugs in combination, although it is relevant to comprehend whether the 
divergences registered in the oxidative status of organisms exposed to the mixtures of 
anticancer drugs and individually are dominated by the mechanisms involved in 
chemotherapy resistance. 
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 Chapter 6 
Toxicity of anticancer drugs: a first 
insight to tropical species 
Prepared for submission to: 
T. G. Fonseca; G. Daniel; G. Eufrasio; A. C. Feitosa; L. Mello; Maria João 
Bebianno; Denis M. S. Abessa. Toxicity of anticancer drugs: a first insight to tropical 
species. 
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6.1 Introduction 
Over the last twenty years, the occurrence of pharmaceuticals in the aquatic 
environment, particularly in surface waters, became a critical issue due to demographic 
projections that prompts an ever-increasing demand for drug consumption worldwide. 
Once these imminent trends prevail in the upcoming global scenario, the input of 
pharmaceuticals as parent molecules, their metabolites and transformation products in 
water bodies are recognized as a great environmental challenge because traditional 
technology of WWTPs are poorly efficient to remove these complex molecules (Lenz 
et al., 2005; Rowney et al., 2009; Besse et al., 2012; Parrella et al., 2014b), and also 
because many regions, especially in developing countries, do not have suitable systems 
to collect and treat sewage. In this sense, household and hospital effluents containing 
pharmaceutical compounds ultimately reach marine ecosystems acting as pseudo-
persistent stressors, to which organisms undergo continuous exposure. With the 
advance of analytical methods, pharmaceutical compounds, including anti-
depressants, analgesics, antibiotics, anti-inflammatories, beta-blockers, among others, 
have been detected at very low concentrations in estuarine and marine waters (ng L-1 
to µg L-1) (Buser et al., 1999; Weigel et al., 2002; Ashton et al., 2004; Togola and 
Budzinski, 2008; Vidal-Dorsch et al., 2012; Pereira et al., 2016a) and sediments (ng 
g-1) (Silva et al., 2011; Long et al., 2013; Beretta et al., 2014; Lara-Martín et al., 2014; 
Moreno-González et al., 2015). In addition, ecotoxicological responses associated to 
these drugs´ MoA have been assessed in representative species living in the water 
column nd sediments, at environmentally relevant concentrations (Escher et al., 2011; 
Madureira et al., 2012; Aguirre-Martínez et al., 2013, 2016a, 2016b).  
A watch list of priority pharmaceuticals including the sex hormones 17α-
ethinylestradiol, 17β-estradiol and the anti-inflammatory diclofenac was established 
by European Union in order to regulate the assessment of these compounds in the 
freshwater environment (Hughes et al., 2013; Lolic et al., 2015). Increasing efforts 
have been dedicated on the identification of priority pharmaceutical compounds either 
by the application of accurate monitoring or modelling approaches. In the policy 
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perspective of pharmaceuticals´ occurrence in marine waters, the European Marine 
Strategy Framework Directive (European Comission, 2008) establishes strategies on 
the methodological criteria to assess the status of environmental quality and anthropic 
environmental pressures, although they seem unclear and elusive, tailored to each 
Member State´s concerns and priority substances compatible to the demand of its 
respective and specific marine conditions and pressures. Since this set of measures are 
devised on the basis of a sound knowledge of the state of marine environment, 
scientific evidence of pharmaceuticals´ fate, bioavailability, and potential early 
warning impacts to biota have asserted the relevance of pharmaceuticals on an 
environmental risk assessment (ERA) in the marine context. In a worldwide outlook, 
regulatory actions with respect to pharmaceuticals in the environment are well 
documented in northern and central European countries, as well as in the United States 
and Canada, where frameworks and guidelines withstand deliberation, and represent a 
progress towards the protection of the marine environment (EMA, 2006; 
Environmental Canada, 2011; Hughes et al., 2013).  
In contrast, scientific knowledge and environmental legislation in most 
developing regions still face significant challenges, as traditionally experienced for 
other aquatic pollutants (Rahman et al., 2009; Fang et al., 2012). Low- and middle-
income countries challenge economical limitations revealed by issues in quality of 
sanitation, inefficient water quality programs and simple technologies (Rahman et al., 
2009; Mohapatra et al., 2016). When existing, sewage treatment alternatives rely on 
household septic systems using filtration and biodegradation performed by naturally 
occurring microorganisms (Singh et al. 2010), systems of pre-conditioning plants set 
up with degritting units following disinfection through chlorination (Abessa et al., 
2006); and primary and/or secondary treatments of wastewater including 
sedimentation, fermentation, photolysis and biodegradation. According to Mohapatra 
et al. (2016), these techniques are less costly than innovative treatment technologies 
and are serviceable for communities with limited resources and infrastructures. These 
processes culminate in the disposal of untreated or partially treated wastewater directly 
into the marine environment, or into inland waters that reach the coast, with substantial 
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loads of chemical mixtures including pharmaceuticals. It is assumed that dilution 
elicited by the receiving water bodies decreases the harmful potential of these 
hazardous substances; however, their continuous release may make the concentrations 
to remain relatively high, thus these chemicals can be sometimes considered 
pseudopersistent. In this sense, the extent of pharmaceutical impact in coastal waters 
is presumably higher in developing countries, where the capacity for wastewater 
treatment is far below the quantity of sewage generated by population (Fang et al., 
2012; Subedi et al., 2015; Balakrishna et al., 2017).  
Accordingly, there is a pressing need to expand the research around the 
occurrence and impacts of pharmaceuticals in aquatic ecosystems in developing 
countries (Rahman et al., 2007; Hughes et al., 2013; Gaw et al., 2014) as there are 
currently far fewer data for Africa, Asia and South America compared to the Europe 
and North America. In general, such reality occurs in the tropical and subtropical 
scenario, where around 75% of global biodiversity is found, and where the number of 
species potentially affected by exposure to pollutants is substantially higher, in contrast 
to the inherent low resilience following disturbing events (Kwok et al., 2007; Hubner 
et al., 2009). Ecotoxicological data used in risk assessment conducted in tropical 
regions are often generated in North America or Europe, based on bioassays with 
temperate test organisms (Kwok et al., 2007; French et al., 2015) and in particular, 
considering the levels of environmental contamination found in regions where sewage 
is generally collected and properly treated. To date, the information on the occurrence 
and distribution of pharmaceuticals in tropical ecosystems is scarce, and even less 
ecotoxicological knowledge was produced to the respective native organisms. Such 
extrapolation may lead to erroneous inferences due to the different sensitivity of 
selected organisms to a chemical on comparable tests from both regions (Garcia et al., 
2008).  
In Todos os Santos Bay (Bahia, Brazil), ibuprofen, atenolol, carbamazepine, 
erythromycin, diclofenac and diazepam were detected in sediments from sub ng g-1 to 
ng g-1 (Beretta et al., 2014). In the Danshui Estuary, at the northern coast of Taiwan, 
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concentrations of pharmaceuticals in seawater ranged as follows: clofibric acid (< 1.4 
to 55.1 ng L-1), diclofenac (< 2.5 to 53.6 ng L-1), ibuprofen (< 2.5 to 57.1 ng L-1) and 
ketoprofen (< 1.7 to 6.59 ng L-1) (Fang et al., 2012). In Bangladesh, the antibiotics 
metronidazole (13.51 ng L), tylosin (16.68 ng L-1) and trimethoprim (17.2 ng L-1) were 
some of the pharmaceutical compounds detected at a high detection frequency in the 
river surface waters (Old Brahmaputra river), as a result of the wide consumption in 
livestock manure, poultry rearing and human treatment (Hossain et al., 2018). 
Recently, a wide array of therapeutic classes and illicit drugs were detected at ng L-1 
in seawater of Santos Bay (São Paulo, Brazil), including ibuprofen, diclofenac, 
acetaminophen, losartan and cocaine (Pereira et al., 2016a; Cortez et al., 2018; Fontes 
et al., 2018; Pusceddu et al., 2018). Ecotoxicological approaches conducted in this 
region revealed that the anti-inflammatory diclofenac (DCF) (Fontes et al., 2018) and 
the anti-hypertensive losartan (LOS) (Cortez et al., 2018) can trigger subtle toxicity 
responses on the sentinel brown mussel Perna perna even via waterborne exposures 
at trace ng L-1, with effects linked to the designed drugs´ MoA, namely the alteration 
of the antioxidant status, lysosomal membrane destabilization and COX inhibition. 
Sulfonamide antibiotics and the antidepressant norfluoxetin showed to bioaccumulate 
in the liver of wild armored catfishes Hypostomus commersoni, from the Acaraguá 
river (Argentina), representing up to 5.6 and 9.1 µg kg-1 wwt, respectively.  
Altogether, the environmental and economic state of low- to middle-income 
regions corroborate to the establishment of an urgent framework for assessment and 
management of ecological risk caused by pharmaceuticals, reinforced by growing 
research with the focus on the impacts to tropical aquatic ecosystems. However, the 
attention to the therapeutic class of anticancer agents has not been yet considered. The 
situation of developing countries can become more complex, because the present 
decade is referenced as an important period in the global health history, since the 
disease burden profile changed toward more non-communicable diseases, particularly 
in these countries, which are expected to experience a significant increase in cancer 
incidence according to the milestone demographic shift promoted by the population 
growth and longevity improvement (Torre et al., 2015). According to the World Health 
  
164 
 
 
Organization (WHO, 2014), by 2030, less developed regions will experience an 
increase of 44% and 97% in new cancer cases among population aged < 65 and > 65 
years old, respectively, against to 2.8% and 48% increase in more developed regions. 
Therefore, it is possible to link such increase in cancer incidences with the 
enhancement of anticancer drugs production and application in treatment and 
supportive care (WHO, 2014); and their increasing concentrations in the environment. 
Anticancer agents are administered in cancer treatments, individually or in 
combination, by means of provoking cell death through cellular and DNA damage and 
the increase of reactive oxygen species (ROS) levels that modulates apoptotic 
signaling pathways (Conklin et al., 2004; Gorrini et al., 2013). Despite efficiency 
against tumour proliferation, these pharmaceuticals are not selective to cancer drivers 
and interact with common biomolecules of normal cells, resulting in cytotoxicity to 
healthy tissues (Heath et al. 2016; Novak et al. 2017). Thus the presence of anticancer 
substances in the aquatic environment may represent substantial risk to non-target 
biota at both freshwater (Grisolia and Cordeiro, 2000; Zounková et al., 2007; Parrella 
et al., 2014b, 2014c; Kovács et al., 2015)  and marine ecosystems (Aguirre-Martínez 
et al., 2016; Moreira et al., 2016; Trombini et al., 2016a; Fonseca et al., 2017; Aguirre-
Martínez et al., 2018; Fonseca et al., 2018).  
According to local hydrodynamic and physical disturbances, pharmaceuticals 
may be trapped in sediments, due to their capacity to bind to organic matter, being 
transferred from water column to sediments. Thus, sediments become another route of 
exposure to biota, particularly the benthic and epibenthic species. Considering the 
forecast of anticancer drugs consumption and the inexistence and/or inefficient 
technologies of WWTPs in tropical countries, allied to the current status of absent 
awareness and data around the potential toxicity of these compounds to tropical native 
organisms, knowledge contributions are essential regarding screening of 
environmental concentrations and marine species responses towards chronic 
exposures. The present study aimed to evaluate the effects of the widely administered 
anticancer agents namely cisplatin (CisPt), cyclophosphamide (CP) and tamoxifen 
(TAM), individually and in tertiary mixtures on the representative tropical marine 
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invertebrates, namely the sea urchin Echinometra lucunter, the amphipod Tiburonella 
viscana and the polychaete Scolelepis squamata. The selection of CisPt, CP and TAM 
for the present toxicity assessment was made according to a combination of criteria 
regarding their consumption and environmental occurrence in water bodies 
worldwide, due to their traditional administration in single and combinatory 
chemotherapies, thus with more clinical information available and knowledge about 
their physico-chemical properties and MoA (Emadi et al., 2009; Dasari and 
Tchounwou, 2014; Shagufta, 2018). 
6.2 Materials and Methods 
6.2.1 Chemicals 
The analytical standards of cis-platinum (II) diamine dichloride (CAS 15663-
27-1), cyclophosphamide monohydrate (Cytoxan) (CAS 0768) and tamoxifen (CAS 
10540-29-01) were purchased from Sigma-Aldrich (Portugal) (Table 6.1). Individual 
stock solutions of CisPt and CP were prepared in ultrapure Milli-Q water, whilst TAM 
was firstly dissolved in the solvent dimethyl sulfoxide (DMSO), following serial 
dilutions in Milli-Q water, with a final concentration of 0.001% (v/v) DMSO to avoid 
solvent toxicity effect during experimental use. Since dermal route of exposure is 
considered to have the predominant role in the uptake of anticancer agents in humans, 
the chemicals  under study were handled under safety criteria using class II biological 
safety cabinet, with appropriate clothing (i.e. open-back, impervious chemotherapy 
protection gown, double powder-free latex gloves and safety goggles). 
 
Table 6.1: Physico-chemical characteristics, structure and metabolism of the selected 
anticancer drugs. 
Properties Cisplatin Cyclophosphamide Tamoxifen 
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Molecular  
Structure 
 
 
MoA 
Causes oxidative stress; 
Binds to nucleophilic 
sites in genomic and 
mitochondrial DNA, 
producing DNA 
adducts and damage 
that inhibits its 
replication and cell 
division 
Causes oxidative 
stress; Reacts with 
N and O atoms of 
DNA bases 
generating 
cytotoxic and 
mutagenic DNA 
adducts 
Causes oxidative stress; 
Binds to estrogen α 
(ERα) and β (ERβ) 
receptors and interrupts 
cell proliferation 
CAS Number 15663-27-1 6055-19-2 54965-24-1 
pKa 5.3 - 7.2 2.3 - 11.1 8.8 (Basic) 
Log Kow -2 0.6 6.3 
Water Solubility 4 ×104 mg L-1 3 ×103 mg L-1 17 mg L-1 
 
6.2.2 Toxicity of single-drug exposures  
Embryo-larval development of E. lucunter 
Adult specimens of the sea urchin E. lucunter were collected at low tide, in the 
Palmas Island (Santos, São Paulo - Brazil), rapidly transported alive to the laboratory, 
where animals were maintained under constant aeration and temperature (25 ± 2°C), 
according to the protocol NBR 15350 established by the Brazilian Association for 
Technical Standards (ABNT, 2012). Spawning was induced by the injection of 3 mL 
KCl 0.5 M into the coelomic cavity of sexually mature individuals. Females were 
individually placed on 400 mL beakers containing filtered seawater (salinity 35) for 
oocytes collection, which were observed under microscope to confirm viability. The 
selected batches of oocytes were pooled and allowed to decant, following serial 
washings by supernatant removal and solution filtration through a 350 µm-mesh, with 
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the addition of 600 mL of dilution water. Spermatic fluid was collected directly from 
the gonopore with the aid of a glass Pasteur pipette and placed into a dry 30-mL glass 
beaker kept on ice. In order to prompt sperm activation, 0.5 mL of spermatic fluid was 
added into 24.5 mL of seawater. Afterwards, 2 mL of active sperm solution was 
introduced into the oocytes solution and stirred with a glass stick rod, over 10 minutes, 
to elicit fertilization. An aliquot of eggs solution was seeded in a Sedgwick–Rafter and 
observed under microscope to ensure that 80–100% of the eggs were fertilized. Four 
10-mL test tube replicates were set up for each treatment, comprised by 
pharmaceuticals individually tested at five test concentrations (CisPt: 0.1, 1, 10, 50 
and 100 ng L-1; CP:10, 50, 100, 500 and 1000 ng L-1; TAM: 0.5, 10, 25, 100 and 500 
ng L-1), jointly with control conditions consisting of seawater and 0.001% DMSO 
solvent. In each replicate, 300-500 embryos were seeded and exposed over 36 ± 4 h, 
at constant temperature (25 ± 2°C) and photoperiod (16 h light:8 h dark), fixed with 
0.5 mL of 40% buffered formaldehyde-borax (pH 7.0) aftermath. Individuals from the 
control groups were analysed under microscope to confirm normal pluteus larvae 
development, by establishing a criterion of minimum 80% to indicate suitability of the 
test.  
 
 
6.2.3 Toxicity of pharmaceuticals in mixtures 
Sediment spiking  
Reference sediments were collected in Engenho d´Água beach, at the north 
coast of São Paulo State (Brazil), during low tide. This spot has been often used as a 
control site, as reported in previous ecotoxicological studies (Abessa et al., 1998; 
Sousa et al., 2007; Maranho et al., 2010; Araujo et al., 2013; Souza et al., 2016). 
Sediments were transported to the laboratory, where they were wet-sieved through a 
2-mm mesh for removal of large debris, seaweed and macrofauna, following drying at 
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80 °C (Thain and Bifield, 2001; ASTM, 2009; Maranho et al., 2014). Sediments were 
disaggregated and stored at 4°C over seven days until the spiking procedure. Dried 
aliquots of the sediments were used to determine grain size distribution by the method 
proposed by Royse (1970). Organic matter content was determined by loss on ignition 
(550 °C, for 5 h), as described by Gross (1971). Afterwards, sediments were re-
hydrated with the same amount of water loss (w.w./d.w.). Procedures of sediment 
spiking were adapted from the sediment suspension technique, described by USEPA 
(2001).  
Briefly, the total volume of sediments correspondent to each treatment, 
conducted in triplicate (i.e. 200 mL of each replicate × 3 = 600 mL of sediment), was 
introduced into 2 L-glass jars, plus inserting aliquots of pharmaceutical solutions to 
compose the tertiary pharmaceutical mixtures with water collected from the reference 
site of sediment, filling a total aqueous volume of 330 mL. Nominal concentrations of 
tertiary pharmaceutical mixtures ranged as follows: 0.1 CisPt + 10 CP + 0.5 ng L-1 
(Mixture A); 10 CisPt + 100 CP + 10 ng L-1 (Mixture B); 100 CisPt + 500 CP + 25 ng 
L-1 (Mixture C); 100 CisPt + 1000 CP + 100 ng L-1 (Mixture D). Each pharmaceutical 
mixture was stirred at a moderate speed with a bench homogenizer, over 30 min. 
Control conditions consisted of unspiked sediments, with DMSO (final concentration 
0.001%) and without. For partitioning and equilibration of pharmaceuticals between 
sediments solid-phase and interstitial water, spiked sediments were kept in the dark, at 
4°C, over seven days. Afterwards, sediment samples with the pharmaceutical mixtures 
were stirred with a spatula and distributed in triplicate in 2 L-glass test beakers.  
 
 
Survival of the amphipod T. viscana 
Amphipods were collected in subtidal zone of the Engenho d´Água beach, at 
low tide, and transported alive to the laboratory where they were acclimated over three 
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days at room temperature (25 ± 2°C), constant aeration and light exposure. The whole-
sediment toxicity bioassay was adapted from the method described by Melo and 
Abessa (2002) and ABNT (2008). The experimental system was set up in a triplicate 
design, depicted by thirty adult individuals transferred to each glass beaker, filled with 
200 mL of spiked sediment and 800 mL of filtered seawater from the site of 
amphipods´ origin. The exposure of amphipods to mixtures A, B, C and D, jointly with 
seawater and DMSO solvent controls, was carried over 10 days under constant aeration 
and lightning, at room temperature (25 ± 2°C). Animals were not fed and overlying 
water was not renewed during the bioassay. At the end of the exposure, the content of 
each test vessel was individually sieved through a 0.5 mm-mesh, and surviving 
organisms registered for acute endpoint. Physico-chemical experimental conditions 
were measured in the beginning (salinity 35.2 ± 0.7; pH 7.65 ± 0.05; air saturation 78.7 
± 5%) and end (salinity 35.6 ± 0.5; pH 8.22 ± 0.1; air saturation 71.5 ± 6.4 %) of the 
bioassay.  
Survival of the polychaete S. squamata 
Specimens of the spionid S. squamata (Muller, 1806) were handpicked in the 
intertidal zone of the sandy beach of Itaguaré, close to the Restinga de Bertioga State 
Park and within the Environmental Protection Area of the Central Coast (Bertioga, São 
Paulo – Brazil), far from urbanized areas. After collection, polychaetes were 
transported alive to the laboratory with sediment and seawater from the site of origin. 
Animals were acclimated over three days until the beginning of the bioassay, kept at 
room temperature (25 ± 2°C), constant aeration and light exposure. Clean control and 
spiked sediments with pharmaceutical mixtures (200 mL) were inserted in 2 L- glass 
jars filed with 800 mL of filtered overlying seawater, in a triplicate design. Twenty-
five individuals were placed in each replicate chamber and exposed over 14 days, with 
static renewal every 48 h necessary to maintain the pharmaceuticals exposure levels, 
in accordance to the experimental set-up conducted with the polychaete N. 
diversicolor, detailed in the previous Chapters 2-4 (Fonseca et al., 2017; 2018). 
Physico–chemical parameters were monitored in the beginning (salinity 35.1 ± 0.7; 
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pH 8.1 ± 0.06; air saturation 114.5 ± 6.2 %) and at the end (salinity 35.3 ± 0.5; pH 8.03 
± 0.05; air saturation 115.2 ± 6.4 %) of the bioassay. At the end of the exposure period, 
the number of living organisms in each treatment replicate was recorded.  
6.2.4 Statistical Analysis 
Data of toxicity bioassays were first checked for normality and 
homocedasticity, respectively by Shapiro Wilk's and Bartlett tests. Once these 
premises were confirmed, Student´s T-test was applied on the embryotoxicity dataset 
of E. lucunter, by comparing each pharmaceutical treatment to the respective control, 
whereas the analysis of variance (One-way ANOVA) was applied for the acute toxicity 
tests conducted with T. viscana and S. squamata in spiked sediment, followed by 
Tukey's test of multiple comparisons to detect significant differences among 
treatments (α = 0.05). 
6.3 Results and Discussion 
To the best of our knowledge, the present study comprises the first 
ecotoxicological assessment of anticancer drugs on tropical marine organisms, 
considering the potential responses provoked by these pharmaceuticals. According to 
the obtained results, single-drug exposures of E. lucunter embryos demonstrated the 
reliability of the embryo-larval development as a chronic endpoint for assessing the 
toxicity of anticancer agents present in seawater at trace concentrations. Surprisingly, 
malformation of embryos did not follow the usual dose-response pattern, in which 
effects increase with the dose. Instead, a U-shaped effect was depicted with a non-
linear significant reduction of viable pluteus larvae at CisPt and CP treatments, 
respectively at the range from 0.1 to 10 ng Pt L-1, and from 50 to 500 ng CP L-1 (Figure 
6.1). However, even though the highest levels of these anticancer agents indicated no 
toxicity in relation to control, these samples would be considered toxic according to 
the acceptability criteria proposed by both USEPA (2002) and CETESB (1999), which 
establishes a minimum of 80% of successful embryo-larval development. 
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The observed effects exhibited a non-monotonic dose-response relationship, in 
which the very low doses exerted significant teratogenicity, defined by birth defects, 
congenital disorders and structural anomalies, in accordance to their designed 
cytotoxic MoAs. In humans, teratogenicity caused by chemotherapy administration 
generates fetal changes over mothers’ pregnancy, deficient growth and a small-for-
gestational-age newborn (Paskulin et al., 2005). Likewise, external abnormalities 
responses in mice fetus were also addressed (Ghaseminezhad and Hejazi, 2015). In 
contrast to the present results, a significant decrease in larval development occurred in 
fertilized eggs of the sea urchin Paracentrotus lividus exposed to the anti-metabolite 
methotrexate, from the concentration of 5 µg L-1 to 1 g L-1, in a dose-response manner 
(Aguirre-Martínez et al., 2016b), whereas the lower concentrations on the range of ng 
L-1 did not depict effects over the development endpoint. In this comparative scenario 
between studies, it is important to bear in mind that not only the drugs´ MoAs are 
distinct, but species´sensitivity are, ever so, crucial to consider. Under an exposure to 
ibuprofen, P. lividus exhibited an EC50 of 10 ng L
-1 for the embryotoxicity endpoint 
(Aguirre-Martínez et al., 2015), whilst the same drug at the concentration of 15 ng L-
1 was enough to provide a null larval viability in the tropical counterpart Lytechinus 
variegatus (Pusceddu et al., 2018). 
In fact, according to a review on clinical trials data regarding chemotherapy 
administration, the application of cytotoxic agents at low-doses achieves a more 
satisfactory efficacy in anti-proliferative responses compared to high conventional-
dose regimen (Xie et al., 2017). Findings obtained from the exposure of embryos of 
Xenopus laevis to CisPt at a range of high doses (10 µg L-1 to 10 mg L-1) did not elicit 
any effect in their development or survival, which reinforce the variation of resistance 
across taxa (Van der Grinten et al., 2010; Bakopoulou et al., 2011; Isidori et al., 2016). 
However, the concentrations of anticancer agents herein tested were chosen according 
to their respective levels detected in the aquatic compartment, particularly in 
freshwater systems of temperate zones, once coastal zones have not been foreseen 
under the screening spectra of anticancer drugs, which includes, in particular, the 
coastal zones of tropical developing regions.  
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Considering both the non-monotonic profile of response herein addressed and 
the trace realistic concentrations at which detrimental effects were elicited, 
experimental set-ups conducted with pharmaceuticals should include a wide range of 
concentrations corresponding to environmental analytical disclosures. This is 
particularly stressed in the case of anticancer drugs, not only because of their high 
cytotoxic, genotoxic and mutagenic potential (Novak et al., 2016; Toolaram et al., 
2014), but also due to their feasible biphasic trend of dose-response, depicted as a 
challenge to the use of a traditional threshold model, which proposes that there is a 
dose below which no effects of a chemical are observed (Chapman, 2002; Vandenberg 
et al., 2012, 2014; Agathokleous, 2018).  
Thus, the comprehension of these trends of responses has crucial implications 
for the risk assessment of anticancer drugs and the establishment of safety levels for 
these chemicals in the nature. Nevertheless, regarding the effects from the exposure to 
environmental concentrations of TAM, a monotonic dose-response relationship was 
evidenced, with increasing teratogenic effects observed from the lowest level (Figure 
6.2). Similarly, embryotoxicity was reported for P. lividus exposed to TAM, with a 
significant decrease in larval viability at the lowest concentration of 1 ng L-1 (Aguirre-
Martínez et al., 2016b). Besides a higher sensitivity compared to adult life stages, the 
selection of embryolarval development represent a quick, relatively easy and sensitive 
toxicity test, with the added advantage of having a low cost and test duration 
(Hutchinson et al., 1998; Aguirre-Martínez et al., 2016b). 
 In both experiments conducted with the sediment-dwellers amphipods and 
polychaetes, no significant differences were detected between survival in organisms 
from control conditions with and without DMSO solvent. In contrast, results indicated 
in Figure 6.1 and 6.2 show the detrimental effects exerted by anticancer mixtures in 
amphipods and polychaetes, respectively. Comparatively, T. viscana presented a 
higher sensitivity to pharmaceuticals than S. squamata. Like the non-monotonic dose 
relationship herein reported for E. lucunter, survival response in amphipods also 
illustrated a non-linear reduction of survival in Mix B and D, both represented by 
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mortality rates of 60%. According to Lagarde et al. (2015), such non-monotonic 
profile has been typically linked to endocrine disrupting compounds, with reports of 
similar ecotoxicological effects in experiments conducted with aquatic organisms 
(Morales et al., 2018; Teng et al., 2018) and on pharmacological studies developed 
with human cell lines (Mater et al., 2014; Vandenberg et al., 2014, 2012; Lagarde et 
al., 2015). Therefore, this biphasic profile could be associated to the predominance of 
TAM´s MoA in mixture, able to interact differently with estrogen receptors and 
signalling proteins, depending of their affinity across the range of tested doses and the 
alternance of antagonist and agonist effects according to the targeted tissue.  
According to the Mixed-Ligand hypothesis, described by Maness et al. (1998), 
at low concentrations of the drug, dimers are more likely to form and induce a 
response, whereas with a subtle increase in concentration (Mix C) there is a block in 
the molecular receptor activity and no interaction with the drug occurs. In contrast, at 
a higher drug concentration (Mix D), dimers are more likely to form and induce a 
response, herein expressed as mortality. Moreover, modulation of TAM MoA may 
disregard ERs´presence (Gundimeda et al., 1996; Bekele et al., 2016), because its anti-
proliferative and cytotoxic effects may be also derived from the prodrug metabolic 
activation and generation of the oxidative metabolites endoxifen and 4-
hydroxytamoxifen. Such metabolites are accountable for the oxidative stress and the 
cascade of signal transduction mediated by protein kinases that culminate in both 
interruption of cell proliferation and apoptosis. It appears credible that the extremes of 
the biphasic response curve are prone to be driven by complementary mechanisms 
conjugated by the cytotoxic potential of CisPt and CP, together with the oxidative 
outcomes of TAM´s metabolic activation, following modulation of ERs, whether 
existent. To date, no evidence exists regarding the expression of ERs in T. viscana that 
could validate the antagonist role of TAM over specific estrogenic targets. However, 
present non-monotonic dose relationship may suggest the presence of a nuclear 
estrogen-like receptor, thus requiring further refined characterization of nuclear ERs 
and its ligand-induced transcriptional activation.  
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Figure 6.1: Percentage of normal pluteus of E. lucunter after exposure of fertilized 
eggs to single anticancer drugs. Asterisks indicate significant differences between drug 
treatments and control (T-test, p < 0.05). 
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Figure 6.2: Survival rates of the amphipod T. viscana (mean and S.D) exposed over 
10 days to control conditions (CT and DMSO), and tertiary mixtures of the anticancer 
drugs. Different letters indicate significant differences (p < 0.05). 
 
 
Figure 6.3: Survival rates of the polychaete S. squamata (mean and S.D) exposed over 
10 days to control conditions (CT and DMSO), and tertiary mixtures of the anticancer 
drugs. Different letters indicate significant differences (p < 0.05). 
 
The native tropical species T. viscana has been so far applied in several 
environmental quality assessments of Brazilian coastal and marine zones under the 
anthropic burden of harbour pollution, as well as untreated industrial and domestic 
effluents, containing complex mixtures of chemical at environmental realistic 
concentrations (Abessa et al., 1998; Melo and Nipper, 2007; Maranho et al., 2010; 
Araujo et al., 2013; Rodrigues et al., 2013; Cesar et al., 2014). This species was 
sensitive to anti-cancer drugs, as observed by the mortality rates. However further 
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studies are necessary to provide the comprehension of biochemical and molecular 
pathways linked to mechanisms that underpin the ultimate response of mortality, 
which are decisive to insert tropical indigenous species in the scenario of comparison 
to temperate biological models. Regarding polychaetes, although the significant acute 
toxicity exerted in organisms from the higher pharmaceutical doses (Mix C and D), 
the survival rate in these drug-treated organisms was reduced less than 10% compared 
to unexposed groups.  
6.4 Conclusions 
Considering the growing need for data concerning the biological impacts of 
pharmaceuticals in the marine environment, this study presents the first data based on 
the toxicity effects of anticancer drugs with biological models of Latin America. 
Larval development of the sea urchin E. lucunter demonstrated to be a sensitive 
endpoint indicating the adverse effects posed by CisPt, CP and TAM at an 
environmental range of concentrations, with respective profiles of response including 
the non-monotonic shape. The sediment dweller organisms herein applied in the 
sediment spiked bioassays with pharmaceuticals in mixtures showed consistent 
sensitivity to anti-cancer drugs in the acute toxicity tests, considering the trace 
concentrations of the chemicals applied. Further analysis of chronic and subchronic 
endpoints are required in order to elucidate and/or confirm the molecular and 
biochemical mechanisms underlying the lethal responses observed to the amphipod T. 
viscana and the polychaete S. squamata, which may be designed as suitable 
bioindicators for studies on the environmental quality of tropical and subtropical 
regions regarding pharmaceuticals. 
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 Chapter 7 
GENERAL DISCUSSION  
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7.1 The issue of anticancer drugs in the marine environment 
Global demographic trends have led to a record in population´s growth, which 
today comprises 7.7 billion people, on a pace to represent 8.9 billion by 2050, mainly 
derived from low- and medium-resource countries. Allied to that, attributes of an ever-
increasing urban society have prompted a decline in fertility rates and an increase in 
life expectancy, accountable for the demographic milestone shift towards structural 
aging of population (Ferlay et al., 2015). These trends, together with modern life-style 
habits (i.e. diet, smoking, infectious agents and environmental pollutants) have been 
crucial to the prominence of chronic and non-communicable diseases, which are 
displacing infection-related ones as major causes of morbidity and mortality in many 
parts of the world (Anand et al., 2008; Stewart and Wild, 2014). In this sense, cancer 
arises as one of the leading causes of death, and remains striking, in a way that, in 
2012, 14.1 million new cases of cancer were diagnosed worldwide, likely to turn into 
27.5 million incidences in 2040 (GLOBOCAN, 2012). In light of the implications that 
cancer disease burden brings to public health and economy, United Nations Resolution 
on noncommunicable diseases have joined efforts with governments in a global 
monitoring framework, aimed at tackling this malignancy through strategies of early 
detection, preventive and control actions (WHO, 2002). Such scenario contributes to 
the increment in production and consumption of anticancer agents applied in 
traditional systemic therapy, managed individually or in mixtures according to the type 
and stage of tumour (Caley and Jones, 2012; Aitken, 2016), under an increasing trend 
of home-based drug administration. 
As every other pharmaceutical consumed, intravenously or via oral ingestion, 
parent molecules of anticancer compounds are metabolized and excreted, in their 
native form or as metabolites, into waterways following to WWTPs. According to 
analytical assessments with particular focus on pharmaceuticals´ detection in effluents 
and surface waters, a large number of anticancer molecules have shown considerable 
recalcitrance either by biological conventional treatments or by highly advanced 
technologies, thus ending up in the aquatic ecosystems at range of sub ng to ng L-1, 
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confirming the inefficiency of their removal. Although anticancer drugs represent 
lower consumption rates compared to other classes of over-the-counter drugs, leading 
to represent a smaller fraction of pharmaceuticals in the environment, they act upon 
essential biomolecules and cell proliferation signaling pathways, such as generate 
signal transduction cascades of cell death, potentially conserved in non-target species 
(Mater et al., 2014). In spite of the increasing number of studies devoted to 
comprehend their environmental toxicity, research has been mainly focused on 
freshwater species in the spotlight of ecotoxicological knowledge, whereas studies 
conducted with coastal counterparts are still scarce and reveal a critical disparity in 
current datasets (Figure 1.11). Therefore, the vulnerability to which marine ecosystems 
undergo in face of the increasing inputs of complex cytotoxic mixtures of 
pharmaceuticals has been neglected (Claessens et al., 2013a; Gaw et al., 2014; 
Moreno-González et al., 2016). Moreover, there is a general paucity of information in 
the scientific literature concerning the multitude of exposure routes to drugs in the 
environment, which clearly disregards the sediment compartment, where higher 
concentrations of contaminants are present in comparison with the overlying water 
(Burton et al, 2003; Simpson et al, 2005). Sediments may constitute not only a sink 
but also a secondary source of pollution, to which special attention should be given 
(Buruaem et al., 2012).  
7.2 Ecotoxicological impacts of anticancer drugs  
When this thesis started, efforts on analytical detection and ecotoxicological 
investigation of pharmaceuticals, mainly elicited in freshwater environments, were 
focused in therapeutic classes including antibiotics, non-steroidal anti-inflammatory 
drugs, antidepressants, antihypertensives, antiepileptic and contraceptives (Weigel et 
al., 2004; Roberts and Thomas, 2006; Togola and Budzinski, 2008; Paíga and Delerue-
Matos, 2013; Nödler et al., 2014). Even though the occurrence of anticancer drugs has 
already been measured in effluents of WWTPs and riverine compartments (Aherne et 
al., 1990, 1985; Richardson and Bowron, 1985), the interest on their fate in marine 
waters and sediments has been reflected only in the detection of TAM (Hilton and 
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Thomas, 2003), and more recently, the survey for methotrexate occurrence (Biel-
Maeso et al., 2018). Until the present thesis starts, only few marine species were used 
as biological models for the investigation of anticancer´s toxicity, under exposure to 
high concentrations and route of exposure not in accordance to a realistic scenario 
(Santos and Pacheco, 1995; Pagano et al., 2001; Roepke et al., 2005).  
 Cancer cells, to which these drugs are designed, have a high demand for ATP 
as a “fuel” for aberrant proliferation, resulting in high accumulation of ROS that needs 
to be counteracted by scavenging mechanisms to avoid the death of tumour cells. In 
fact, ROS levels are regulated to a range able to activate cell transduction pathways 
critical for cancer growth and progression (Gorrini et al., 2013; Qiu et al., 2015). In 
this sense, the MoA of cytotoxic drugs relies on the overwhelming tumour cells´ 
defense through suppression of ROS scavengers and induction of oxidative stress, 
following physiological dysfunction, cell damage and apoptosis (Chu, 1994; Dasari 
and Bernard Tchounwou, 2014; Fukai and Ushio-Fukai, 2011; Qiu et al., 2015; 
Reedijk, 1999).  
7.2.1 Effects of cisplatin in N. diversicolor 
The platinum-based drug CisPt remains as one of the most widely utilized 
antineoplastic pharmaceuticals worldwide. The present findings clearly showed that 
the presence of CisPt at 100 ng Pt L-1 in the seawater elicit effects linked to the drug´s 
MoA, by means of the sharp inhibition of SOD and CAT, accountable for the 
dismutation of the superoxide anion to H2O2, following transformation to H2O, 
respectively (Fukai and Ushio-Fukai, 2011). In this sense, the burst of oxidizing 
superoxide and hydrogen peroxide, that could not be eliminated due to the suppression 
of this first line of defense against ROS, seemed to be buffered by the protective 
reduced GSH, due to the significant induction of Se-GPx activity (Ben Ameur et al., 
2012; Cozzari et al., 2015; Djordjevic et al., 2011). This enzyme has a critical role in 
the detoxification of products deriving from ROS-promoted oxidation of lipids, like 
malondialdehyde and 4-hydroxyalkenals (Aquilano et al., 2014). However, the 
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considerable high levels of LPO by-products addressed in polychaetes submitted to 
the highest Pt level clearly indicated that such scavenging mechanisms were not 
sufficient to avoid membrane damage (Gomes et al., 2014; Viarengo et al., 2007). 
Besides, GSH maintain the essential thiol status of cysteine residues on 
proteins, and conjugates with a great variety of electrophilic compounds like CisPt, 
more often through the nucleophilic attack catalysed by GST, which aims to increase 
drug solubility and favour its excretion (Aquilano et al., 2014; Fuertes et al., 2003; 
Penner et al., 2012; Prabhu et al., 2004).The significant inhibition of GST activity 
registered at 100 ng Pt L-1 could be attributed to the GSH depletion in cells in face of 
a high conjugation rate to the drug (Doz et al.1993; Fuertes et al.2003; Hagrman et 
al.2003). Stornetta et al. (2017) addressed that elevated GSH levels in KB-3-1 
epidermoid carcinoma cells were associated with a 3-fold reduction in drug-DNA 
adducts, in the same way that the treatment of cancer cells with buthionine 
sulfoximine, a thiol inhibitor, induced the formation of DNA crosslinks and cell death 
(David-Cordonnier et al., 2003). Similarly, metallothionein (MT) comprises another 
endogenous cysteine-rich molecule that limit the amount of CisPt available for 
interaction with DNA (Doz et al., 1993; Huska et al., 2009; Wang, 1998). The 
significant increase in intracellular concentration of MT in N. diversicolor, at the 
highest CisPt concentration (i.e. 100 ng CisPt L-1) (Fig. 2.4), is in agreement with 
several oncological studies reporting its induction in human cell lines treated with 
cytotoxic platinum-based drugs (Doz et al., 1993; Florea and Büsselberg, 2011; 
Fuertes et al., 2003; Huska et al., 2009; Kelley et al., 1988; Komiya et al., 1991; Smith 
et al., 2006; Wang, 1998). Huska et al. (2009) demonstrated that the electrochemical 
signal corresponding to the MT-cisPt complex, detected via voltammetry in rat-blood 
treated intraperitoneally with the drugs, enhanced over time. On the other hand, it was 
addressed that the Cat2 signal, representative to presence of free –SH moieties, 
decreased, correlating well with the fact that free thiol moieties of MT are saturated by 
CisPt.  
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It has been found that resistance undergo through the mechanism in which the 
aquated CisPt lose one or two chloride ligands inside the cell, followed by the 
replacement by cysteine thiolates of MTs (Zhang et al., 2011). Altogether, 
intracytoplasmic covalent binding of thiol to platinum compounds reduces the 
proportion of drug available to interact with nuclear DNA, widely known to modulate 
resistance mechanisms during chemotherapy (Dabrowiak et al., 2002; Gagné et al., 
2008; Huska et al., 2009; Reedijk, 1999; Won et al., 2008). In this sense, it is 
conceivable that the absence of genotoxicity, herein assessed by the Comet assay, was 
attributed to mechanisms of drug modulation and resistance described in mammalians. 
Another possible explanation for that is based on the different types of crosslinks 
between DNA, that increase structural alterations of crosslinked DNA fragments and 
contributed to less DNA migration in electrophoresis (Merk and Speit, 1999). 
Detrimental responses leading to an ultimate cytotoxicity are not solely attributed to 
genotoxicity, since only a small fraction of CisPt actually binds to DNA. Thus, the 
above-mentioned imbalance in antioxidant potential play a consistent role in the 
toxicity of CisPt (Sadzuka et al., 1992). 
Biochemical mechanisms of defence seemed to be inefficient to fight against 
oxidative stress and may have contributed to alterations in the energy expenditure 
(Pires et al., 2016a) as indicated by the decrease of burrowing rates among those 
polychaetes exposed to the highest concentration. This behavioural outcome may 
ultimately resound in ecological impacts, since organisms become more susceptible to 
predators when lying on the sediment surface (Amiard-Triquet, 2009; Bonnard et al., 
2009). Moreover, an impaired burrowing is also reflected in the bioturbation event, a 
relevant habit displayed by N. diversicolor for the irrigation and particle mixing that 
ultimately afford changes in the oxi-reduction state of chemicals and provide 
displacement of organic matter to another infauna (Thit et al., 2015). Few studies have 
so far linked this behavioural alteration to neurotransmitters´ role, vital for normal 
muscular function, particularly in the investigation of pharmaceuticals (Boyd et 
al.2002; Bonnard et al.2009). As such, it was hypothesized that the reduction in the 
number of buried organisms at the highest CisPt concentration was attributed to the 
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neurotoxic event of AChE activity inhibition (Figure 2.3), similar to findings described 
in previous studies conducted with human erythrocytes, where the electrophilic 
reactive products of CisPt are accountable for the neurological side-effects (Aljafari, 
1995). An interesting aspect to highlight is that despite the neurotoxic response of 
AChE inhibition was observed only at 100 ng Pt L-1, which represents an 
environmental worst-case concentration, modulation of AChE activity also occurred 
at 10 ng Pt L-1 by its significant induction, suggested to be linked to an adaptation of 
physiological fitness over the hormetic phenomena (Calabrese and Blain, 2005). 
Therefore, it is important to remark that besides a profile of toxicity consistent with 
the platinum-based MoA was addressed in N. diversicolor, at 100 ng Pt L-1, the 
sediment dweller biological model showed to respond, in a non-monotonic way, to the 
drug uptake at sub-toxic level. 
7.2.2 Effects of cyclophosphamide in N. diversicolor 
Along with CisPt, CP is one of the oldest and most frequently prescribed 
cytotoxic drug in cancer treatment, but the first one to draw attention in an aquatic 
ecotoxicological perspective (Matsumoto and Cólus, 2000; Zounková et al., 2007). 
Nevertheless, the present results fulfill gaps of risks under an environmental realistic 
way including the benthic environment. The antioxidant responses depicted by N. 
diversicolor exposed to CP showed to disregard the cytotoxic profile caused by CisPt, 
due to significant enzymatic disruptions at the lowest CP level tested (10 ng L-1), in 
which burrowing performance of individuals seemed to be more impaired, in contrast 
to the fully-buried organisms at the highest CP level (Figure 3.2). In face to the lack 
of neurotoxic responses, the changes determined in the behaviour of polychaetes are 
assumed to have no relationship with AChE activity.  
The metabolism of CP includes the production of the reactive acrolein via β-
elimination of aldophosphamide. This electrophilic and highly toxic reactive species 
is readily bound to GSH in the cytosol and interferes in the glutathione-related 
detoxification pathway (Peña-Llopis et al., 2002; Singh et al., 2014). Since CAT 
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showed to exert its role in clearance of hydrogen peroxide, there was no significant 
alteration of Se-GPx activity, in contrast to the induction addressed in CisPt exposure 
at the highest concentration. In the present case, it may be hypothesized that the 
increment of CP concentration, at 500 and 1000 ng L-1, led to an exhaustion of radicals´ 
neutralization and accumulation of ROS, able to cause T-GPx inactivation. Because of 
such defense failure, the accumulation of hydrogen peroxide levels is potentially 
involved in oxidative damage to cellular components, liable for the side effects 
reported over chemotherapeutic treatment with this drug (Dumontet et al., 2001; Yu 
et al., 2006).  
Increased levels of GST activity are directly associated with resistance to 
alkylating drugs in model tumour systems (Dumontet et al., 2001). Furthermore, 
herein, the 14-day exposure to the highest CP concentration led to a marked depletion 
of GST, as observed at 100 ng Pt L-1, providing basis to the rationale of glutathione-
depleting compounds as sensitizing agents in alkylating-resistant tumour cells 
(Dumontet et al., 2001; Singh et al., 2014). The present findings on the profile of GST 
activity confirm the suppression of this metabolic route during the cytotoxic MoA of 
CP, in resemblance to CisPt (Singh et al., 2014). Such effect diverges from other 
pharmaceuticals´ detoxification which are usually associated with increased GST 
activity (Martín-Diaz et al., 2009; Aguirre-Martinez et al., 2013; Buffet et al., 2014; 
Maranho et al., 2014; Aguirre-Martinez et al., 2016a) and emphasizes the inclination 
to the activation of specific pathways of cellular defense according to the chemical 
(Sun and Zhou, 2008; Faria et al., 2009; Cozzari et al., 2015). Again, the production 
of cytotoxic and reactive metabolites indicates the failure in the antioxidant defense 
and the elevation of products from lipid peroxidation. Following their generation, these 
primary by-products undergo further reactions to form secondary products of lipid 
peroxidation, including the malondialdehyde and 4-HNE, herein determined, in 
addition to acrolein. In other words, along with the production of acrolein by means of 
CP metabolism, this reactive species is a general product of lipid peroxidation able to 
trigger further oxidative chain reaction in membranes (Conklin 2004; Singh et al., 
2014). This may be the explanation to the increase of 1.8-fold levels of LPO by-
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products determined in N. diversicolor exposed to CP in comparison to those of 
cisplatin, besides the reasonable effects resultant from the depletion of the antioxidant 
status. Collectively, these impairments could have been responsible for the increased 
levels of DNA damage. However, the actual MoA relative to genotoxicity request the 
metabolic activation of the CP prodrug by CYP450 and ultimately generate the 
aziridinium intermediate species, able to bind to nucleophilic N7-position of guanine 
in DNA (Crook et al., 1986; Codrington et al., 2004), although it needs to be 
confirmed. 
7.2.3 Effects of tamoxifen in N. diversicolor 
The findings regarding the biochemical outcomes of TAM exposure in the 
benthic polychaete confirmed its potential to cause critical effects at an environmental 
realistic concentration (0.5 ng L-1 in seawater). Although there is little research 
pertaining the quantification of anticancer drugs in coastal zones, such concentration 
may be prone to be encountered at a distant location from land, where currents play an 
important role in the dilution of the target analytes (Moreno-González et al., 2015; 
Alygizaks et al., 2016). Again, as reported for the above-mentioned cytotoxic drugs, a 
very low concentration can stimulate and trigger antioxidant mechanisms, as herein 
indicated by the significant increase of SOD and Se-GPx activities (Figure 4.2), in a 
non-monotonic dose-response. Although not extensively explored in ecotoxicology, 
due to the pursuit to determine chemicals´ threshold levels, this kind of relationship 
was described from bacteria to vertebrates under a wide array of environmental 
stressors (Chapman, 2002; Mater et al., 2014).  
In contrast to the biotransformation metabolism described for N. diversicolor 
exposed to cisplatin and cyclophosphamide, the activity of GST did not change in 
polychaetes exposed to any TAM-concentration, in accordance to the gathered 
knowledge of TAM metabolism in mammalians, that does not encompass GST phase 
II enzyme but is extensively metabolized by phase I cytochrome P450. It may be then 
suggested that the unaltered GST activity is derived from a pharmacokinetic pathway 
  
186 
 
 
rather than the fact that the concentration range herein applied was not enough to 
trigger this detoxification via. Surprisingly, TAM evoked oxidative damage in the 
whole range of concentrations and, as documented in human cells under drug therapy, 
LPO increase may disregard prodrug metabolism neither ERα expression and its 
activation for the simple fact that TAM prodrug can embeds itself in the lipid 
membranes and generates superoxide and oxidative stress, with further activation of 
apoptotic cascade (Trachootham et al., 2009; Lushchak, 2011; Bekele et al., 2016). 
However, only under the highest TAM concentration, polychaetes presented an 
expressive DNA damage which may be attributed to the conversion of TAM into its 
intermediary putative active metabolite α-hydroxytamoxifen, which is able to bind 
covalently to DNA and damage the double strands (Figure 4.7), as reported in human 
peripheral blood lymphocytes and MCF-7 cells (Wozniak et al., 2007). In other words, 
even though there is a lack of disclosure on estrogen receptors´ expression in N. 
diversicolor, it is plausible that the metabolic activation has only occurred at 100 ng 
L-1, and that the prodrug oxidative potential provided detrimental effects all over the 
concentration range tested. It is important to bear in mind that TAM metabolic activity 
is described as complex in pharmacology, considering its capacity to display agonist 
and antagonist potential depending of the target line of cells. Likewise, herein, AChE 
activity increased in a dose-response manner, also related to the increment of 
impairments in burrowing ability, which is dissonant to the previous results obtained 
with N. diversicolor exposed to CisPt and CP.  
7.2.4 Effects of mixtures of anticancer drugs on N. diversicolor 
Knowledge concerning the presence of anticancer drugs in the marine 
environment is very scant in detriment to the broad conventional classes of 
pharmaceuticals, and even less investigation deals with the intricate reality of chemical 
interactions involving different anticancer agents. Joining the facts that the selected 
drugs have a highly toxic potential to ultimately elicit cell death, and their 
administration in combination during cancer treatment, it was hypothesized that the 
toxic effects caused by tertiary mixtures would be increasingly toxic to the benthic 
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model N. diversicolor, in a dose-response manner. Nevertheless, the results indicated 
that at the intermediary concentrations (Mixtures C and D), the overall profile of 
oxidative stress seemed to be driven by TAM, when compared with the effects derived 
in the bioassay conducted individually. It is suggested that over the single-drug 
exposure, at these respective concentrations, TAM activate oxidative stress by prodrug 
membrane contact. This pathway avoided (or inhibited) the influx of the cytotoxic 
CisPt and CP, a required step for the activation of the drugs in the cytosol, thus 
silencing endpoints observed in the respective single-drugs bioassays. Changes could 
have occurred in structure or function of proteins involved in drug transport delivery, 
namely in the copper transporter proteins CTR1, accountable for the intake of CisPt 
and drug resistance (Dasari and Tchounwou, 2014; Ma et al., 2015).  
Yet, at the highest mixture concentration (Mix D), the sharp inhibition of CAT 
activity (90%) is a potential synergistic effect, whereas the inhibition of GST activity 
indicates an additive interaction (Figure 5.8). At the lowest mixture concentration 
(MIX A), the suppression of GST activity is dissonant to the respective single-drug 
responses (Figure 5.8). Indeed, PCA indicate that biochemical responses in specimens 
exposed to Mix A correspond to those reported for Mix D as well as to those from 
single CP exposure (Figure 5.7). Drugs at the low concentrations (Mix A) may be 
accountable for inducing significant levels of T-GPx activity (Figure 5.3-D) as a 
potential protective effect promoted by responsive mechanisms facilitated at low 
concentrations, such as drug permeability (Alfarouk et al., 2015). It is hypothesized 
that despite the activation of the antioxidant system in polychaetes submitted to Mix 
A, ROS were not sufficiently scavenged and detoxification was not enough to 
overcome injuries provided by LPO by-products (Pires et al., 2016a), culminating in 
mid-grade DNA damage at levels higher than those of the other mixtures (Table 5.1), 
as the effect reported in the single exposure to 0.5 ng L-1 of TAM, potentially prone to 
generate LPO by-products in this mixture (Figure 5.8).  
Regarding neurotoxicity, AChE activity was inhibited in organisms exposed to 
Mix D, although burrowing capacity was similar to unexposed animals (Figure 5.1), 
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which is in contrast with those exposed to Mix A, where burrowing was impaired but 
no changes is AChE activity were observed.  According to these results, it seems that 
the mechanism involved in the burrowing impairment is different from those driven 
by AChE activity alterations. At the intermediary concentrations (Mix B and C), the 
anticancer compounds also triggered oxidative damage in polychaetes, although no 
pronounced effects on neuroactivity, antioxidant and biotransformation metabolisms. 
In these two mixtures, biochemical effects of polychaetes were similar to those 
reported in single-TAM exposures (Chapter 4), suggesting an antagonist interaction of 
the cytotoxic CisPt and CP at their respective doses and the dominance of TAM MoA 
over their cytotoxic potential in Mix C and D. These results confirm that the 
combination of endpoints cannot be calculated by simply adding the effects of the 
individual components in the mixture. 
7.2.5 Effects of anticancer agents on tropical/subtropical biological models  
Considering that pharmaeuticals have been left behind in governmental 
frameworks of low- to middle-income nations, it is essential that the scientific 
community addresses current gaps in ecotoxicological knowledge by taking into 
account the vulnerability of aquatic ecosystems in tropics, where the biodiversity is 
greater and more sensitive to contaminants (Freitas and Rocha, 2012; Moreira et al., 
2014). Concomitantly, the incidence of cancer is growing at a fast pace and anticancer 
drugs´discharge and impacts to the coastal ecosystems have been never questioned in 
these zones. An ongoing debate is to what extent toxicological benchmarks and 
environmental criteria developed for species living in temperate regions are valid and 
applicable for ecological risk assessment of species in other geographical areas such 
as in tropical regions, which demands more ecotoxicological data under these 
conditions, using native indigenous test organisms (Gunnarsson and Castillo, 2018).   
 According to the obtained results, single-drug exposures to E. lucunter 
embryos demonstrate the reliability of such early-life as a chronic endpoint for toxicity 
assessment of anticancer drugs present at trace concentrations in seawater. As 
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illustrated by some of the effects displayed by N. diversicolor under single-drug 
exposures, the development of the pluteus larvae also revealed a significant decrease 
in its viability through a U-shaped dose-response in embryos submitted (Figure 6.1) to 
CisPt and CP. In other words, the lowest concentration of CisPt (0.1 ng Pt L-1), able to 
produce the herein reported teratogenic effects, was predicted to occur in surface 
waters from a tidal river in UK (Vyas et al., 2014) receiving hospital wastewaters with 
oncology ward burden. However, it is important to stress that sources of Pt from 
platinum-based drugs coexist with, typically much larger, inputs from vehicle 
emissions in the urban setting. In the case of CP, levels far superior to 50 ng L-1 of CP, 
able to cause embryotoxicity in E. lucunter, were already measured in surface waters 
from Australia, Romania and Thailand (Busetti et al., 2009; Moldovan, 2006; 
Usawanuwat et al., 2014). To date, environmental screening of anticancer molecules 
was not yet executed in the Brazilian coastal zone, neither in any other region from 
Latin America. In contrast to the effects elicited by both cytotoxic drugs, a non-
monotonic dose-response relationship was observed in embryos exposed to TAM, at 
which the lowest concentration 0.5 ng L-1 caused significant teratogenicity (Figure 
6.2). In reference to the criteria proposed by the regional environmental guidelines 
established in São Paulo (Brazil) (CETESB, 1999), it is noteworthy that a significant 
sensitivity of this biological model was registered in the present study, which confirms 
its reliability as a tropical biological model counterpart in the toxicity assessment of 
anticancer drugs, such as its feasible performance by features as low cost and test 
duration (Hutchinson et al., 1998; Aguirre-Martínez et al., 2016).  
In the bioassays conducted with the sediment-dwellers biological models, in 
spiked sediment with mixtures, T. viscana demonstrated a higher sensitivity to 
pharmaceuticals compared to S. squamata, in a way that the survival response was also 
characterized by a non-linear reduction of survival in Mix B and D. According to 
Lagarde et al. (2015), such non-monotonic profile has been typically linked to 
endocrine disrupting compounds, with reports of similar ecotoxicological effects in 
experiments conducted with aquatic organisms (Morales et al., 2018; Teng et al., 
2018) and on pharmacological studies developed with human cell lines (Mater et al., 
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2014; Vandenberg et al., 2014, 2012; Lagarde et al., 2015). The present non-
monotonic dose relationship suggests the presence of a nuclear estrogen-like receptor, 
thus requiring further refined characterization of nuclear ERs and its ligand-induced 
transcriptional activation. Sequencing of cDNA encoding for ERs, analysis of its 
expression and homologies with vertebrate counterparts are further steps for a more 
comprehensive application of tropical indigenous species, not only regarding 
endocrine disruptive ability of receptor modulators at environmental trace levels, but 
also to understand the key role that ERs play in cell growth or maintenance (Lv et al., 
2017). The present findings from sediment spiking procedure conducted with both 
tropical species of amphipods and polychaetes pinpoint the relevance of the sediment 
compartment as an essential target of study on environmental impacts of anticancer 
drugs, even as if an acute endpoint, which actually depicts a reasonable concern in 
view of the detrimental effects reported over survival at low ng L-1. 
7.2.6 Anticancer drugs in an Environmental Risk Perspective 
In Europe, the environmental legislation framework involved in the definition 
of protective measures for aquatic pollutants is represented by a broad set of policies 
that directly or indirectly encompass the issue of conventional pharmaceuticals. The 
Marine Strategy Framework Directive of the European Union (Directive 
2008/56/2008) establishes that each country member is responsible for conducting its 
monitoring in accordance to particularities of coastal and marine regions, also 
connected with other transversal policies. In addition, as part of the strategy 
implemented by the Directive 2013/39/EU, all the member states shall monitor the 
emerging risks prone by each pharmaceutical compound (Pereira et al., 2016b). This 
is also an issue that must be gauged and circumscribed by action plans under the global 
agenda of Sustainable Development Goals, established by United Nations. In contrast, 
anticancer drugs still face several limitations and gaps in the set of environmental 
assessment, since many of them were formulated before the new criteria for 
authorization and release in the pharmaceutical market (EMA, 2006). In this sense, 
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CisPt, CP and TAM are just some of the anticancer molecules not assisted in terms of 
risk control.  
The European Medicine Agency guideline proposed a trigger value of PEC of 
10 ng L-1, as a limit that separates the exposure estimation in the first phase of the 
environmental risk assessment from the test requirements in the subsequent second 
phase (Kummerer et al., 2016). With regard to the review of literature, both CP and 
TAM needed to be examined with toxicity tests. According to the present toxicological 
outcomes, harmful biochemical effects occurred even at sub ng L-1, as verified in the 
single drug exposure of TAM to N. diversicolor. Regardless of the value established 
by ERA, the scientific validity for determining an “action limit” approach may be 
questioned, particularly for this endocrine disruptive drug. This compound is fitted 
together with other endocrine disruptor chemicals that trigger an overall trend of non-
monotonic dose-response and, therefore, does not conceive a safe dose and must be 
addressed irrespective of the quantity released into the environment (EMA, 2006).  
The non-monotonicity represents a challenge to fundamental concepts in 
toxicology and standardized approaches for investigating this aspect within the risk 
assessment context are still missing (Vandenberg et al., 2014; Lagarde et al., 2015). 
Another parameter entangled in the TAM assessment is that even though this 
compound remain in Phase I because of a PEC of water column below the action limit, 
its log Kow is > 4.5, thus the assessment is recommended through another technical 
guidance, in line with the European approach for risk assessment of general industrial 
chemicals in the context of REACH regulation (Registration, Evaluation, 
Authorization and Restriction of Chemicals) (ECHA, 2008). 
In accordance to the thesis´ findings, it can be assumed that a traditional dose-
response toxicity profile, to which a threshold level is associated, is not appropriate to 
set up protection measures also for the cytotoxic agents CisPt and CP. These results 
challenge risk assessment dogma, as an issue stemming primarily from the scarcity of 
relevant ecotoxicity data on aquatic non-target organisms. Such compounds interact 
directly with DNA and are therefore of special concern to be considered in-depth in 
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Phase II of the EMA guideline (EMA, 2006). However, at that point, the purpose of 
the analysis is to predict the concentration of the substance for which adverse effects 
were not expected to occur, by the use of standardized bioassays conducted with algae 
growth inhibition endpoint, Daphnia sp. reproduction test and the early life stage test 
with fish. In addition to the urgency of a commitment with the marine species 
counterparts and data generation, ecotoxicological approaches from now on developed 
with anticancer drugs should include discussions whether the analysed endpoints 
applied in a risk assessment are in fact consistent to their designed biological effects 
(Booker et al., 2014; Kummerer et al., 2016). Besides, the use of more sensitive 
species, including those sediment-dwelling ones, is highly required, with application 
right on the first step of an ERA in the marine context. Herein, the use of a battery of 
biochemical biomarkers with the polychaete N. diversicolor reinforced the application 
of this biological model in the assessment of sublethal changes triggered by 
pharmaceuticals, particularly in regard to this potent therapeutical class of drugs.  
Another restraint of this tiered approach regards to the expression of a degree 
of uncertainty through the extrapolation from the test data to the real environment, 
since pharmaceuticals do not occur isolated. It relies on covering the additional risk of 
unknown components in a non-defined mixture, by applying an additional assessment 
factor of 10 to account for ‘mixture uncertainty’, in every single-substance assessment 
(Backhaus and Karlsson, 2014). On the other hand, in accordance to the Brazilian 
environmental reality (probably similar to other developing countries), sources of 
oncological waste are most likely to feed into municipal waste systems and discharged 
directly into the surface/coastal waters via straight-piping of raw sewage. The national 
concern regarding pharmaceuticals in the environment is currently hampered only by 
tools to provide the proper discard of waste from hospital and health care services, 
according to the Brazilian Constitutional text (Art. 200) that attributes the role of 
control and monitoring of substances and medical procedures to the National Health 
System, jointly to the Federal Resolution CONAMA 358/2005 (Brazil, 2005). This set 
of laws acts in order to avoid illicit practices that would generate harmful discards to 
the environment, besides affording the duty to the responsible parties to execute 
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actions for the appropriate and responsible waste management, from its generation 
until the destination. According to the law, the antineoplastic drugs must be treated by 
means of “reuse, recuperation or recycling” or “specific treatment and disposal (Brazil, 
2005). It is important to point out that according to this legislation, effluents containing 
a cytotoxic burden are jointly inserted in the group of chemicals able to be “discharged 
into water bodies or public sewage system, as long as complying the guidelines from 
environmental agencies and water resources managers”, with the absence of 
requirements for an environmental screening and monitoring of molecules in the 
aquatic compartment. At a federal aegis of decision-making, the scenario of dialogue 
with scientific production and background about the risk of pharmaceutical in 
Brazilian coastal waters is still incipient or missing. Developing nations, as Brazil, 
should ground their environmental legislation to practices developed and successfully 
experienced by Northern countries. 
 It is of high priority that these regions generate a wide background of 
information regarding the sensitivity of tropical biological models towards anticancer 
exposures, in accordance to a range of environmental concentrations recommended to 
soon get discovered in coastal zones. As showed in this investigation, 
tropical/subtropical species seem to be more sensitive to anticancer drugs than 
temperate organisms. Furthermore, knowledge of possible overseen risks associated 
with the introduction of such substances into the aquatic environment can help to 
propose a proper environmental framework that include the assessment of these 
molecules and that can also underline the demand for suitable technologies of 
wastewater treatment from the municipal burden, and also hospital/oncology wards. 
Such measures must be taken before critical ecologic and human health problems take 
place due to long-term exposure, assuming the perception that invest in pollution 
prevention is preferable than remediation and restoration actions, with the pertinent 
logic to minimize both risks and public cost. The overall environmental issue of this 
particular class of anticancer agents diverges substantially from those over-the-
counters´groups, which introduction into waterways is able to be minimized through a 
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variety of individual actions by population, such as the proper disposal of the 
traditional medicines employed.  
7.3 Conclusions 
Altogether, the multibiomarker approach herein applied revealed that the 
occurrence of anticancer agents, at a realistic range of concentrations in the aquatic 
environment, are able to disrupt the burrowing behaviour, biochemical and antioxidant 
status, cause neurotoxicity, oxidative damage and genotoxicity in N. diversicolor, right 
in agreement to drug´s designed MoAs over cancer treatment, which then confirms 
their unspecific toxicity not only to normal growing cells, as already reported to 
humans, but also to non-target organisms. Besides, results collectively indicated that 
CisPt and CP loads into water column exert hazardous effects in the sediment 
compartment even though the physico-chemical properties of these hydrophilic drugs 
do not lead to estimates of risks towards subtropical and temperate sediment dwelling 
species, thus highlighting the sediment compartment as an important repository of 
these harmful molecules in the marine environment. It is relevant to remark that TAM, 
assumed to comprise a targeted therapy on nuclear estrogen receptors, also altered 
significantly the biochemical parameters and depicted a genotoxic potential. The 
present thesis also confirmed that research and regulatory frameworks shall adjust the 
environmental pollution perspective to the scenario of anticancer drugs´pollution, 
which indicated non-monotonic profiles of toxicity responses at trace concentrations 
of single-drug and combined exposures, both in tropical and temperate biological 
models. In addition, it is noteworthy to reinforce that the sublethal responses obtained 
through drug´s exposures, individually, are not enough to predict the effects offered 
by these pharmaceuticals when combined.  
There is a scarcity of knowledge about the environmental impacts posed by 
these anticancer agents in the aquatic ecosystems, therefore, a monumental gap 
between decision making gathered to this issue in developed and developing regions. 
Although contrasting, challenges currently faced represent a typical shortage related 
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to political and economical realities of each country, which must be assumed as a 
priority to the progress in the sanitary and ecological perspectives. Dialogues across 
disciplines connected to new drug design and manufacturing, WWTPs engineering, 
environmental chemistry and ecotoxicology must be conducted to gather new 
solutions to control and minimize pollution by anticancer agents, and therefore risks 
to environmental and health, that cannot be dissociated from any other aspects of 
sustainable living. 
7.4 Future Perspectives  
• In light of the evidence of the multiple toxicity effects of anticancer identified 
throughout this thesis and the strength of their presence in the marine environment, it 
is crucial that further research are committed not only to investigate the several 
biological mechanisms that still need to be clarified in marine non-target organisms, 
but also to ultimately engender reasonable attention to their input in water bodies 
worldwide, under the spectra of priority and hazardous substances. To that end, the 
following key points represent relevant aspects to be considered for future 
approaches, from environmental features to pharmacokinetic particularities of drugs 
in exposed species: 
• Perform environmental assessments and monitoring of the current realistic 
concentrations of anticancer agents and their active metabolites present in coastal 
waters and sediments worldwide, also quantifying their respective bioaccumulation in 
tissues of representative species, both in developed and under-development regions, in 
order to set up a panorama of drug distribution and exposure scenarios across the 
global coastal zones. 
• Assess whether bioavailability and reactivity of CisPt, CP and TAM vary 
according to environmental changes of ionic strength (or changes in physical-chemical 
properties, such as pH, Eh and temperature), depicting the relevance of estuarine water 
course. 
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• Evaluate drug-resistance mechanisms activated in representative marine species 
during exposure to the cytotoxic CisPt, individually and in mixture with other 
anticancer compounds. 
• Target the signaling pathways and caspase activity in representative marine 
species, in order to confirm the efficacy of the ultimate MoA of anticancer drugs at 
environmentally relevant levels. 
• Investigate the MoA involved in the metabolic activation of the prodrugs CP and 
TAM in marine species. 
• Identify and characterize of estrogen-like receptors in marine organisms, and the 
interference of TAM in endocrine metabolism and cell proliferation. 
•  Estimate species sensitivity distributions (SSDs) on the basis of laboratory 
toxicity data for a wide array of marine organisms, in order to demonstrate differences 
in sensitivities derived in tropical and temperate zones, as well as determine potential 
non-monotonic profiles of responses. 
• Determine shifts in protein and gene profile expressions (based on genomics, 
metabolomics, transcriptomics and proteomics), thus subsidizing the identification of 
precise metabolism pathways of anticancer agents and the selection of profitable 
biomarkers. 
• Considering the genotoxic and mutagenic potential of anticancer agents, 
investigate their potential to trigger mechanisms of cancer generation in non-target 
organisms. 
•  Propose dialogues across environmental health scientists, toxicologists, and risk 
assessors to determine how the low-dose effects and non-monotonic dose responses 
influence a specific risk assessment to anticancer agents. 
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• Foster fellowships across medical research in an attempt to forewarn this science 
branch about drug´s cradle-to-grave and encourage its active involvement on 
environmental stewardship, including ecological and human health consequences, 
with an emerging discussion of the overall issue in the root of medical literature. 
• Engage society in scientific debates as part of the environmental responsibility in 
aquatic pollution regarding the consumption of pharmaceuticals in general, 
highlighting the individual conduct as a measure to prevent and control impacts. 
• Expand sewage connection and implement efficient WWTPs´ technologies able 
to reduce the pharmaceuticals burden, particularly in regions reliant on septic tanks or 
small decentralized systems for sewage treatment disposal. 
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